<chapter label="CHAPTER 8" id="ch0008">
<title><emphasis role="strong">Renal and Urinary Tract Disorders</emphasis></title>
<sect1 id="ch0008s0244"><title><emphasis role="strong">ACUTE KIDNEY INJURY (ACUTE RENAL FAILURE)</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis></para>
<para>Acute kidney injury (AKI) has been defined as a sudden decrease in kidney function that happens within a few hours or few days, which may or may not be associated with a decrease in urine output, and is usually marked by a rise in serum creatinine concentration or by azotemia (a rise in blood urea nitrogen [BUN] concentration). The term <emphasis>acute renal failure</emphasis> is used when the kidney injury results in the need for renal replacement therapies (RRT), including (but not limited to) intermittent hemodialysis.</para>
</listitem>
<listitem><para><emphasis role="strong">Stages and Phases (Dirkes, 2015; Palevsky, 2017)</emphasis></para>
<para>Several classifications have been used over time to describe kidney failure. In recent years, more work has been applied to defining and classifying acute kidney injury (formerly called acute renal failure) including:</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>In 2012, the Kidney Disease Improving Global Outcomes (KDIGO) work group released clinical practice guidelines for AKI to improve definition and staging criteria. These define AKI as <emphasis role="strong">any</emphasis> of the following:</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Increase in serum creatinine by 0.3 mg/dL or more within 48 hours, <emphasis role="strong">OR</emphasis></para></listitem>
<listitem><para>Increase in serum creatinine to 2.5 times baseline or more within the last 7 days, <emphasis role="strong">OR</emphasis></para></listitem>
<listitem><para>Urine output less than 0.5 mL/kg/h for 6 hours (Acute Kidney Injury Work Group, 2012).</para>
</listitem></orderedlist></listitem>
<listitem><para>AKI has four phases, described as:</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Onset: has a triggering event, renal blood flow is diminished; lasts hours to days</para></listitem>
<listitem><para>Oliguric/anuric: BUN and creatinine (Cr) are elevated; electrolyte and acid base disturbances present; may last 8 to 14 days (or longer), depending on cause and renal replacement therapies.</para></listitem>
<listitem><para>Diuretic: occurs as AKI is corrected; increased glomerular filtration rate (GFR); typically lasts 1 to 2 weeks</para></listitem>
<listitem><para>Recovery: normalization of fluid and electrolyte imbalances. GFR returns to 70% to 80% of normal; lasts several months to a year.</para>
</listitem></orderedlist></listitem>
<listitem><para>Urine output phases are described as anuria, oliguria, and nonoliguria and can point to causes of AKI. <emphasis>Note:</emphasis> Approximately 50% to 60% of all causes of AKI are nonolguric (Workeneh et al, 2017).</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Anuria (&lt;100 mL/d): may be associated with such conditions as urinary tract obstruction, renal artery obstruction, rapidly progressive glomerulonephritis, and bilateral diffuse renal cortical necrosis</para></listitem>
<listitem><para>Oliguria (100&ndash;400 mL/d): may be associated with conditions such as prerenal failure and hepatorenal syndrome</para></listitem>
<listitem><para>Nonolguria (&gt;400 mL/d): may be associated with conditions such as acute interstitial nephritis, acute glomerulonephritis, partial obstructive nephropathy, nephrotoxic and ischemic acute tubular necrosis (ATN), radiocontrast-induced AKI, and rhabdomyolysis</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology (National Kidney Foundation, 2017; Workeneh et al, 2017)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Multiple causes include conditions causing decreased blood flow (prerenal), diseases or conditions causing direct damage to kidney (intrarenal), and blockage of structures of the urinary tract (postrenal).</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Prerenal failure: blood volume depletion due to hemorrhage, &ldquo;third-space&rdquo; sequestration of fluid as in edema or ascites in advanced liver disease, or burns; dehydration due to gastrointestinal (GI) losses or overuse of diuretics; septic or anaphylactic shock; heart failure (HF) with renal insufficiency, myocardial infarction (MI), trauma; renal artery obstruction; and certain nephrotoxic drugs, such as nonsteroidal anti-inflammatory drugs (NSAIDs), cyclooxygenase inhibitors, angiotensin-converting enzyme (ACE) inhibitors; synthetic cannabinoids (SCs).</para></listitem>
<listitem><para>Intrarenal (intrinsic) failure: resulting from direct injury with structural and functional damage to kidney from ischemia, hypoperfusion, and primary kidney disease. Can be caused by infections (<emphasis>Note:</emphasis> Sepsis is one of the most common causes of AKI); blood transfusion reaction, renal artery stenosis; and direct damage from nephrotoxic substances, such as radiocontrast media, cyclosporine, heavy metals (e.g., lead, mercury), cytotoxic drugs (e.g., certain chemotherapy agents), and certain antibiotics (e.g., carbenicillins, aminoglycosides).</para></listitem>
<listitem><para>Postrenal failure: most commonly occurs with stones in the ureters, bladder, or urethra; from trauma or edema associated with infection, prostatic hypertrophy, or cancer; cervical cancer; strictures of renal artery</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Risk factors</emphasis>&mdash;While there are many risk factors, the older client (75 or older) is at particular risk. This may be due to age-related structural and functional changes in the kidney; comorbid conditions (e.g., diabetes, hypertension, influenza, sepsis, heart or liver failure), polypharmacy (including a variety of nephrotoxic drugs) and an increase in hospitalizations, and high-risk medical and surgical procedures (Thornburg &amp; Gray-Vickrey, 2016; Workeneh et al, 2017).</para></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: Infections commonly complicate the course of AKI and have been reported to occur in as many as 33% of patients with AKI. Neurologic signs of uremia are a common complication of AKI and have been reported in approximately 38% of patients with AKI (Workeneh et al, 2017). In one study, survivors of severe AKI had an unfavorable health-related quality of life (mentally and physically) compared with general population (Wang et al, 2015).</para></listitem>
<listitem><para>Mortality: One recent study revealed that while acute kidney injury requiring dialysis (AKI-D) admissions are on the rise, hospital mortality for AKI-D has declined significantly between 2001 and 2011 (Brown et al, 2016).</para></listitem>
<listitem><para>Costs: A recent study based on 2012 figures found that AKI in the United States was associated with increased hospitalization costs of $7933 per patient/per day compared to patients without AKI and that costs were comparable to those for stroke, pancreatitis, and pneumonia (Zeng et al, 2014).</para>
</listitem></orderedlist></listitem></orderedlist>
<note id="ch0008s0244note0616">
<title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Acute tubular necrosis (ATN):</emphasis> Structural injury or tissue necrosis within the kidney, caused by ischemia or toxic injury. Necrosis is usually patchy, but injury can be widespread. ATN should be suspected in any individual presenting after a period of hypotension secondary to cardiac arrest, hemorrhage, sepsis, drug overdose, or surgery.</para>
<para><emphasis role="strong">Anuria:</emphasis> Urine output less than 100 mL/d.</para>
<para><emphasis role="strong">Azotemia:</emphasis> Buildup of nitrogenous waste products, specifically urea, in the blood.</para>
<para><emphasis role="strong">Calculus:</emphasis> Mass of solid material or metabolic substance&mdash;kidney or bladder stone.</para>
<para><emphasis role="strong">Catabolic:</emphasis> Destructive metabolism, or breakdown, of proteins for energy results in muscle wasting, loss of lean muscle mass, and negative nitrogen balance.</para>
<para><emphasis role="strong">Glomerular filtration rate (GFR):</emphasis> Rate of fluid filtration through the kidney glomeruli.</para>
<para><emphasis role="strong">Glomerulonephritis:</emphasis> Inflammation of the glomerular capillary walls, causing impaired filtration.</para>
<para><emphasis role="strong">Hydronephrosis:</emphasis> Kidney enlargement caused by urine backing up from the bladder into the kidney or inability of urine to drain from the kidney into bladder; excessive reflux stretches the kidney, causing functional damage to it.</para>
<para><emphasis role="strong">Myoglobin:</emphasis> Form of hemoglobin found in muscle tissue and released into urine when tissue damage occurs.</para>
<para><emphasis role="strong">Nephrotoxins:</emphasis> Chemical substances, including medications that can cause kidney damage.</para>
<para><emphasis role="strong">Nonoliguric AKI:</emphasis> Urinary output more than 400 mL/d.</para>
<para><emphasis role="strong">Oliguria:</emphasis> Urinary output less than 400 mL/d.</para>
<para><emphasis role="strong">Orthostatic hypotension:</emphasis> Decrease in blood pressure when person rises from seated or lying position; often associated with hypovolemia.</para>
<para><emphasis role="strong">Parenchymal disease:</emphasis> Connective tissue of the kidney is damaged and scarred.</para>
<para><emphasis role="strong">Polyuria:</emphasis> Excretion of large amounts (2&ndash;6 L/24 hr) of urine, lacking concentration and regulation of waste products; occurs during diuretic phase of AKI, with head injury (diabetes insipidus [DI]) and diabetic ketoacidosis (DKA).</para>
<para><emphasis role="strong">Porphyrins:</emphasis> Nitrogen-containing chemical components of hemoglobin.</para>
<para><emphasis role="strong">Pyelonephritis:</emphasis> Infection of the kidney&rsquo;s medulla or cortex.</para>
<para><emphasis role="strong">Renal replacement therapy (RRT):</emphasis> Umbrella term used for life-saving treatments for renal failure, including hemodialysis, peritoneal dialysis, hemofiltration, and renal transplantation.</para>
<para><emphasis role="strong">Uremia:</emphasis> Toxic clinical syndrome associated with fluid, electrolyte, and hormone imbalances and metabolic abnormalities due to deterioration of renal function and the deleterious effects of azotemia on organ systems.</para>
</note>
<sect2 id="ch0008s0245"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Client will be treated in inpatient acute medical, surgical, or intensive care unit.</para>
</sect2>
<sect2 id="ch0008s0246"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para>Fluid and electrolyte imbalances (see Davis<emphasis>Plus</emphasis>)</para>
<para>Metabolic acidosis&mdash;primary base bicarbonate deficiency (see Davis<emphasis>Plus</emphasis>)</para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0008s0254">Renal dialysis&mdash;general considerations</link></para>
<para><link linkend="ch0008s0249">Chronic kidney disease with end stage renal failure</link></para>
<para><link linkend="ch0013s0318">Sepsis/septicemia</link></para>
<para><link linkend="ch0006s0219">Total nutritional support: parenteral/enteral feeding</link></para>
<para><link linkend="ch0005s0144">Upper gastrointestinal bleeding</link></para>
<table frame="top" id="ch0008s0244ta0348"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">DIAGNOSTIC DIVISION<?lb?>MAY REPORT</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Fatigue, weakness, malaise</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Muscle weakness, loss of tone</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Hypotension or hypertension, including accelerated (malignant) hypertension, eclampsia, or gestational hypertension</para></listitem>
<listitem><para>Cardiac dysrhythmias associated with hyperkalemia and hypocalcemia</para></listitem>
<listitem><para>Weak, thready pulses; orthostatic hypotension (hypovolemia)</para></listitem>
<listitem><para>Jugular vein distention (JVD), full and bounding pulses (hypervolemia)</para></listitem>
<listitem><para>Generalized tissue edema, including periorbital area, ankles, sacrum</para></listitem>
<listitem><para>Pallor (anemia); bleeding tendencies</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ELIMINATION</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Change in usual urination pattern&mdash;increased frequency (early failure and early recovery) or decreased frequency or oliguria (later phase)</para></listitem>
<listitem><para>Dysuria, hesitancy, urgency, and retention (obstruction or infection)</para></listitem>
<listitem><para>Abdominal bloating, diarrhea, or constipation</para></listitem>
<listitem><para>History of benign prostatic hyperplasia (BPH) or kidney or bladder stones</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Change in urinary color; for example, ranges from absence of color to deep yellow, reddish-brown, and cloudy</para></listitem>
<listitem><para>Oliguria: Production of a small amount of urine with no other indicators (e.g., presence of stones or prostate enlargement) generally favors AKI. A gradually diminishing urine output may indicate a urethral stricture or bladder outlet obstruction due to prostate enlargement.</para></listitem>
<listitem><para>Polyuria: occurs during diuretic phase of AKI, with head injury (diabetes insipidus [DI]) and diabetic ketoacidosis (DKA).</para></listitem>
<listitem><para>Anuria: Abrupt anuria suggests acute urinary obstruction, acute and severe glomerulonephritis, or embolic renal artery occlusion (Workeneh et al, 2017).</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Nausea, anorexia, heartburn</para></listitem>
<listitem><para>Vomiting</para></listitem>
<listitem><para>Weight gain (edema), weight loss (dehydration)</para></listitem>
<listitem><para>Use of diuretics</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Changes in skin turgor and moisture</para></listitem>
<listitem><para>Edema&mdash;generalized, dependent</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Headache, blurred vision</para></listitem>
<listitem><para>Muscle cramps or twitching, &ldquo;restless leg&rdquo; syndrome, numbness, tingling</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Altered mental state&mdash;decreased attention span, inability to concentrate, loss of memory, confusion, decreasing level of consciousness (LOC) (azotemia, electrolyte and acid-base imbalance)</para></listitem>
<listitem><para>Twitching, muscle fasciculation, seizure activity</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Flank pain, headache</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Guarding or distraction behaviors, restlessness</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Shortness of breath</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Tachypnea, dyspnea, increased rate and depth; Kussmaul&rsquo;s respiration can be compensatory mechanism because of metabolic acidosis.</para></listitem>
<listitem><para>Cough productive of pink-tinged sputum (pulmonary edema)</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Recent transfusion reaction</para></listitem>
<listitem><para>Current or recent hospitalization (<emphasis>Note:</emphasis> Most community-acquired AKI is secondary to volume depletion; as many as 90% of cases are estimated to have a potentially reversible cause) (Sinert &amp; Peacock, 2015)</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Fever (sepsis, dehydration)</para></listitem>
<listitem><para>Petechiae, ecchymotic areas on skin</para></listitem>
<listitem><para>Pruritus, dry skin</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Family history of polycystic disease, hereditary nephritis, urinary calculus, malignancy</para></listitem>
<listitem><para>History of exposure to toxins, such as drugs (cyclosporine, amphotericin B, cocaine), environmental poisons (e.g., ethyl alcohol, ethylene glycol, mercury vapors, lead, cadmium, or other heavy metals), substance abuse</para></listitem>
<listitem><para>Current or recent use of nephrotoxic drugs, such as aminoglycoside antibiotics, amphotericin B; anesthetics; ACE inhibitors and vasodilators; NSAIDs such as ibuprofen, naproxen</para></listitem>
<listitem><para>Recent diagnostic testing with radiographic contrast media reaction</para></listitem>
<listitem><para>Concurrent conditions&mdash;tumors in the urinary tract, gram-negative sepsis, trauma or crush injuries, hemorrhage, disseminated intravascular coagulation (DIC), burns, electrocution injury, autoimmune disorders (e.g., scleroderma, vasculitis), vascular occlusion or surgery, diabetes mellitus (DM), cardiac or liver failure</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May require alteration or assistance with medications, treatments, supplies, transportation, and homemaker or maintenance tasks</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0008s0244ta0349"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST<?lb?>WHY IT IS DONE</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Kidney function studies:</emphasis></para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis>Note:</emphasis> BUN, Cr, GFR, and urine output have long been standard tests for assessing renal function. But recent research shows BUN and creatinine tests don&rsquo;t reflect real-time kidney function or accurately reflect the GFR or degree of tubular injury. Recently, the emphasis has been shifting from biomarkers indicating kidney failure to those that signal a change in kidney function.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Blood urea nitrogen (BUN):</emphasis> Measures the by-product of protein metabolism in the liver, filtered by the kidneys and excreted in urine.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevated BUN is highly suggestive of kidney dysfunction. <emphasis>Note:</emphasis> Although BUN can be affected by many factors, including drug therapy, nutritional status (including high protein intake), GI bleeding, trauma, and infection, and because BUN takes up to 24 hours to rise, it doesn&rsquo;t indicate when kidney injury occurred.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Creatinine (Cr):</emphasis> End product of muscle and protein metabolism filtered by the kidneys and excreted in urine.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>AKI presents clinically as a rapidly rising creatinine (Cr) over several hours or days. <emphasis>Note:</emphasis> Serum creatinine level is affected by the person&rsquo;s muscle mass, age, race, and gender. Also, it may not rise for 12 to 24 hours after kidney injury.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">BUN/Cr ratio:</emphasis> Ratio helps determine whether factors other than kidney failure are causing changes in the levels. Normal ratio is 10:1.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In normal individuals and in client with intrinsic renal disease, the BUN will be approximately 10 times that of Cr. Therefore, a BUN/Cr ratio considerably greater than 10 suggests a prerenal (decreased renal perfusion) or postrenal (obstruction) cause of renal failure.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">AKI biomarkers (e.g., cystatin C, kidney injury molecule 1 [KIM-1], neutrophil gelatinase-associated lipocalin [NGAL], interleukin-18 [IL-18])</emphasis></para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Research is currently being conducted regarding use of new biomarkers for more accurate, real-time indicators of AKI and need for renal replacement therapies (Dirkes, 2015; Siew et al, 2011).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Complete blood count (CBC):</emphasis> Battery of screening tests, which typically includes hemoglobin (Hgb); hematocrit (Hct); red blood cell (RBC) count, morphology, indices, and distribution width index; platelet count and size; and white blood cell (WBC) count and differential.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hgb is decreased in presence of acute blood loss or chronic anemia, which is the main hematologic effect of AKI. RBCs are often decreased because of increased fragility and decreased survival time. Elevated WBC count (leukocytosis) can point to infection (such as sepsis) as a cause of AKI (Workeneh et al, 2017).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Arterial blood gases (ABGs):</emphasis> Determines the pH and the percentage of oxygen, carbon dioxide, and bicarbonate in arterial blood.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Metabolic acidosis (pH less than 7.2) may develop because of decreased renal ability to excrete hydrogen and end products of metabolism. Bicarbonate is decreased.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Electrolytes or renalytes:</emphasis> Electrically charged minerals found in body tissues and blood in the form of dissolved salts. They help move nutrients into and wastes out of the body&rsquo;s cells, maintain water balance, and stabilize the body&rsquo;s pH level.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sodium&mdash;usually increased but may vary.</para>
<para>Potassium&mdash;elevated related to retention and cellular shifts (acidosis) or RBC hemolysis.</para>
<para>Rapid increase in K+ is common with AKI.</para>
<para>Chloride, phosphorus, and magnesium&mdash;usually elevated.</para>
<para>Calcium&mdash;commonly decreased in AKI and may require replacement.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum osmolality:</emphasis> Measures the amount of chemicals dissolved in the serum. Kidneys excrete or reabsorb water to keep osmolality in range of 280 to 300 mOsm/kg. Chemicals that affect serum osmolality include sodium, chloride, bicarbonate, protein, and glucose.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Higher-than-normal levels can indicate dehydration or renal tubular necrosis. Lower-than-normal levels are associated with fluid volume overload or syndrome of inappropriate antidiuretic hormone secretion (SIADH).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">URINE TESTS</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Volume:</emphasis> In AKI, volume is variable.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Often less than 400 mL/24 hr (oliguric phase), which occurs within 24 to 48 hours after renal insult. May be less than 100 mL/24 hr (anuric phase) or more than 400 mL/24 hr (nonoliguric) when renal damage is associated with nephrotoxic agents such as contrast media or antibiotics. <emphasis>Note:</emphasis> Recently, practitioners have been emphasizing the importance of the volume of urine output as a marker for AKI because it&rsquo;s easy to measure and directly reflects glomerular filtration rate (GFR)/kidney function in real time (Dirkes, 2015).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Color:</emphasis> Determine presence of RBCs, Hgb, myoglobin, and porphyrins.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Presence of RBCs is always pathologic (Workeneh et al, 2017). Reddish-brown, cola-, or tea-colored urine is suggestive of glomerular damage and acute tubular necrosis (ATN) or presence of myoglobin in the urine.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Specific gravity:</emphasis> Measures density of urine compared to water with normal range of 1.005 to 1.030.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased in poor renal perfusion. Decreased in kidney disease, such as glomerulonephritis and pyelonephritis with loss of ability to concentrate. Specific gravity that is fixed at 1.010 reflects severe renal damage.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">pH:</emphasis> Measures level of acidity.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Alkaline urine (pH greater than 7) can be found in urinary tract infections (UTIs) and renal tubular necrosis.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Osmolality or osmolarity:</emphasis> Measures the ratio of water and solutes, such as electrolytes, acids, and other metabolic wastes, processed by the kidneys and released in urine. When body fluid is balanced, normal urine osmolarity is in the range of 300 to 900 mOsm/L.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Urine with higher osmolarity is concentrated with less water and a higher solute load, indicating a prerenal cause. Urine with decreased osmolarity is dilute with few solutes, indicating that the cause of renal failure resides in the kidney itself.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Cr clearance:</emphasis> Calculates glomerular filtration rate (GFR) by measuring the amount of Cr cleared from the blood and filtered into urine in 24 hours.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Best indicator of overall kidney function, as reduced Cr clearance correlates with increased circulating creatinine.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Sodium:</emphasis> Determines hydration status and ability to conserve or excrete Na.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Usually increased if ATN is cause of AKI and if kidney is not able to reabsorb sodium, although it is typically decreased in other causes of prerenal azotemia.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Fractional excretion sodium (FeNa):</emphasis> Calculated measure of renal tubule function.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reveals inability of tubules to reabsorb sodium. Readings of less than 1% indicate prerenal disorders; higher than 1% reflects intrarenal disorders.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Protein:</emphasis> The protein most likely to appear in urine is albumin. The term <emphasis>albuminuria</emphasis> is sometimes used when a urine test detects albumin specifically.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>High-grade proteinuria (3 to 4+) strongly indicates glomerular damage when RBCs and casts are also present. Low-grade proteinuria (1 to 2+) and WBCs may be indicative of infection or interstitial nephritis. In ATN, proteinuria is usually minimal.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Casts:</emphasis> Tubules in the kidneys secrete proteins. Under some circumstances, these proteins precipitate out to form cylindrical impressions of the tubules called casts.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Usually signal renal disease or infection. Cellular casts with brownish pigments and numerous renal tubular epithelial cells are diagnostic of ATN. Red casts suggest acute glomerular nephritis.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">OTHER DIAGNOSTIC STUDIES</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Kidney/abdominal ultrasound:</emphasis> Imaging technique that uses high-frequency sound waves and a computer to create images of blood vessels, tissues, and organs.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluates existing renal disease and obstruction of the urinary collecting system. The degree of hydronephrosis does not necessarily correlate with the degree of obstruction.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Kidney, ureter, bladder (KUB) x-ray:</emphasis> X-ray of the abdomen, showing the kidneys, ureters, and bladder.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Demonstrates size and structure of kidneys, ureters, and bladder; reveals presence of abnormalities, such as cysts, tumors, or stones.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Computed tomography (CT) scan, with or without enhancement:</emphasis> X-ray procedure that uses a computer to produce a detailed picture of a cross section of the body.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ultrasound and computed tomography (CT) are modalities of first choice in renal imaging.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Magnetic resonance imaging (MRI):</emphasis> Imaging test that uses powerful magnets and radio waves to create pictures of the body. It does not use radiation.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Can be used in case of compromised renal function, severe contrast allergy, or in case radiation exposure is a problem (e.g., in children and pregnant women) or as a problem-solving modality when CT findings are nondiagnostic.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">CT or MRI urography:</emphasis> Examines the urinary tract before and after administration of intravenous contrast material that includes excretory phase images.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These tests provide detailed anatomic depiction of each of the major portions of the urinary tract&mdash;the kidneys, intrarenal collecting systems, ureters, and bladder&mdash;and thus allow for comprehensive evaluation of the entire urinary system at work. Magnetic resonance (MR) has the advantage of not using ionizing radiation and the potential to provide more functional information than CT.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Intravenous pyelogram (IVP) also called intravenous urography (IVU):</emphasis> X-ray examination and fluoroscopic visualization of the kidneys, ureters, and bladder using contrast material.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This test has largely been replaced by CT, CT urography, and MRI as the primary test for evaluating the urinary system (Fulgham &amp; Bishoff, 2011). However, it may be used alone or in combination with CT to identify filling defects such as caused by trauma, stones, or tumors.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Aortorenal angiography:</emphasis> Fluoroscopic examination using contrast to examine the renal blood vessels for signs of blockage or abnormalities.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determines if blood vessel blockage is reducing renal flow.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Endourology:</emphasis> Diagnostic and therapeutic operative procedures performed through instruments&mdash;cystoscopic, pelviscopic, or laparoscopic.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides direct visualization of urethra, bladder, ureters, and kidneys to diagnose problems or to biopsy or remove small lesions or calculi.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Renal biopsy</emphasis></para></listitem></itemizedlist>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be indicated when renal function does not return for a prolonged time.</para>
</entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0008s0247"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Reestablish or maintain fluid and electrolyte balance.</para></listitem>
<listitem><para>Prevent complications.</para></listitem>
<listitem><para>Provide emotional support for client and significant other (SO).</para></listitem>
<listitem><para>Provide information about disease process, prognosis, and treatment needs.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0008s0248"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Homeostasis achieved.</para></listitem>
<listitem><para>Complications prevented or minimized.</para></listitem>
<listitem><para>Current situation dealt with realistically by client/family.</para></listitem>
<listitem><para>Disease process, prognosis, and therapeutic regimen understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0008s0244note0617">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">excess Fluid Volume</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Compromised regulatory mechanism (renal failure)</para>
<para>Excessive sodium intake; excessive fluid intake</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Intake exceeds output, oliguria; alteration in specific gravity</para>
<para>Alteration in blood pressure (BP), increase in central venous pressure (CVP); jugular vein distention</para>
<para>Edema, weight gain over short period of time</para>
<para>Pulmonary congestion</para>
<para>Alteration in mental status, restlessness</para>
<para>Decrease in Hgb/Hct, electrolyte imbalance, azotemia</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Fluid Overload Severity</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate stabilized fluid volume as evidenced by balanced intake and output with urinary specific gravity and other laboratory studies near normal, stable weight and vital signs within client&rsquo;s normal range, and absence of edema.</para>
</note>
<note role="none" id="ch0008s0244note0618">
<table frame="top" id="ch0008s0244ta0350"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Hypervolemia Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Record accurate intake and output (I&amp;O). Include &ldquo;hidden&rdquo; fluids, such as intravenous (IV) antibiotic additives, liquid medications, ice chips, and frozen treats. Measure GI losses and estimate insensible losses, such as diaphoresis.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Low urine output less than 400 mL/24 hr may be first indicator of acute failure, especially in a high-risk client. Accurate I&amp;O are necessary for determining fluid replacement needs and reducing risk of fluid overload. <emphasis>Note:</emphasis> Hypervolemia occurs in the anuric phase of AKI.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor urine specific gravity.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Measures the kidney&rsquo;s ability to concentrate urine. In intrarenal failure, specific gravity is usually equal to or less than 1.010, indicating loss of ability to concentrate the urine.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Weigh daily at same time of day, on same scale, with same equipment and clothing.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Daily body weight is best monitor of fluid status. A weight gain of more than 0.5 kg/d suggests fluid retention.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess skin, face, and dependent areas for edema. Evaluate degree of edema (on scale of +1 to +4).</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Edema occurs primarily independent tissues of the body, such as hands, feet, and lumbosacral area. Client can gain up to 10 lb (4.5 kg) of fluid before pitting edema is detected. Periorbital edema may be a presenting sign of this fluid shift because these fragile tissues are easily distended by even minimal fluid accumulation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor heart rate, BP, and central venous pressure (CVP), if available.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tachycardia and hypertension can occur because of (1) failure of the kidneys to excrete urine, (2) excessive fluid resuscitation during efforts to treat hypovolemia or hypotension, and (3) changes in the renin-angiotensin system, which helps regulate long-term blood pressure and blood volume. <emphasis>Note:</emphasis> Invasive monitoring may be needed for assessing intravascular volume, especially in clients with poor cardiac function.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate lung and heart sounds.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fluid overload may lead to pulmonary edema and heart failure (HF), as evidenced by development of adventitious breath sounds and extra heart sounds. (Refer to ND: <link linkend="ch0006s0199note0487">risk for decreased Cardiac Output</link>, below.)</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess level of consciousness; investigate changes in mentation and presence of restlessness.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May reflect fluid shifts, accumulation of toxins, acidosis, electrolyte imbalances, or developing hypoxia.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Plan oral fluid replacement with client, within multiple restrictions. Intersperse desired beverages throughout 24 hours. Vary offerings, such as hot, cold, and frozen.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps avoid periods without fluids, minimizes boredom of limited choices, and reduces sense of deprivation and thirst.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Correct any reversible cause of AKI, such as replacing blood losses, discontinuing nephrotoxic drug, removing obstruction via surgery.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Current treatment for AKI is mainly supportive. Maintenance of circulating volume and correction of biochemical abnormalities are the primary goals of treatment. Kidneys may be able to return to near-normal functioning, thus preventing or limiting long-term residual effects.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Insert and maintain indwelling catheter, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Catheterization excludes lower tract obstruction and provides means of accurate monitoring of urine output during acute phase; however, indwelling catheterization may be contraindicated because of increased risk of infection.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory and diagnostic studies, such as the following:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>BUN, Cr</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assesses progression and management of renal dysfunction, failure. <emphasis>Note:</emphasis> Dialysis is indicated if ratio is higher than 10:1 or if therapy fails to correct fluid overload or metabolic acidosis.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Serum sodium</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hyponatremia may result from fluid overload (dilutional) or kidney&rsquo;s inability to conserve sodium. Hypernatremia indicates total body water deficit.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Serum potassium</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Lack of renal excretion or selective retention of potassium by the tubules leads to hyperkalemia, requiring prompt intervention.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hgb/Hct</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased values may indicate hemodilution associated with hypervolemia; however, during prolonged failure, anemia frequently develops as a result of decreased RBC production. Other possible causes&mdash;active or occult hemorrhage&mdash;should also be evaluated.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Serial chest x-rays</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased cardiac size, prominent pulmonary vascular markings, pleural effusion, and infiltrates indicate acute responses to fluid overload or chronic changes associated with renal failure and HF.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer and restrict fluids, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fluid management is usually calculated to replace output from all sources as well as estimate insensible losses due to metabolism and diaphoresis. Prerenal failure is treated with volume replacement and vasopressors. The oliguric client with adequate circulating volume or fluid overload who is unresponsive to fluid restriction and diuretics requires dialysis.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medication, as indicated, for example:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Diuretics, such as furosemide (Lasix), bumetanide (Bumex), torsemide (Demadex), and mannitol (Osmitrol)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Given early in oliguric phase of AKI in an effort to convert to diuretic phase, flush the tubular lumen of debris, reduce hyperkalemia, and promote adequate urine volume.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Vasodilators, such as fenoldopam (Corlopam)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be given to decrease systemic vascular resistance (SVR) and increase renal blood flow. It has been noted to improve renal function in patients with severe hypertension.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antihypertensives, such as clonidine (Catapres), methyldopa (Aldomet), and prazosin (Minipress)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be given to treat hypertension by counteracting effects of decreased renal blood flow and/or circulating volume overload.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for renal replacement therapy (RRT) as indicated, such as hemodialysis (HD), peritoneal dialysis (PD), or continuous renal replacement therapy (CRRT).</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Done to reduce volume overload, correct electrolyte and acid-base imbalances, and remove toxins. The type of dialysis chosen for AKI depends on the degree of hemodynamic compromise and client&rsquo;s ability to withstand the procedure. <emphasis>Note:</emphasis> Although it technically can be used, peritoneal dialysis is not frequently used in patients with AKI (Workeneh et al, 2017). (Refer to CP: <link linkend="ch0008s0254">Renal Dialysis</link>.)</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0244note0619">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for decreased Cardiac Output</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Altered preload&mdash;fluid deficit, hypovolemia caused by vasodilation, insufficient intake, excessive fluid losses</para>
<para>Altered afterload&mdash;fluid overload, fluid shifts (venous distention)</para>
<para>Alteration in heart rate or rhythm (e.g., potassium, calcium imbalance; uremic effects on cardiac muscle)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Cardiac Pump Effectiveness</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain cardiac output as evidenced by BP and HR and rhythm within client&rsquo;s usual limits and peripheral pulses strong and equal, with appropriate capillary refill time.</para>
</note>
<note role="none" id="ch0008s0244note0620">
<table frame="top" id="ch0008s0244ta0351"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Hemodynamic Regulation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor BP and heart rate.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fluid volume excess, combined with hypertension, which often occurs in renal failure, and effects of uremia increase cardiac workload and can lead to cardiac failure. In AKI, cardiac failure is usually reversible.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe electrocardiogram (ECG) or telemetry for changes in rhythm.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes in electromechanical function may become evident in response to accumulation of toxins and electrolyte imbalance. For example, hyperkalemia is associated with a peaked T wave, wide QRS complex, prolonged PR interval, and flattened or absent P wave. Hypokalemia is associated with flattened T wave, peaked P wave, and appearance of U waves. Prolonged QT interval may reflect calcium deficit.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate heart sounds.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Development of S<subscript>3</subscript>/S<subscript>4</subscript> is associated with fluid volume excess and congestive HF. Pericardial friction rub may be only manifestation of uremic pericarditis, requiring prompt intervention and, possibly, acute dialysis.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess color of skin, mucous membranes, and nailbeds. Note capillary refill time.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pallor may reflect vasoconstriction or anemia&mdash;common in AKI, whether associated with actual blood loss or abnormalities in life of RBCs. Cyanosis is a late sign and is related to pulmonary congestion or cardiac failure. A long capillary refill time is associated with hypovolemic states.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note occurrence of cardiac dysrhythmias and changes in blood pressure, especially when accompanied by mental status changes, muscle and generalized weakness.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These are clinical manifestations of magnesium deficiency (along hypocalcemia and hypokalemia) and include risk of cardiac arrest. <emphasis>Note:</emphasis> Magnesium deficiency in AKI has been associated with nonrecovery of renal function in the intensive care unit (ICU) population (Fulop et al, 2017; Tomasi et al, 2013)</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Investigate reports of muscle cramps, numbness or tingling of fingers, with muscle twitching and hyperreflexia.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These are symptoms of hypocalcemia. Calcium levels are typically somewhat decreased with AKI. If phosphorus levels are also high, hypocalcemia can become severe, which can also affect cardiac contractility and function.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain bedrest or encourage adequate rest and provide assistance with care and desired activities.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces oxygen consumption and cardiac workload.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory studies, such as the following:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Potassium</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>During oliguric phase, hyperkalemia is present but often shifts to hypokalemia in diuretic or recovery phase. Any potassium value associated with ECG changes requires intervention. <emphasis>Note:</emphasis> A serum level of 6.5 mEq or higher constitutes a medical emergency.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Calcium</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In addition to its own cardiac effects, calcium deficit enhances the toxic effects of potassium.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Phosphorus</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be abnormal because of reduced renal excretion or excess release of cellular phosphate.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Magnesium</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In acute renal failure, hypermagnesemia can occur during the oliguric phase, then return to normal during the diuretic phase. If a client receives exogenous magnesium (e.g., magnesium-containing laxative or antacid) during the oliguric phase, severe hypermagnesemia can result, especially if the patient is acidotic. Dialysis or calcium administration may be necessary to combat the CNS-depressive effects of an elevated serum magnesium level.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer and restrict fluids as indicated. (Refer to NDs: <link linkend="ch0008s0244note0617">excess Fluid Volume</link> and <link linkend="ch0008s0244note0621">risk for deficient Fluid Volume</link>.)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cardiac output depends on circulating volume&mdash;affected by both fluid excess and deficit&mdash;and myocardial muscle function.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide supplemental oxygen, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maximizes available oxygen for myocardial uptake to reduce cardiac workload and cellular hypoxia.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inotropic agents</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be used to improve cardiac output by increasing myocardial contractility and stroke volume.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Calcium gluconate</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Serum calcium is often low but usually does not require specific treatment in AKI. Calcium gluconate may be given to treat hypocalcemia and to offset the effects of hyperkalemia by modifying or reducing cardiac irritability.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aluminum hydroxide gels (Amphojel, Basalgel)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased phosphate levels may occur as a result of failure of glomerular filtration and require use of phosphate-binding antacids to limit phosphate absorption from the GI tract.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Glucose and insulin solution</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Temporary measure to lower serum potassium by driving potassium into cells when cardiac rhythm is endangered.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sodium bicarbonate or sodium citrate</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be used to correct metabolic acidosis or hyperkalemia by increasing serum pH if client is severely acidotic. Used with caution as it can exacerbate fluid overload and cause tetany by decreasing the ionized calcium concentration. Acidosis that does not respond to medical therapy is an indication for dialysis.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for and assist with dialysis, as necessary.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be indicated for persistent dysrhythmias and progressive HF unresponsive to other therapies.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0244note0621">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for deficient Fluid Volume</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Active fluid loss (e.g., excessive loss of fluid losses through urine, nasogastric [NG] or wound drainage; [diuretic phase of AKI])</para>
<para>Insensible losses&mdash;diaphoresis; fever</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Fluid Balance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Display I&amp;O near balance, good skin turgor, moist mucous membranes, palpable peripheral pulses, stable weight and vital signs, and electrolytes within normal range.</para>
</note>
<note role="none" id="ch0008s0244note0622">
<table frame="top" id="ch0008s0244ta0352"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Fluid Monitoring</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Measure I&amp;O accurately. Weigh daily.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps estimate fluid replacement needs. <emphasis>Note:</emphasis> Rising urinary volume and delayed return of tubular reabsorption capabilities may lead to hypovolemia.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Calculate insensible fluid losses.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fluid intake should approximate losses through urine, nasogastric (NG) or wound drainage, and insensible losses&mdash;diaphoresis and metabolism. <emphasis>Note:</emphasis> Some sources believe that fluid replacement should not exceed two-thirds of the previous day&rsquo;s output to prevent prolonging the diuresis.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage fluid intake. Provide allowed fluids throughout 24-hour period.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Diuretic phase of AKI may revert to oliguric phase if fluid intake is not maintained or nocturnal dehydration occurs.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor BP, noting postural changes, and heart rate.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Orthostatic hypotension and tachycardia suggest hypovolemia.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note signs and symptoms of dehydration, such as dry mucous membranes, thirst, dulled sensorium, and peripheral vasoconstriction.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In diuretic or postobstructive phase of renal failure, urine output can exceed 3 L/d. Extracellular fluid (ECF) volume depletion activates the thirst center, and sodium depletion causes persistent thirst, unrelieved by drinking water. Continued fluid losses and inadequate replacement may lead to hypovolemic state.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Monitor laboratory studies, such as sodium.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>In nonoliguric AKI or in diuretic phase of AKI, large urine losses may result in sodium wasting, while elevated urinary sodium acts osmotically to increase fluid losses. Restriction of sodium may be indicated to break the cycle.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0244note0623">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for Infection</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Chronic illness; malnutrition</para>
<para>Invasive procedures/devices; alteration in skin integrity</para>
<para>Immunosuppression; decrease in hemoglobin [anemia]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Infection Severity</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
<para>Experience no signs or symptoms of infection.</para>
</note>
<note role="none" id="ch0008s0244note0624">
<table frame="top" id="ch0008s0244ta0353"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Infection Protection</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Model and promote good handwashing by client and staff.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of cross-contamination.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoid invasive procedures, instrumentation, and manipulation of indwelling catheters whenever possible. Use aseptic technique when caring for IVs and invasive lines. Change site and dressings per protocol. Note edema and purulent drainage.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Limits introduction of bacteria into body. Early detection and treatment of developing infection may prevent sepsis.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide routine catheter care and promote meticulous perianal care. Keep urinary drainage system closed and remove indwelling catheter as soon as possible.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces bacterial colonization and risk of ascending urinary tract infection (UTI).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage deep breathing, coughing, and frequent position changes.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents atelectasis and mobilizes secretions to reduce risk of pulmonary infections. <emphasis>Note:</emphasis> Sepsis can be present when AKI occurs but also can follow AKI in a critically ill client.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess skin integrity. Note if client is scratching, reports itching. (Refer to CP: <link linkend="ch0008s0249">Renal Failure: Chronic</link>; ND: <link linkend="ch0008s0249note0639">risk for impaired Skin Integrity</link>.)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Excoriations from scratching may become secondarily infected.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor vital signs.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fever higher than 100.4&deg;F (38.0&deg;C) with increased pulse and respirations is typical of increased metabolic rate resulting from inflammatory process, although sepsis can occur without a febrile response.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor laboratory studies, such as WBC count with differential.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although elevated WBCs may indicate generalized infection, leukocytosis is commonly seen in AKI and may reflect inflammation or injury within the kidney. A shifting of the differential to the left is indicative of infection.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Obtain specimen(s) for culture and sensitivity and administer appropriate antibiotics, as indicated.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Verification of infection and identification of specific organism aids in choice of the most effective treatment. <emphasis>Note:</emphasis> A number of anti-infective agents require adjustments of dose or time while renal clearance is impaired.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0244note0625">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">deficient Knowledge regarding condition, prognosis, treatment, self-care, and discharge needs</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient information or interest in learning; insufficient knowledge of resources</para>
<para>Alteration in cognitive functioning or memory</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Insufficient knowledge</para>
<para>Inaccurate follow-through of instructions; development of preventable complications</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Kidney Disease Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of condition, disease process, prognosis, and potential complications.</para>
<para>Verbalize understanding of therapeutic needs.</para>
<para>Participate in learning process.</para>
<para>Initiate necessary lifestyle changes and participate in treatment regimen.</para>
</note>
<note role="none" id="ch0008s0244note0626">
<table frame="top" id="ch0008s0244ta0354"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review disease process, prognosis, and precipitating factors, if known.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides knowledge base from which client can make informed choices.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Explain level of renal function after acute episode is over.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may experience residual defects in kidney function, which may or may not be permanent.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss renal dialysis or transplantation if these are likely options for the future.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although these options would have been previously presented by the physician, client may now be at a point when options need to be considered and decisions made and may desire additional input.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review dietary plan and restrictions. Include fact sheet listing food and fluid restrictions.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Adequate nutrition is necessary to promote healing and tissue regeneration; adherence to restrictions may prevent complications.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client to observe characteristics of urine and amount and frequency of output.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes may reflect alterations in renal function and need for dialysis.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Establish regular schedule for weighing.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful tool for monitoring fluid and dietary status and needs.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review fluid intake and restriction (if indicated). Remind client to spread fluids over entire day and to include all fluids (e.g., ice) in daily fluid counts.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Depending on the cause and phase of AKI, client may need to either restrict or increase intake of fluids.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss activity restriction and gradual resumption of desired activity. Encourage use of energy-saving and relaxation techniques and diversional activities.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client with severe AKI may need to restrict activity and may feel weak for an extended period during lengthy recovery phase, requiring measures to conserve energy and reduce boredom and depression.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss reality of continued presence of fatigue.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased metabolic energy production, presence of anemia, and states of discomfort commonly result in fatigue.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine and prioritize activities of daily living (ADLs) and personal responsibilities. Identify available resources and support systems.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps client manage lifestyle changes that may be needed to meet personal and family needs.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend scheduling activities with adequate rest periods.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents excessive fatigue and conserves energy for healing and tissue regeneration.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review medication use. Encourage client to discuss all medications, including over-the-counter (OTC) drugs and herbal supplements, with healthcare provider.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Medications that are concentrated in or excreted by the kidneys can cause toxic cumulative reactions and permanent damage to kidneys. Some supplements may interact with prescribed medications and may contain electrolytes.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize necessity of follow-up care and laboratory studies.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Renal function can be slow to return&mdash;up to 12 months following AKI&mdash;and deficits may persist, requiring frequent monitoring to avoid complications.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Identify symptoms requiring medical intervention, such as decreased urinary output, sudden weight gain, presence of edema, lethargy, bleeding, signs of infection, and altered mental status.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Prompt evaluation and intervention may prevent serious complications and progression to chronic renal failure (CRF).</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0244note0627">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS</emphasis> following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">risk for imbalanced Fluid Volume (specify)</emphasis>&mdash;dependent on cause, duration, and stage of recovery</para></listitem>
<listitem><para><emphasis role="bi">Fatigue</emphasis>&mdash;disease state, malnutrition, anemia</para></listitem>
<listitem><para><emphasis role="bi">risk for Infection</emphasis>&mdash;immunosuppression, malnutrition, increased environmental exposure</para></listitem>
<listitem><para><emphasis role="bi">ineffective Health Management</emphasis>&mdash;complexity of therapeutic regimen, economic difficulties, perceived benefit/barriers</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0008s0249"><title><emphasis role="strong">RENAL FAILURE: CHRONIC KIDNEY DISEASE AND END-STAGE RENAL DISEASE</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Renal failure is the end result of chronic kidney disease (CKD), which is the consequence of gradual, progressive destruction of nephrons and decrease in glomerular filtration rate (GFR) over time, resulting in loss of kidney function that produces major changes in all body systems.</para></listitem>
<listitem><para>CKD is defined as an abnormality in kidney function or structure for more than 3 months and is classified based on cause, glomerular filtration rate (GFR) category, and albuminuria category (Kidney Disease Improving Global Outcomes [KDIGO], 2012; The Renal Association, 2017; Smith, 2016). The risk of CKD progressing to kidney failure increases as kidney function diminishes and/or urine protein (albuminuria) increases.</para></listitem>
<listitem><para>Client with CKD generally experiences progressive loss of kidney function and is at risk for end-stage renal disease (ESRD). The rate of progression is unique to the individual and depends on age, the underlying diagnosis, the success of preventive measures.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">CKD Stages (KDIGO, 2012; Pradeep, 2017)</emphasis> Chronic kidney disease is classified in stages G1 to G5 (based on the GFR) and A1 to A3 (based on the albumin to creatinine ratio [ACR]). These classifications correspond to the degree of nephron loss and changes in GFR and are used in conduction with other markers of kidney disease such as albuminuria, hematuria, and electrolyte abnormalities due to tubular disorders, renal histological abnormalities, and/or structural abnormalities detected by imaging. (<emphasis>Note:</emphasis> People with CKD stages 1 to 3 are frequently asymptomatic, and despite reduction in GFR, they do not experience clinically evident disturbances in water or electrolyte balance or endocrine/metabolic derangements.)</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Stage 1</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>GFR may be normal or slightly higher than normal (&gt;90 mL/min/1.73 m<superscript>2</superscript>).</para></listitem>
<listitem><para>Albuminuria (excretion &gt;30 mg/24 hr or albumin/creatinine ratio &gt;30 mg/g [&gt;3 mg/mmol])</para></listitem>
<listitem><para>Urine sediment abnormalities, electrolyte and other abnormalities (tubular disorders), and histological and structural abnormalities may be identified in lab or imaging studies.</para></listitem>
<listitem><para>Kidney dysfunction is present; however, it may be undiagnosed due to lack of symptoms.</para>
</listitem></orderedlist></listitem>
<listitem><para>Stage 2</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>GFR is mildly decreased (60 to 89 mL/min/1.73 m<superscript>2</superscript>), slight elevation in BUN/Cr</para></listitem>
<listitem><para>Albuminuria (excretion &gt;30 mg/24 hr or albumin/creatinine ratio &gt;30 mg/g [&gt;3 mg/mmol])</para></listitem>
<listitem><para>Urine sediment abnormalities, electrolyte and other abnormalities (tubular disorders), and histological and structural abnormalities</para></listitem>
<listitem><para>Client may be asymptomatic or have hypertension.</para></listitem>
<listitem><para>Polyuria and nocturia may be present&mdash;high-output failure.</para>
</listitem></orderedlist></listitem>
<listitem><para>Stages 3a and 3b</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Moderate reduction in GFR (45 to 59 mL/min/1.73 m<superscript>2</superscript>) <emphasis role="strong">in 3a</emphasis> and (30 to 44 mL/min/1.73 m<superscript>2</superscript>) <emphasis role="strong">in 3b</emphasis></para></listitem>
<listitem><para>Albuminuria (excretion &gt;30 mg/24 hr or albumin/creatinine ratio &gt;30 mg/g [&gt;3 mg/mmol])</para></listitem>
<listitem><para>Fluid and electrolyte abnormalities may be present but are not clinically significant.</para></listitem>
<listitem><para>Client may be asymptomatic or have hypertension.</para>
</listitem></orderedlist></listitem>
<listitem><para>Stage 4</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Severe reduction in GFR (15 to 29 mL/min/1.73 m<superscript>2</superscript>) and/or very high albuminuria (&gt;300 mg/24 hr)</para></listitem>
<listitem><para>Client has endocrine/metabolic derangements or disturbances in water or electrolyte balance, protein-energy malnutrition, loss of lean body mass, muscle weakness; peripheral and pulmonary edema</para></listitem>
<listitem><para>Timely referral to a nephrologist when glomerular filtration rate approaches 30 mL/min/1.73 m<superscript>2</superscript> is believed to improve ESRD outcome and appropriate selection of dialysis modality.</para>
</listitem></orderedlist></listitem>
<listitem><para>Stage 5</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>End-stage renal disease/kidney failure (GRF &lt;15 mL/min/1.73 m<superscript>2</superscript>, or on dialysis)</para></listitem>
<listitem><para>Client has metabolic acidosis, cardiovascular complications such as pericarditis, encephalopathy, neuropathies, and many other manifestations demonstrating end-stage disease.</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology (Pradeep, 2017)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Multiple causes, including (but not limited to):</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Primary renal (i.e., primary glomerular and tubular) disorders (e.g., polycystic kidney disease, glomerulonephritis, IgA nephropathy)</para></listitem>
<listitem><para>Acute tubular necrosis (ATN) from unresolved acute kidney injury (AKI)</para></listitem>
<listitem><para>Diabetes (40%) and hypertension (25.2%) are responsible for most cases of ESRD resulting in dialysis (Alper et al, 2017).</para></listitem>
<listitem><para>Chronic infections: glomerulonephritis, pyelonephritis, beta-hemolytic streptococci infection; hepatitis B and C; HIV; syphilis</para></listitem>
<listitem><para>Vascular diseases: hypertensive nephrosclerosis, renal artery stenosis, renal vein thrombosis, vasculitis</para></listitem>
<listitem><para>Obstructive processes: longstanding renal calculi, benign prostatic hyperplasia (BPH)</para></listitem>
<listitem><para>Cystic disorders: polycystic or medullary kidney disease</para></listitem>
<listitem><para>Collagen and connective tissue diseases: rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and collagen vascular disease</para></listitem>
<listitem><para>Tumors: malignant (multiple myeloma) or benign</para></listitem>
<listitem><para>Genetics: Although most cases of CKD are acquired, researchers have begun to identify genetic contributions to increased risk for development or progression of CKD.</para></listitem>
<listitem><para>Nephrotoxic agents: drugs, such as aminoglycosides, tetracyclines; contrast dyes; heavy metals, NSAIDs</para>
</listitem></orderedlist></listitem>
<listitem><para>Highest incidence of ESRD occurs in individuals older than age 70 years; men are 64% more likely than women to develop ESRD (although CKD is more common in women than men [16% vs 13%]), and African Americans are three times more likely than whites to have ESRD (Alper et al, 2017; Centers for Disease Control and Prevention [CDC], 2017; Pradeep, 2017).</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: In 2015, 124,111 new cases of end-stage renal disease (ESRD) were reported with a total of nearly 500,000 patients receiving dialysis treatment and well over 200,000 living with a kidney transplant (United States Renal Data System [USRDS], 2017).</para></listitem>
<listitem><para>Mortality: In 2013, adjusted mortality rates remained higher for Medicare patients with CKD (117.9/1000) than for those without CKD (47.5/1000), and these rates increased with CKD severity, although this gap narrowed during the period from 2001 to 2013 (National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK], 2016a). Deaths in the dialysis population are associated with (1) cardiovascular disease, (2) sepsis, and (3) cerebrovascular disease (Pradeep, 2017). Mortality rates continue to decrease for dialysis and transplant patients, having fallen by 28% and 40%, respectively, since 1996 (NIDDK, 2016a).</para></listitem>
<listitem><para>Cost: In 2015, the total Medicare spending for beneficiaries with kidney disease was nearly $100 billion. This included over $64 billion in spending for all Medicare beneficiaries who have CKD and another $34 billion for beneficiaries with ESRD (USRDS, 2017).</para>
</listitem></orderedlist></listitem></orderedlist>
<note id="ch0008s0249note0628">
<title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">ACR (albumin to creatinine ratio):</emphasis> Determines the relationship between the albumin and creatinine in the urine and estimates the amount of albumin excreted in 24 hours. A urine albumin-to-creatinine ratio above 30 mg/g is higher than normal.</para>
<para><emphasis role="strong">Acute tubular necrosis (ATN):</emphasis> Structural injury or tissue necrosis within the kidney, caused by ischemia or toxic injury. Necrosis is usually patchy, but injury can be widespread.</para>
<para><emphasis role="strong">Albuminuria:</emphasis> Too much albumin in the urine is a sign of <emphasis role="strong">kidney disease</emphasis>. Albumin is a protein found in the blood and should not be found in urine. A damaged kidney lets some albumin pass into the urine.</para>
<para><emphasis role="strong">Anuria:</emphasis> Urine output less than 100 mL/24 hr.</para>
<para><emphasis role="strong">Azotemia:</emphasis> Buildup of nitrogenous waste products, specifically urea, in the blood (BUN).</para>
<para><emphasis role="strong">Chronic kidney disease or chronic renal failure:</emphasis> Kidney damage or decreased kidney GFR of less than 60 mL/min/1.73 m<superscript>2</superscript> for 3 or more months.</para>
<para><emphasis role="strong">Ecchymosis:</emphasis> Superficial bleeding under the skin&mdash;purple or black-and-blue bruise.</para>
<para><emphasis role="strong">End-stage renal disease (ESRD):</emphasis> GFR less than 15 mL/min or receiving dialysis.</para>
<para><emphasis role="strong">Glomerular filtration rate (GFR):</emphasis> Rate of fluid filtration through the kidney glomeruli.</para>
<para><emphasis role="strong">Nephrotoxins:</emphasis> Chemical substances, including medications that can cause kidney damage.</para>
<para><emphasis role="strong">Nocturia:</emphasis> Frequent urination after retiring to bed.</para>
<para><emphasis role="strong">Oliguria:</emphasis> Urinary output less than 400 mL/24 hr.</para>
<para><emphasis role="strong">Osteitis fibrosa:</emphasis> Bones become soft and deformed due to increased metabolism or high bone turnover associated with increased levels of parathyroid hormone. Leads to bone pain, tenderness, and increased risk of fractures.</para>
<para><emphasis role="strong">Polyuria:</emphasis> Excretion of large amounts (2&ndash;6 L/24 hr) of urine, lacking concentration and regulation of waste products. Occurs during diuretic phase of AKI.</para>
<para><emphasis role="strong">Porphyrins:</emphasis> Nitrogen-containing chemical components of hemoglobin.</para>
<para><emphasis role="strong">Purpura:</emphasis> Hemorrhagic state characterized by patches of purplish discoloration, resulting from extravasation of blood into the skin. Purpura does not blanch with pressure.</para>
<para><emphasis role="strong">Pyelonephritis:</emphasis> Infection of the kidney medulla or cortex.</para>
<para><emphasis role="strong">Renal osteodystrophy:</emphasis> Bone disease that occurs when the kidneys fail to maintain the proper levels of calcium and phosphorus in the blood.</para>
<para><emphasis role="strong">Uremia:</emphasis> Toxic clinical syndrome associated with fluid, electrolyte, and hormone imbalances and metabolic abnormalities due to deterioration of renal function and the deleterious effects of azotemia on organ systems.</para>
</note>
<sect2 id="ch0008s0250"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Primary care of the individual with chronic kidney disease is at the community level, although inpatient acute hospitalization may be required for life-threatening complications.</para>
</sect2>
<sect2 id="ch0008s0251"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0007s0224">Anemias&mdash;iron deficiency, anemia of chronic disease, pernicious, aplastic, hemolytic</link></para>
<para>Fluid and electrolyte imbalances (see Davis<emphasis>Plus</emphasis>)</para>
<para><link linkend="ch0002s0027">Heart failure: chronic</link></para>
<para><link linkend="ch0002s0022">Hypertension: severe</link></para>
<para>Metabolic acidosis&mdash;primary base bicarbonate deficiency (see Davis<emphasis>Plus</emphasis>)</para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0005s0144">Upper gastrointestinal bleeding</link></para>
<para><emphasis role="strong">Additional associated nursing diagnoses are found in:</emphasis></para>
<para><link linkend="ch0008s0244">Acute kidney injury (acute renal failure)</link></para>
<para><link linkend="ch0008s0254">Renal dialysis&mdash;general considerations</link></para>
<table frame="top" id="ch0008s0249ta0355"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Clients with chronic renal failure may not have any symptoms at all until normal kidney function declines to 20% or less. At that stage, an array of symptoms, such as the following, may appear.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC DIVISION<?lb?>MAY REPORT</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Extreme fatigue, weakness, malaise</para></listitem>
<listitem><para>Sleep disturbances&mdash;insomnia, restlessness, somnolence</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Muscle weakness, loss of tone, decreased range of motion (ROM)</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of prolonged or severe hypertension</para></listitem>
<listitem><para>Palpitations, chest pain (angina)</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Hypertension, jugular vein distention (JVD)</para></listitem>
<listitem><para>Cardiac dysrhythmias, distant heart sounds</para></listitem>
<listitem><para>Pericardial friction rub if uremic pericarditis is present</para></listitem>
<listitem><para>Full or bounding pulses</para></listitem>
<listitem><para>Generalized tissue and pitting edema of feet, legs, and hands</para></listitem>
<listitem><para>Enlargement of liver, spleen, and heart</para></listitem>
<listitem><para>Pallor, bronze-gray, yellow skin</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Stress factors&mdash;financial, relationship</para></listitem>
<listitem><para>Feelings of helplessness, hopelessness, powerlessness</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Denial, anxiety, fear, anger, irritability, personality changes</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ELIMINATION</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Decreased urinary frequency, oliguria, anuria (advanced failure)</para></listitem>
<listitem><para>Abdominal bloating, diarrhea, or constipation</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Change in urine color&mdash;deep yellow, red, brown, cloudy</para></listitem>
<listitem><para>Oliguria, may become anuric</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Anorexia</para></listitem>
<listitem><para>Heartburn, nausea, vomiting, unpleasant metallic taste in mouth</para></listitem>
<listitem><para>Rapid weight gain (edema), weight loss (malnutrition)</para></listitem>
<listitem><para>Use of diuretics</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Muscle wasting, decreased subcutaneous fat, debilitated appearance</para></listitem>
<listitem><para>Gum ulcerations; bleeding of gums, tongue</para></listitem>
<listitem><para>Abdominal distention, ascites, liver enlargement (end stage)</para></listitem>
<listitem><para>Changes in skin turgor and moisture</para></listitem>
<listitem><para>Edema&mdash;generalized, dependent</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">HYGIENE</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Difficulty performing activities of daily living (ADLs)</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Thin, dry, brittle nails and hair</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Headache, blurred vision</para></listitem>
<listitem><para>Numbness, tingling, and weakness, especially of lower extremities (peripheral neuropathy)</para></listitem>
<listitem><para>Muscle cramps or twitching, &ldquo;restless leg&rdquo; syndrome, burning numbness of soles of feet</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Altered mental state&mdash;continuum of symptoms can be present, depending on stage of disease, such as decreased attention span, inability to concentrate, loss of memory, confusion, decreasing level of consciousness, stupor, coma</para></listitem>
<listitem><para>Twitching, muscle fasciculation, seizure activity</para></listitem>
<listitem><para>Gait abnormalities</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Flank pain, headache, muscle cramps, or leg pain&mdash;worse at night</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Guarding, distraction behaviors, restlessness</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Shortness of breath, sudden nighttime dyspnea</para></listitem>
<listitem><para>Cough with or without thick, tenacious sputum</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Tachypnea, dyspnea, increased rate and depth (Kussmaul&rsquo;s respiration may be associated with metabolic acidosis)</para></listitem>
<listitem><para>Cough productive of pink-tinged sputum (pulmonary edema)</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Itching skin, frequent scratching</para></listitem>
<listitem><para>Recent or recurrent infections</para></listitem>
<listitem><para>Bleeding tendencies</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Scratch marks, petechiae, ecchymotic areas on skin</para></listitem>
<listitem><para>Fever (sepsis, dehydration); normothermia may actually represent an elevation in client who has developed a lower-than-normal body temperature (effect of chronic renal failure [CRF] and depressed immune response)</para></listitem>
<listitem><para>Bone fractures; calcium phosphate deposits (metastatic calcifications) in skin, soft tissues, joints; limited joint movement</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SEXUALITY</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Decreased libido, amenorrhea, infertility</para></listitem>
<listitem><para>Erectile dysfunction</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SOCIAL INTERACTION</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Difficulties imposed by condition, such as unable to work, maintain social contacts, or usual role function in family</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Family history of polycystic disease, hereditary nephritis, urinary calculus, malignancy</para></listitem>
<listitem><para>History of poorly controlled hypertension or diabetes (high risk for renal failure), exposure to toxins, such as nephrotoxic drugs, drug overdose, environmental poisons</para></listitem>
<listitem><para>Current or recent use of nephrotoxic antibiotics, angiotensin-converting enzyme (ACE) inhibitors, chemotherapy agents, heavy metals, NSAIDs, radiocontrast agents</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May require alteration or assistance with medications, treatments, supplies; transportation; homemaker or maintenance tasks</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0008s0249ta0356"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">TEST<?lb?>WHY IT IS DONE</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Blood urea nitrogen (BUN):</emphasis> Measures the by-product of protein metabolism in the liver, filtered by the kidneys and excreted in urine.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Levels are elevated in chronic kidney disease. ESRD is characterized by marked elevation of BUN.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Creatinine (Cr):</emphasis> End product of muscle and protein metabolism filtered by the kidneys and excreted in urine.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The level of creatinine in the blood helps estimate the glomerular filtration rate (GRF). Can be quite elevated before symptoms of CRF are present in unmonitored client. Markedly elevated in late stage.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">BUN/Cr ratio:</emphasis> Ratio helps determine whether factors other than kidney failure are causing changes in numbers. Normal ratio is 10:1.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ratio is less than 10:1, especially in later stages of CRF. Impaired filtration causes reduced BUN reabsorption, thereby lowering BUN/Cr ratio.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Glomerular filtration rate (GFR):</emphasis> Calculated from serum Cr levels and adjusted for mean normal body surface area. GFR is approximately 90 mL/min in the healthy adult.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>GFR is used to stage renal failure. Symptoms are typically absent until GFR falls below 60 (stage 3). The client in severe CRF with a GFR between 15 and 29 (stages 4&ndash;5) is a candidate for dialysis or transplantation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Complete blood count (CBC):</emphasis> Battery of screening tests, which typically includes hemoglobin (Hgb); hematocrit (Hct); red blood cell (RBC) count, morphology, indices, and distribution width index; platelet count and size; and white blood cell (WBC) count and differential.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hgb decreases because of anemia, usually less than 7 to 8 g/dL. Anemia develops from decreased renal synthesis of erythropoietin, the hormone responsible for bone marrow stimulation for RBC production. RBC survival is decreased, and bleeding tendency is increased from the uremia-induced platelet dysfunction.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Arterial blood gases (ABGs):</emphasis> Determines the pH and the percentage of oxygen, carbon dioxide, and bicarbonate in arterial blood.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased pH. Metabolic acidosis (less than 7.2) occurs because of loss of renal ability to excrete hydrogen and ammonia or end products of protein catabolism. Bicarbonate and PCO<subscript>2</subscript> decreased.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Electrolytes (renalytes):</emphasis> Electrically charged minerals found in body tissues and blood in the form of dissolved salts that help move nutrients into and wastes out of the body&rsquo;s cells, maintain water balance, and stabilize the body&rsquo;s pH level.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Sodium:</emphasis> Helps to evaluate hydration status and progression of renal failure.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be low if kidney &ldquo;wastes sodium&rdquo; or normal, reflecting dilutional state of hypernatremia.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Potassium:</emphasis> Fluctuation in levels can create life-threatening situations, affecting therapeutic choices.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevated related to potassium retention, with decline in GFR below 20 to 25 mL/min diminishes kidney ability to excrete potassium, or with cellular shifts (acidosis), or tissue release (RBC hemolysis). In ESRD, electrocardiogram (ECG) changes may not occur until potassium is 6.5 mEq or higher. The resulting hyperkalemia poses a life-threatening emergency, which requires frequent and immediate intervention. <emphasis>Note:</emphasis> Potassium may also be decreased if client is on potassium-wasting diuretics or when client is receiving dialysis treatment.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Phosphorus:</emphasis> Has a direct impact on parathyroid function and bone health.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>As GFR declines, less phosphate is filtered and excreted; however, serum levels may remain normal initially because of increased parathyroid hormone (PTH) secretion and the associated increase in renal excretion of phosphorus. As CRF advances to stages IV and V, serum levels rise and bone complications such as osteitis fibrosa may develop.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Calcium:</emphasis> Important in feedback mechanism for inhibiting PTH synthesis and skeletal bone turnover.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypocalcemia may become severe as a result of low plasma calcitriol levels impairing intestinal absorption or from calcium binding to elevated serum phosphate levels.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Magnesium:</emphasis> Helps maintain normal muscle and nerve function, keeps heart rhythm steady, promotes normal blood pressure, and is known to be involved in energy metabolism and protein synthesis.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In end-stage renal disease, the limited ability of the kidney to excrete an increased magnesium load may result in toxic concentrations in serum. While hypermagnesemia is a hazard when magnesium-containing drugs are given, magnesium balance may be normal or even decreased in many uremic individuals. This is usually due to decreased dietary intake combined with the impaired intestinal magnesium absorption that characterizes late-stage renal failure.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Proteins (especially albumin):</emphasis> Evaluates nutritional status and predicts mortality in clients receiving dialysis.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased serum level may reflect protein loss via urine, fluid shifts, decreased intake, or decreased synthesis because of malnutrition.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum osmolality:</emphasis> Measures the amount of chemicals dissolved in the serum. Kidneys excrete or reabsorb water to keep osmolality in range of 285 to 295 mOsm/kg. Chemicals that affect serum osmolality include sodium, chloride, bicarbonate, proteins, and glucose.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Higher than 285 mOsm/kg; often equal to urine.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">URINE TESTS</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Volume:</emphasis> Reflection of declining renal function, possible development of AKI superimposed on CRF.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Usually less than 400 mL/24 hr (oliguria) or urine is absent (anuria).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Color:</emphasis> Changes in color or clarity indicate developing complications.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Abnormally cloudy urine may be caused by pus, bacteria, fat, colloidal particles, phosphates, or urates. Dirty, brown sediment indicates presence of RBCs, Hgb, myoglobin, and porphyrins.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Specific gravity:</emphasis> Measures density of urine compared to water, with normal range of 1.005 to 1.030.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Less than 1.015 or fixed at 1.010 reflects severe renal damage.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Protein (albuminuria):</emphasis> Dipstick test used as a screening tool to detect glomerular injury (prevalent in persons with diabetes, hypertension, or glomerular disease) that has caused glomeruli to lose selective permeability and leak protein, particularly albumin, which is excreted in the urine.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>High-grade persistent proteinuria (3 to 4+) strongly indicates glomerular damage, especially when RBCs and casts are also present. Low-grade proteinuria (1 to 2+) and WBCs may be indicative of infection or interstitial nephritis.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Total protein-Cr (albumin-Cr) ratio:</emphasis> Spot urine collection for total protein-to-creatinine ratio allows reliable approximation (extrapolation) of total 24-hour urinary protein excretion.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A value greater than 3.0 to 3.5 g is within the nephrotic range; less than 2.0 g is characteristic of tubulointerstitial problems.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Osmolality:</emphasis> Measures the ratio of water and solutes, such as electrolytes, acids, and other metabolic wastes, processed by the kidneys and released in urine. When body fluid is balanced, normal urine osmolality is in the range of 300 to 900 mOsm/kg.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Less than 350 mOsm/kg is indicative of tubular damage, and urine/serum ratio is often 1:1.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Cr clearance:</emphasis> Calculates GFR by measuring the amount of Cr cleared from the blood and filtered into urine in 24 hours.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Best indicator of overall kidney function, as reduced Cr clearance correlates with increased circulating Cr. May be significantly decreased&mdash;less than 80 mL/min in early kidney disease; less than 10 mL/min in ESRD.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Sodium:</emphasis> Determines hydration status and ability to conserve or excrete Na.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>More than 40 mEq/L because kidney is not able to reabsorb sodium.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">OTHER DIAGNOSTIC STUDIES</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Renal ultrasound:</emphasis> Imaging technique that uses high-frequency sound waves and a computer to create images of blood vessels, tissues, and organs.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Kidney size can be correlated with certain conditions&mdash;large kidney may be present in hyperfiltration, or small, echogenic kidney may be associated with advanced kidney disease. Ultrasound can also document presence of tumors, polycystic disease, or other obstruction in upper urinary system.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Doppler ultrasound/duplex Doppler study:</emphasis> Test that uses high-frequency sound waves (ultrasound) to measure the amount of blood flow through your arteries and veins.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Noninvasive study to evaluate problems in the kidneys caused by restricted blood flow (renal artery stenosis).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Computed tomographic (CT) scans:</emphasis> X-ray procedure that uses a computer to produce a detailed picture of a cross section of the body.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Demonstrates vessel disorders and kidney mass.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Magnetic resonance imaging (MRI):</emphasis> Imaging technique that uses a magnetic field and radio waves to create detailed images of the organs and tissues within the body.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in person who requires a CT scan but who cannot receive intravenous contrast; reliable in the diagnosis of renal vein thrombosis.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Kidney, ureter, bladder (KUB) x-ray:</emphasis> X-ray of the abdomen, showing the kidneys, ureters, and bladder.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Demonstrates size and structure of kidneys, ureters, and bladder; reveals presence of abnormalities, such as cysts, tumors, or stones.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Aortorenal angiography:</emphasis> Fluoroscopic examination, which uses contrast to examine the renal blood vessels for signs of blockage or abnormality.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assesses renal circulation and identifies extravascularities and masses. <emphasis>Note:</emphasis> Contrast media can precipitate renal failure in damaged kidney.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Renal biopsy:</emphasis> Percutaneous renal biopsy currently is performed most often with ultrasound guidance.</para></listitem></itemizedlist>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Biopsy is generally indicated when renal impairment or proteinuria approaching the nephrotic range is present and diagnosis is still unclear.</para>
</entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0008s0252"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Maintain homeostasis.</para></listitem>
<listitem><para>Prevent complications.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, and treatment needs.</para></listitem>
<listitem><para>Support adjustment to lifestyle changes.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0008s0253"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Fluid and electrolyte balance stabilized.</para></listitem>
<listitem><para>Complications prevented or minimized.</para></listitem>
<listitem><para>Disease process, prognosis, and therapeutic regimen understood.</para></listitem>
<listitem><para>Dealing realistically with situation and initiating necessary lifestyle changes.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0008s0249note0629">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for Electrolyte Imbalance</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Renal dysfunction; compromised regulatory function</para>
<para>Excessive fluid volume; vomiting diarrhea</para>
<para>Insufficient fluid volume</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Electrolyte &amp; Acid/Base Balance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Be free of complications resulting from electrolyte imbalances (e.g., muscle weakness/cramps, fatigue, dysrhythmias, impaired cognition)</para>
</note>
<note role="none" id="ch0008s0249note0630">
<table frame="top" id="ch0008s0249ta0357"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Electrolyte Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess specific client risk, noting disease process that may lead to/exacerbate electrolyte imbalances (e.g., chronic kidney disease, noncompliance with kidney diet; home dialysis program; presence of other conditions, such as diabetes/other endocrine disorders, heart failure with chronic use of diuretics).</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps to identify potential concerns requiring evaluation and intervention.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note client&rsquo;s age and developmental level, which can increase the risk for electrolyte imbalance.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This risk group may include the elderly or individuals unable to meet their own needs or monitor their health status (e.g., client who is unconscious for unknown cause or length of time; homeless person, trauma victim).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review client&rsquo;s daily medications. Discuss client&rsquo;s medications with primary healthcare provider to determine if changes should or can be made in client&rsquo;s medications or dosages.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>To identify those associated with risk for electrolyte imbalance (e.g., including and not limited to diuretics, laxatives, certain antidepressants, corticosteroids).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate fluid intake and output, being aware whether client is currently on dialysis and, if so, what type. Measure and document 24-hour fluid deficit or excess.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Many factors (e.g., inability to take fluids for any reason; hemorrhage, excessive fluid resuscitation; vomiting, use of diuretics or dialysis) affect fluid balance, disrupting electrolyte transport, function, and excretion.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggest client keep a diary of foods/fluids ingested when electrolyte imbalances occur or are difficult to manage.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review of actual intake may help identify hidden sources of electrolyte-containing foods, especially in ethnic diets that are not included on standard nutritional lists.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess mental status, noting client/caregiver report of change, such as altered attention span, recall of current events, and other cognitive functions.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes can be associated with electrolyte imbalance (e.g., commonly sodium).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor heart rate and rhythm.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tachycardia, bradycardia, and other dysrhythmias are associated with potassium, calcium, and magnesium imbalance.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note presence/severity of anorexia; persistent vomiting, acute or chronic diarrhea; high nasogastric tube output; loss of bowel sounds.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Any disturbance of the gastrointestinal system carries with it the potential for electrolyte imbalances.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate motor strength and function, noting steadiness of gait, handgrip strength, and reactivity of reflexes.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Imbalances of sodium, potassium, calcium, magnesium, and phosphorus can impact neuromuscular function.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Collaborate in the treatment of underlying conditions.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>To prevent, limit, or treat effects if electrolyte imbalances caused by disease or organ dysfunction.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Consult with nutritionist/dietician to educate client/SO and to recommend or provide balanced nutrition, using best route for feeding as prescribed by condition. Restrict micronutrients (e.g., foods high in sodium, potassium glucose) as indicated, according to kidney function and comorbid conditions.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Obtaining and utilizing electrolytes and other minerals are dependent on client receiving them in a readily available form (including food and supplements via ingestion, enteral or parenteral feeding). If client with CKD is on dialysis (either peritoneal or hemodialysis), nutrients and electrolytes may be restricted or added depending on client&rsquo;s needs. Refer to CP: <link linkend="ch0008s0254">Renal dialysis for general and specific dietary concerns</link> for client&rsquo;s needs.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0249note0631">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for decreased Cardiac Output</emphasis></title>
<para><emphasis role="strong">Risk Factors May Include</emphasis></para>
<para>Altered afterload&mdash;[e.g., systemic vascular resistance (SVR)]</para>
<para>Altered preload&mdash;[e.g., decreased venous return]</para>
<para>Alteration in heart rate, rhythm</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Cardiac Pump Effectiveness</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain cardiac output as evidenced by blood pressure (BP) and heart rate/rhythm within client&rsquo;s usual range; peripheral pulses strong and equal with prompt capillary refill time.</para>
<para>Identify signs of cardiac decompensation, alter activities, and seek help appropriately.</para>
</note>
<note role="none" id="ch0008s0249note0632">
<table frame="top" id="ch0008s0249ta0358"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Hemodynamic Regulation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify client at risk.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may have preexisting cardiac problems. But there is also potential for cardiac output issues to develop in client with CKD, particularly in later stages.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess presence and degree of hypertension: Monitor BP and note postural changes, such as sitting, lying, and standing.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Significant hypertension can occur because of disturbances in the renin-angiotensin-aldosterone system caused by renal dysfunction. Although hypertension is common, orthostatic hypotension may develop because of intravascular fluid deficit, response to effects of antihypertensive medications, or uremic pericardial tamponade.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate heart and lung sounds. Evaluate presence/degree of peripheral edema, vascular congestion, and reports of dyspnea.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>S<subscript>3</subscript>/S<subscript>4</subscript> heart sounds with muffled tones, tachycardia, irregular heart rate, tachypnea, dyspnea, crackles, wheezes, and edema or jugular distention suggest heart failure (HF).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Investigate reports of chest pain, noting location, radiation, severity (0 to 10 or similar scale), and whether or not it is intensified by deep inspiration and supine position.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although myocardial infarction (MI) is common, approximately half of clients on dialysis develop pericarditis, potentiating risk of pericardial effusion and tamponade.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Evaluate heart sounds, noting onset of friction rub, falling blood pressure, diminished or absent peripheral pulses, distended jugular veins, pallor, and obvious changes in mentation.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Can indicate cardiac tamponade, a medical emergency.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess activity level and response to activity.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Weakness can be attributed to heart failure and anemia.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory and diagnostic studies, such as the following:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Electrolytes&mdash;potassium, sodium, calcium, magnesium; BUN/Cr</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Imbalances can alter electrical conduction and cardiac function.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Chest x-rays</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in identifying developing cardiac failure and response to therapies.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Collaborate in treatment of underlying disease or conditions, where possible.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Slowing progression of CKD in early stages can be aided by interventions, such as controlling BP, managing diabetes, treating hyperlipidemia, and avoiding toxins such as NSAIDs, intravenous (IV) contrast dye, and aminoglycosides.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aggressive treatment of hypertension is needed to reduce SVR and aid in prevention of HF and MI. <emphasis>Note:</emphasis> Doses and dosing intervals of drugs that are excreted or metabolized renally are adjusted according to the residual GFR.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Statins, such as atorvastatin (Lipitor) and simvastatin (Zocor)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Statins may be used to treat elevated plasma cholesterols because of increased risk for coronary events, especially when GFR is below 60.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>ACE inhibitors, such as enalapril (Vasotec), or angiotensin receptor blockers (ARBs), such as irbesartan (Avapro) and losartan (Cozaar)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These drugs may be prescribed not only to lower BP and reduce protein in the urine but also to slow the progression of kidney disease.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Erythropoietin-stimulating agents (ESAs) such as Epogen, EPO or erythropoietin-stimulating proteins, such as somatropin (Nutropin) or darbepoetin alpha (Aranesp)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be given to treat anemia associated with CKD when hemoglobin falls below 10 to improve oxygen-carrying capacity of circulating hemoglobin and reduce left ventricular strain. <emphasis>Note:</emphasis> ESA resistance, or hyporespon-siveness, can occur in client with CKD (not on dialysis) where the desired hemoglobin (Hb) concentration is not achieved despite higher than usual doses of ESAs (Berns, 2017).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer oxygen, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cardiac function can be improved with use of oxygen if client is severely anemic or metabolic acidosis and electrolyte abnormalities are causing dysrhythmias.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for renal replacement therapy (RRT), such as hemodialysis, peritoneal dialysis, or renal transplantation.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduction of uremic toxins and correction of electrolyte imbalances and fluid overload may limit or prevent cardiac manifestations, including hypertension and pericardial effusion.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist with pericardiocentesis, as indicated.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Accumulation of fluid within pericardial sac can compromise cardiac filling and myocardial contractility, impairing cardiac output and potentiating risk of cardiac arrest.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0249note0633">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for Activity Intolerance</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Circulatory problem [anemia]; physical deconditioning</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Activity Tolerance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Participate in desired activities free of physiological signs of intolerance (e.g., pulse, respirations, and blood pressure remain within client&rsquo;s normal range).</para>
</note>
<note role="none" id="ch0008s0249note0634">
<table frame="top" id="ch0008s0249ta0359"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Energy Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note reports of increasing fatigue and weakness. Observe for tachycardia, pallor of skin and mucous membranes, dyspnea, and chest pain.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May reflect effects of anemia and cardiac response necessary to keep cells oxygenated.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor level of consciousness (LOC) and behavior.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Anemia may cause cerebral hypoxia manifested by changes in mentation, orientation, and behavioral responses.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Evaluate response to activity and ability to perform tasks. Assist as needed and develop schedule for rest.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Anemia decreases tissue oxygenation and increases fatigue, which may require intervention, changes in activity, and rest.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory studies, such a RBCs, Hgb/Hct.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Uremia decreases production of erythropoietin in the bone marrow, thus depressing RBC production and survival time. In CKD, Hgb and Hct are usually low but tolerated (e.g., client may not be symptomatic until Hgb is below 7).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer fresh blood and packed red cells (PRCs), as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be necessary when client is symptomatic with anemia. PRCs are usually given when client is experiencing fluid overload or receiving dialysis treatment. Washed RBCs are used to prevent hyperkalemia associated with stored blood.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Erythropoietin-stimulating agents such as preparations (Epogen, Procrit)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Stimulates the production and maintenance of RBCs, thus decreasing the need for transfusion. <emphasis>Note:</emphasis> Recent data showing increased risks of cardiovascular events with ESAs in CKD caused the Food and Drug Administration (FDA) to issue a black box warning about their use. Thus, clinicians have been advised to use the lowest possible ESA dose to reduce the need for transfusion and discontinue the ESA as quickly as possible (Alper et al, 2017; FDA, 2011).</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Iron preparations, such as folic acid (Folvite) and cyanocobalamin (Rubesol-1000)</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Useful in managing symptomatic anemia related to nutritional and dialysis-induced deficits. <emphasis>Note:</emphasis> Iron should not be given with phosphate binders because they may decrease iron absorption.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0249note0635">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for Bleeding</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Abnormal blood profile&mdash;decreased RBC production and survival, altered clotting functions (suppressed erythropoietin production or secretion)</para>
<para>[Hypertension]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Blood Loss Severity</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Experience no signs and symptoms of bleeding or hemorrhage.</para>
<para>Maintain or demonstrate improvement in laboratory values.</para>
</note>
<note role="none" id="ch0008s0249note0636">
<table frame="top" id="ch0008s0249ta0360"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Bleeding Precautions</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note client report of pain in specific areas and whether the pain is increasing and is diffuse or localized.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>To determine possible sources of bleeding.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess vital signs, noting changes such as new or worsening hypertension. Investigate potential causes (especially if client has frequent nosebleeds).</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nosebleeds are a common occurrence with CKD (especially when on dialysis) and may be associated with hypertension and use of medications such as anticoagulants, immunosuppressants, and glucocorticoids.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review medications periodically.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>To identify those (prescriptions, OTC products, and herbals) that may cause, or exacerbate, bleeding.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe for oozing from venipuncture sites, bleeding, or ecchymotic areas following slight trauma, petechiae, and joint swelling or mucous membrane involvement&mdash;bleeding gums, recurrent epistaxis, hematemesis, melena, and hazy or red urine.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Bleeding can occur easily because of capillary fragility and altered clotting functions and may worsen anemia.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Test gastrointestinal (GI) secretions and stool for occult blood.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Mucosal changes and altered platelet function due to uremia may result in gastric mucosal erosion and GI hemorrhage.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide soft toothbrush and electric razor. Use smallest needle possible and apply prolonged pressure following injections or vascular punctures.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of bleeding and hematoma formation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Protect at-risk client from trauma such as falls.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>To reduce risk of injury causing overt or hidden hemorrhage.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory studies, such as the following:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Platelet count, clotting factors</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suppression of platelet formation and inadequate levels of factors III and VIII impair clotting and potentiate risk of bleeding. <emphasis>Note:</emphasis> Bleeding may become intractable in ESRD.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prothrombin time (PT) level</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Abnormal prothrombin consumption lowers serum levels and impairs clotting.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Collaborate in evaluating need for replacing blood (or specific components).</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be needed to replace losses or prevent complications associated with severe anemia.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Iron preparations, such as folic acid (Folvite) and cyanocobalamin (Rubesol-1000)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in managing symptomatic anemia related to nutritional and dialysis-induced deficits. <emphasis>Note:</emphasis> Iron should not be given with phosphate binders because they may decrease iron absorption.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Cimetidine (Tagamet), ranitidine (Zantac), and antacids</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be given prophylactically to reduce or neutralize gastric acid and thereby reduce the risk of GI hemorrhage.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0249note0637">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for acute Confusion</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Metabolic abnormalities&mdash;electrolyte imbalances, increased blood urea nitrogen (BUN)/creatinine, azotemia, decreased hemoglobin</para>
<para>Fluctuations in sleep-wake cycle</para>
<para>Infection</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Cognition</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain or regain optimal level of mentation.</para>
<para>Identify ways to compensate for cognitive impairment and memory deficits.</para>
</note>
<note role="none" id="ch0008s0249note0638">
<table frame="top" id="ch0008s0249ta0361"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Reality Orientation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor for impairment in thinking ability, memory, and orientation. Note attention span.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Uremic syndrome&rsquo;s effect can begin with minor confusion or irritability and progress to altered personality, inability to assimilate information or participate in care. Awareness of changes provides opportunity for evaluation and intervention.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ascertain from significant other (SO) client&rsquo;s usual level of mentation.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides comparison to evaluate development, progression, or resolution of impairment.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide SO with information about client&rsquo;s status.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Some improvement in mentation may be expected with restoration of more normal levels of BUN, electrolytes, and serum pH.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide quiet, calm environment and judicious use of TV, radio, and visitation.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Minimizes environmental stimuli to reduce sensory overload and confusion while preventing sensory deprivation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reorient to surroundings, person, and so forth. Provide calendars, clocks, and outside window.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides clues to aid in maintaining reality.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Present reality concisely and briefly, and do not challenge illogical thinking if present.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Confrontation potentiates defensive reactions and may lead to client mistrust and heightened denial of reality.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Communicate information and instructions in simple, short sentences. Ask direct, yes or no questions. Repeat explanations as necessary.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May aid in reducing confusion when present and increases possibility that communications will be understood and remembered.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Establish a regular schedule for expected activities.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aids in maintaining reality orientation and may reduce fear and confusion.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promote adequate rest and undisturbed periods for sleep.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sleep deprivation may further impair cognitive abilities.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Fluid/Electrolyte Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor laboratory studies, such as BUN/Cr, serum electrolytes, glucose level, and ABGs (PO<subscript>2</subscript>, pH).</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Correction of imbalances can have profound effects on cognition.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide supplemental oxygen (O<subscript>2</subscript>) as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Correction of hypoxia alone can improve cognition.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoid use of barbiturates and opiates.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Drugs normally detoxified in the kidneys will have increased half-life and cumulative effects, worsening confusion.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Prepare for dialysis.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Marked deterioration of thought processes may indicate worsening of azotemia and general condition, requiring prompt intervention to regain homeostasis.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0249note0639">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for impaired Skin Integrity</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Accumulation of toxins in the skin</para>
<para>Impaired circulation (anemia with tissue ischemia) or sensation (peripheral neuropathy)</para>
<para>Changes in skin turgor&mdash;edema</para>
<para>Reduced activity, immobility</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Tissue Integrity: Skin and Mucous Membranes</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain intact skin.</para>
<para><emphasis role="strong">Risk Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate behaviors and techniques to prevent skin breakdown or injury.</para>
</note>
<note role="none" id="ch0008s0249note0640">
<table frame="top" id="ch0008s0249ta0362"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Skin Surveillance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inspect skin for changes in color, turgor, and vascularity. Note redness and excoriation. Observe for ecchymosis and purpura.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicates areas of poor circulation and early breakdown that may lead to decubitus formation and infection.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor fluid intake and hydration of skin and mucous membranes.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Detects presence of dehydration or fluid overload that affects circulation and tissue integrity at the cellular level.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inspect dependent areas for edema. Elevate legs, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Edematous tissues are more prone to breakdown. Elevation promotes venous return, limiting venous stasis and edema formation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Change position frequently, move client carefully, pad bony prominences with sheepskin, and use elbow and heel protectors.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreases pressure on edematous, poorly perfused tissues to reduce ischemia.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide soothing skin care, restrict use of soaps, and apply ointments or creams such as lanolin or Aquaphor.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Baking soda and cornstarch baths decrease itching and are less drying than soaps. Lotions and ointments may be desired to relieve dry, cracked skin.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Keep linens dry and wrinkle-free.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces dermal irritation and risk of skin breakdown.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate reports of itching.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although dialysis has largely eliminated skin problems associated with uremic frost, itching can occur because the skin is an excretory route for waste products, such as phosphate crystals associated with hyperparathyroidism in ESRD.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend client use cool, moist compresses to apply pressure to, rather than scratch, pruritic areas. Keep fingernails short; encourage use of gloves during sleep, add vinegar (acetic acid) to bath water, as needed.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Alleviates discomfort and reduces risk of dermal injury.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggest wearing loose-fitting cotton garments.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents direct dermal irritation and promotes evaporation of moisture on the skin.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Provide foam or flotation mattress.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Reduces prolonged pressure on tissues, which can limit cellular perfusion, potentiating ischemia and necrosis.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0249note0641">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for impaired Oral Mucous Membrane</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Decrease in salivation, dehydration; fluid restrictions; inadequate nutrition; immunosuppression</para>
<para>Treatment regimen; chemical irritation (conversion of urea in saliva to ammonia)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Oral Health</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain integrity of oral mucosa.</para>
<para><emphasis role="strong">Risk Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Identify and initiate specific interventions to promote healthy oral mucosa.</para>
</note>
<note role="none" id="ch0008s0249note0642">
<table frame="top" id="ch0008s0249ta0363"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Oral Health Maintenance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inspect oral cavity: note moistness, character of saliva, presence of inflammation, ulcerations, and leukoplakia.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides opportunity for prompt intervention and prevention of infection.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide fluids throughout 24-hour period within prescribed limit.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents excessive oral dryness from prolonged period without oral intake.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Offer frequent mouth care or rinse with 0.25% acetic acid solution. Provide gum, hard candy, or breath mints between meals.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Mucous membranes may become dry and cracked. Mouth care soothes, lubricates, and helps freshen mouth taste, which is often unpleasant because of uremia and restricted oral intake. Rinsing with acetic acid helps neutralize ammonia formed by conversion of urea.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage good dental hygiene after meals and at bedtime. Recommend avoidance of dental floss.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces bacterial growth and potential for infection. Dental floss may cut gums, potentiating bleeding.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend client stop smoking and avoid lemon and glycerin products or mouthwash containing alcohol.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These substances are irritating to the mucosa and have a drying effect, potentiating discomfort.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Provide artificial saliva as needed, such as Ora-Lube.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Prevents dryness, buffers acids, and promotes comfort.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0249note0643">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">ineffective Health Management</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Complexity of therapeutic regimen; complexity of healthcare system; insufficient knowledge of therapeutic regimen</para>
<para>Economically disadvantaged</para>
<para>Perceived seriousness of condition, benefit or barrier; powerlessness</para>
<para>Insufficient social support</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Difficulty with prescribed regimen</para>
<para>Ineffective choices in daily living for meeting health goals</para>
<para>Unexpected acceleration of illness symptoms</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Self-Management: Kidney Disease</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of condition, disease process, and potential complications.</para>
<para>Verbalize understanding of therapeutic needs.</para>
<para>Correctly perform necessary procedures and explain reasons for the actions.</para>
<para>Demonstrate and initiate necessary lifestyle changes.</para>
<para>Participate in treatment regimen.</para>
</note>
<note role="none" id="ch0008s0249note0644">
<table frame="top" id="ch0008s0249ta0364"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review disease process, prognosis, and future expectations. Educate regarding natural disease progression, different dialysis modalities, renal transplantation, and client&rsquo;s option to refuse or discontinue chronic dialysis.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides knowledge base from which client can make informed choices. Kidney failure choices depend on stage of disease and include doing no treatment, hemodialysis, peritoneal dialysis, and kidney transplantation. No matter which option is chosen, the client faces many lifestyle changes, including a complicated treatment plan involving several medications, diet and exercise modification, and appointments with numerous healthcare providers. <emphasis>Note:</emphasis> Client at stage 4 must be evaluated and prepared for renal replacement therapy&mdash;dialysis or transplantation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Address client&rsquo;s and SO&rsquo;s feelings, concerns, and methods of dealing with situation. Offer compassionate listening and honest answers to questions. Refer to appropriate support resources.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Common reactions to diagnosis include disbelief, anxiety, anger at self and others, and mild to severe depression (including suicidal ideation). (Refer to CP: <link linkend="ch0014s0338">Psychosocial Aspects of Care</link>; ND: <link linkend="ch0014s0338note0534">risk for self-/other-directedViolence</link>.)</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review dietary modifications or restrictions, including the following:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Dietary modifications are primarily required for person not on dialysis.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Phosphorus&mdash;milk, cheese, carbonated drinks, processed foods, poultry, corn, and peanuts</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Dietary restrictions to control serum phosphorus, which are routinely recommended, are usually associated with a reduction in protein intake. This may lead to protein-energy wasting and poor survival. A better solution may be the use of specific nutritional supplements high in energy and protein content but lower in phosphorus (Gonz&aacute;lez-Parra et al, 2012).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fluid, potassium, and sodium restrictions, when indicated</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>If fluid retention is a problem, client may need to restrict intake of fluid, such as previous day&rsquo;s output plus 500 mL for insensible losses, and restrict dietary potassium and sodium as prescribed. If fluid overload is present, diuretic therapy or dialysis will be part of the regimen. (Refer to CP: <link linkend="ch0008s0244">Acute Kidney Injury</link>, ND: <link linkend="ch0002s0027note0031">excess Fluid Volume</link>.)</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss other nutritional concerns such as regulating protein intake according to level of renal function&mdash;generally 0.6 to 0.7 g/kg of body weight per day of good-quality protein, such as meat, chicken, fish, and eggs.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Metabolites that accumulate in blood derive almost entirely from protein catabolism; as renal function declines, proteins may be restricted proportionately. Too little protein can result in malnutrition. <emphasis>Note:</emphasis> Client on dialysis may not need to be as vigilant with protein intake.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage adequate calorie intake, especially from carbohydrates in the nondiabetic client.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Spares protein, prevents wasting, and provides energy. <emphasis>Note:</emphasis> Use of special glucose polymer powders can add calories to enhance energy level without extra food or fluid intake.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss drug therapy, including use of vitamin D, calcium supplements, and phosphate binders, such as calcium acetate (PhosLo), calcitriol (Caltrate), sevelamer (Renagel), and avoidance of magnesium antacids (Mylanta, Maalox, Gelusil).</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents serious complications, such as reducing phosphate absorption from the GI tract and supplying calcium to maintain normal serum levels, reducing risk of bone demineralization and fractures and tetany; however, use of aluminum-containing products should be monitored because accumulation in the bones potentiates osteodystrophy. Magnesium-containing products potentiate hypermagnesemia, which is already present late in chronic kidney disease and carries the risk of causing neurological problems (e.g., seizures). <emphasis>Note:</emphasis> Supplemental vitamin D may be required to facilitate calcium absorption.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Emphasize importance of reading all product labels&mdash;drugs and foods&mdash;and not taking medications (including over-the-counter products) without prior approval of healthcare provider.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>It is difficult to maintain electrolyte balance when exogenous intake is not factored into dietary restrictions; for example, hypercalcemia can result from routine supplement use in combination with increased dietary intake of calcium-fortified foods and medications containing calcium.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Instruct in (or review) BP or glucose monitoring at home and provide information on obtaining monitoring equipment, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Because hypertension and poor glycemic control are high risk factors in kidney disease progression, self-monitoring and management are important. Also, hypertension is worsened by CRF, often requiring management with antihypertensive drugs, necessitating close observation of treatment effects, such as vascular response to medication.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Emphasize need for smoking cessation, if client smokes. Refer for nicotine medications and support resources.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Smoking increases renal vasoconstriction and exacerbates hypertension.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review strategies to prevent constipation, including stool softeners, such as Colace, and bulk laxatives, such as Metamucil, but avoiding magnesium products (milk of magnesia).</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduced fluid intake, changes in dietary pattern, and use of phosphate-binding products often result in constipation that is not responsive to nonmedical interventions. Use of products containing magnesium increases risk of hypermagnesemia.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review measures to prevent bleeding or hemorrhage, such as use of soft toothbrush, electric razor, avoidance of constipation, forceful blowing of nose, strenuous exercise, or contact sports.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risks related to alteration of clotting factors and decreased platelet count.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Caution against exposure to external temperature extremes.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Peripheral neuropathy may develop, especially in lower extremities, because of effects of uremia and electrolyte/acid-base imbalances impairing peripheral sensation and potentiating risk of tissue injury.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss role of fatigue in client&rsquo;s daily or desired activities. Advise establishing a routine exercise program within limits of individual ability and rest periods with activities. Instruct in energy conservation techniques.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fatigue due to anemia, sleep disturbances, malnutrition, and failure of kidneys to clear toxins can greatly reduce client&rsquo;s tolerance for activity. At the same time, exercise is needed to maintain muscle tone and joint flexibility; reduces risks associated with immobility, including bone demineralization.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Address sexual concerns.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Physiological effects of uremia and antihypertensive therapy may impair sexual desire and performance.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify available resources such as nephrologist, nutritionist, and other specialists, as indicated. Emphasize necessity of medical and laboratory follow-up.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Close monitoring of renal function and electrolyte balance is necessary to adjust dietary prescription, treatment, and to make decisions about possible options such as dialysis or transplantation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss quality-of-life concerns, such as pros and cons of each treatment option, refusing or withdrawing dialysis, medical care advance directives, and durable power of attorney.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>When kidney disease is chronic or end stage, client and SO may want to discuss issues with others, such as family, social worker, and religious counselor, and should have the opportunity to receive information to make informed choices.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify signs and symptoms requiring immediate medical evaluation, such as the following:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Low-grade fever, chills, changes in characteristics of urine or sputum, tissue swelling or drainage, and oral ulcerations</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Depressed immune system, anemia, and malnutrition all contribute to increased risk of infection.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Numbness or tingling of digits, abdominal and muscle cramps, carpopedal spasms, and pain and tenderness in extremities</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Uremia and decreased absorption of calcium may lead to peripheral neuropathies. <emphasis>Note:</emphasis> Client is also at risk for development of thrombophlebotic complications.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Joint swelling or tenderness, decreased ROM, and reduced muscle strength</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hyperphosphatemia with corresponding calcium shifts from the bone may result in deposition of the excess calcium phosphate as calcifications in joints and soft tissues. Symptoms of skeletal involvement are often noted before impairment in organ function is evident.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Headaches, blurred vision, periorbital or sacral edema, and red eyes</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggestive of development and poor control of hypertension and changes in eyes caused by calcium.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide client and family information resources, such as books, articles, and informational websites; the National Kidney Foundation; and the American Association of Kidney Patients.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Offers client and SO opportunity to obtain information, support, and sources of funding.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0249note0645">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS</emphasis> following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">excess Fluid Volume</emphasis>&mdash;compromised regulatory mechanism</para></listitem>
<listitem><para><emphasis role="bi">Fatigue</emphasis>&mdash;disease state, malnutrition, anemia, stress, depression</para></listitem>
<listitem><para><emphasis role="bi">ineffective Health Management</emphasis>&mdash;complexity of therapeutic regimen, decisional conflicts (e.g., client value system, health beliefs, cultural influences), powerlessness, economic difficulties, family conflict, social support deficit</para></listitem>
<listitem><para><emphasis role="bi">Hopelessness</emphasis>&mdash;deteriorating physiological condition, long-term stress, prolonged activity limitations</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0008s0254"><title><emphasis role="strong">RENAL DIALYSIS&mdash;GENERAL CONSIDERATIONS</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Procedure</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Process that substitutes for kidney function by removing excess fluid and accumulated endogenous or exogenous toxins</para></listitem>
<listitem><para>Type of fluid and solute removal depends on the client&rsquo;s underlying pathophysiology, current hemodynamic status, vascular access, availability of equipment and resources, and healthcare providers&rsquo; training.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Indications</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Treatment for acute kidney injury (AKI) or chronic end-stage renal disease (ESRD)</para></listitem>
<listitem><para>Indicated in AKI for (Spinner, 2014) the following:</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">A</emphasis>cid-base problems: such as severe acidosis</para></listitem>
<listitem><para><emphasis role="strong">E</emphasis>lectrolyte problems: such as acute life-threatening hyperkalemia</para></listitem>
<listitem><para><emphasis role="strong">I</emphasis>ntoxications: removal of toxins due to overdose of certain drugs (e.g., ethanol, some antiretroviral drugs, aminoglycosides, and antibiotics)</para></listitem>
<listitem><para><emphasis role="strong">O</emphasis>verload: (fluid)</para></listitem>
<listitem><para><emphasis role="strong">U</emphasis>remic symptoms caused by the inability to excrete nitrogenous wastes, parathyroid hormone, proteins, and other physiological substances in toxic levels</para>
</listitem></orderedlist></listitem>
<listitem><para>Indicated in chronic kidney disease (Lameire &amp; Biesen, 2010; Pradeep, 2017)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Pericarditis or pleuritis (urgent indication)</para></listitem>
<listitem><para>Progressive uremic encephalopathy or neuropathy, with signs such as confusion, asterixis, myoclonus, wrist or foot drop, or, in severe cases, seizures (urgent indication)</para></listitem>
<listitem><para>A significant tendency for bleeding attributable to uremia (urgent indication)</para></listitem>
<listitem><para>Fluid overload unresponsive to diuretics</para></listitem>
<listitem><para>Life-threatening hypertension unresponsive to antihypertensive medications</para></listitem>
<listitem><para>Persistent metabolic disturbances unresponsive to medical therapy (such as hyperkalemia, metabolic acidosis, hypercalcemia, hypocalcemia, and hyperphosphatemia)</para></listitem>
<listitem><para>Failure to thrive; malnutrition</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Types</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Choice of dialysis is determined by three main factors:</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Type of renal failure (acute or chronic)</para></listitem>
<listitem><para>Client&rsquo;s particular physical condition</para></listitem>
<listitem><para>Access to dialysis resources</para></listitem></orderedlist></listitem>
<listitem><para>Two primary types of dialysis</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Hemodialysis (HD)</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Requires placement of a venous access and a filtering machine removing the blood from the body, running it through a dialyzer, and then returning it to the body</para></listitem>
<listitem><para>Conventional HD may be done three times a week over 3 to 4 hours, either at a facility or in the home, or daily dialysis may be done during the day or night hours, often at home.</para>
</listitem></orderedlist></listitem>
<listitem><para>Peritoneal dialysis (PD)</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Requires a surgically placed abdominal catheter for infusing dialysate fluid into the peritoneal cavity for a predetermined dwell time and then draining it out</para></listitem>
<listitem><para>Procedure may be carried out at home through gravity system or automated pump.</para>
</listitem></orderedlist></listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: In 2014, approximately 468,000 individuals with ESRD received dialysis in the United States (414,180 receiving HD and 53,820 receiving PD). An additional 193,000 with ESRD received transplants as the initial mode of therapy (USRDS, 2015a).</para></listitem>
<listitem><para>Mortality: Dialysis patients continue to have substantially higher mortality, and fewer expected remaining life years, when compared with the general population who have cancer, diabetes, or cardiovascular disease. However, the relative and absolute decline in mortality for dialysis patients in the past 15 years has been greater than for cancer, diabetes, or cardiovascular disease. In 2014, the adjusted mortality rate for dialysis patients was 166 per 1000 patient-years (USRDS, 2015a).</para></listitem>
<listitem><para>Costs: In 2014, total Medicare payments for HD treatments were $26.1 billion, while payments for PD were approximately $3.6 billion (USRDS, 2015b).</para>
</listitem></orderedlist></listitem></orderedlist>
<note id="ch0008s0254note0646">
<title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Access:</emphasis> Point on the body where a needle or catheter is inserted to gain entry to the bloodstream. Arteriovenous (AV) access is via graft, fistula, or central vein line.</para>
<para><emphasis role="strong">AV fistula:</emphasis> Vascular access is made by joining an artery to a vein under the skin to make a bigger blood vessel.</para>
<para><emphasis role="strong">AV graft:</emphasis> Soft plastic tube to join an artery and a vein under the skin.</para>
<para><emphasis role="strong">Dialysate:</emphasis> Fluid used in both PD and HD that cleanses the blood and replaces needed electrolytes.</para>
<para><emphasis role="strong">Disequilibrium syndrome:</emphasis> Nausea, vomiting, and hypertension, occasionally with convulsions, which develops within several hours after starting HD for renal failure; it is apparently caused by too rapid removal of urea from the extracellular fluid (ECF) compartment, with movement of water into cells and cerebral edema.</para>
<para><emphasis role="strong">Dry weight:</emphasis> The lowest weight a patient can tolerate without the development of symptoms or hypotension. Because physiological dry weight is that weight resulting from normal renal function, vascular permeability, serum protein concentration, and body volume regulation, dry weight in HD should, theoretically, be lower.</para>
<para><emphasis role="strong">Intradialytic parenteral nutrition (IDPN):</emphasis> Involves infusing hyperalimentation fluids during the time of dialysis&mdash;through the vascular shunt or intraperitoneally&mdash;to normalize the amounts of albumin, glucose, and other nutrients in the bloodstream and to decrease the associated morbidity and mortality associated with protein-calorie malnutrition.</para>
<para><emphasis role="strong">Ultrafiltration:</emphasis> Blood management method that removes noncellular water and low-molecular-weight solutes from anticoagulated blood through an extracorporeal (external from the body) filter.</para>
</note>
<sect2 id="ch0008s0255"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Primary focus is at the community level at the dialysis center, although inpatient acute stay may be required during initiation of therapy.</para>
</sect2>
<sect2 id="ch0008s0256"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0007s0224">Anemias&mdash;iron deficiency, anemia of chronic disease, pernicious, aplastic, hemolytic</link></para>
<para><link linkend="ch0002s0027">Heart failure: chronic</link></para>
<para><link linkend="ch0005s0164">Peritonitis</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0013s0318">Sepsis/septic shock</link></para>
<para><link linkend="ch0006s0219">Total nutritional support: parenteral/enteral feeding</link></para>
<table frame="top" id="ch0008s0254ta0365"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">***Refer to CPs: <link linkend="ch0008s0244">Acute Kidney Injury</link> and/or <link linkend="ch0008s0249">Chronic Kidney Disease</link> and <link linkend="ch0008s0249">End-Stage Renal Disease</link> for assessment information.</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC DIVISION<?lb?>MAY REPORT</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May require assistance with treatment regimen, transportation, activities of daily living (ADLs), homemaker and maintenance tasks, end-of life decisions, palliative care</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0008s1257"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<para>***Studies and results are variable, depending on reason for dialysis, degree of kidney involvement, and client considerations, such as distance from treatment center, cognition, available support, and insurance options. <emphasis role="strong">Refer to CPs: <link linkend="ch0008s0244">Acute Kidney Injury</link> and/or <link linkend="ch0008s0249">Chronic Kidney Disease</link> and <link linkend="ch0008s0249">End-Stage Renal Disease</link> for diagnostic studies.</emphasis></para>
</sect2>
<sect2 id="ch0008s0257"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Promote homeostasis and general well-being.</para></listitem>
<listitem><para>Maintain comfort.</para></listitem>
<listitem><para>Prevent complications.</para></listitem>
<listitem><para>Support client independence and self-care.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, and treatment needs.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0008s0258"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Fluid and electrolyte balance maximized.</para></listitem>
<listitem><para>Complications prevented or minimized.</para></listitem>
<listitem><para>Discomfort alleviated.</para></listitem>
<listitem><para>Dealing realistically with current situation; independent within limits of condition.</para></listitem>
<listitem><para>Disease process, prognosis, and therapeutic regimen understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<para><emphasis role="strong">This section addresses the general nursing management issues of client receiving some form of dialysis.</emphasis></para>
<note id="ch0008s0254note0647">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">imbalanced Nutrition: less than body requirements</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient dietary intake, [increased metabolic demands]; inability to digest food/absorb nutrients (result of uremia, medication side effects; loss of peptides/amino acids; abdominal distention)</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Food intake less than recommended daily allowance; satiety immediately upon ingesting food; abdominal pain/cramping</para>
<para>Insufficient interest in food; perceived inability to ingest food; alterations in taste sensation; food [renal diet] aversion</para>
<para>Insufficient muscle tone; [decreased subcutaneous fat or muscle mass]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Nutritional Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate stable weight or gain toward goal with normalization of laboratory values and no signs of malnutrition.</para>
</note>
<note role="none" id="ch0008s0254note0648">
<table frame="top" id="ch0008s0254ta0366"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Nutrition Therapy</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Ascertain type and stage of kidney disease and note client&rsquo;s food intake and nutrition status before starting dialysis. Note type of dialysis client is (or will be) receiving (hemodialysis [HD] or peritoneal [PD]).</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may present with widely varying nutrition needs (e.g., new diabetic with kidney failure, severe malnutrition related to long-term kidney disease, or be new to renal replacement therapy [RRT] and require dietary modifications). Each person&rsquo;s diet prescription is different, but the principal restrictions include protein, potassium, sodium, and phosphorus.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor amount and type of ingested food. Calculate daily caloric intake prior to and periodically during dialysis.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies nutritional deficits and diet therapy needs. Caloric intake during dialysis must be adequate for meeting daily metabolic demands, as well as for treating the malnutrition typically associated with ESRD.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Recommend client/significant other (SO) keep a food diary, including estimation of ingested calories, protein, and electrolytes of individual concern&mdash;sodium, potassium, chloride, magnesium, and phosphorus.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps client realize &ldquo;big picture&rdquo; and allows opportunity to alter dietary choices to meet individual desires within identified restrictions.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note presence of nausea and anorexia.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These symptoms accompany accumulation of endogenous toxins and can alter or reduce food intake. Medical interventions may be needed to improve client&rsquo;s desire and ability to eat.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage client to participate in menu planning.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May enhance oral intake and promote sense of control.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Recommend small, frequent meals. Schedule meals according to dialysis needs.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Smaller portions may enhance intake. Type of dialysis influences meal patterns; for instance, clients receiving HD might not be fed directly before or during procedure because this can alter fluid removal, and clients undergoing PD may be unable to ingest food while abdomen is distended with dialysate.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage use of herbs and spices such as garlic, onion, pepper, parsley, cilantro, and lemon.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Adds zest to food to help reduce boredom with diet, while reducing potential for ingesting too much potassium and sodium.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Suggest socialization during meals.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides diversion and promotes social aspects of eating.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage frequent mouth care.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces discomfort of oral stomatitis and metallic taste in mouth associated with uremia, which can interfere with food intake.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Perform complete nutrition assessment, using appropriate anthropometric and nutrition tools, consisting of laboratory studies (e.g., total proteins, glucose, micronutrients), comparison of initial weight with both usual body weight and percent of ideal body weight, and review of food diaries.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assesses adequacy of nutrient utilization and points to diet therapy needs. <emphasis>Note:</emphasis> Malnutrition is often present to some degree in any client with severe or chronic kidney disease. Studies have shown that the presence of malnutrition prior to initiation of dialysis is strongly predictive of increased mortality (Kalantar-Zadeh &amp; Fouque, 2017).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Refer to nutritionist or dietitian to develop diet appropriate to client&rsquo;s needs.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>It is necessary to develop a highly individual dietary program to meet needs within specific limitations. Nutrition-related concerns include maintenance of acceptable weight and serum proteins, prevention of renal osteodystrophy (defective bone development), and reduction of cardiovascular risks associated with protein energy malnutrition, electrolyte and micronutrient deficiencies (Kalantar-Zadeh &amp; Fouque, 2017).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide a balanced diet with prescribed calories and high-quality protein.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The client on hemodialysis (HD) may not be calorie limited. However, in peritoneal dialysis (PD), some calories come from dialysate solution (contains dextrose), thus reducing client&rsquo;s calories requirements from food (Swaford, n.d.). Protein intake in a clinically stable hemodialysis client is currently recommended to be 1.2 to 1.4 g/kg body weight/d, 60% of which should come from sources high in biological value (e.g., fish, poultry eggs) (Kalantar-Zadeh &amp; Fouque, 2017; Swaford, n.d.).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Restrict sodium (usually to 2 g or less/d) to manage body fluids and potassium as prescribed. Avoid bacon, ham, other processed meats and foods, orange juice, and tomato soup.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These electrolytes can quickly accumulate, causing fluid retention, weakness, and potentially lethal cardiac dysrhythmias. <emphasis>Note:</emphasis> Potassium removal is more efficient on PD because the treatment occurs daily. A typical daily goal for PD patients is 3000 to 4000 mg of potassium (Swaford, n.d.).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Limit foods high in calcium and phosphorus, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Mineral and bone disorder in CKD occurs when damaged kidneys and abnormal hormone levels cause calcium and phosphorus to be out of balance. This disorder commonly occurs in people with CKD and affects most people receiving dialysis. <emphasis>Note:</emphasis> It has been recommended that (in general) calcium intake should be limited to 2000 mg/d and phosphorus limited to 800 to 1000 mg/d while on either HD or PD (National Institute for Diabetes and Digestive and Kidney Diseases [NIDDK], 2015; Swaford, n.d.).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer multivitamins, including folic acid; vitamins B<subscript>6</subscript>, C, and D; and iron supplements, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Replaces vitamin and mineral deficits resulting from malnutrition, anemia, or loss during dialysis.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer parenteral supplements, as indicated, or interdialytic parenteral nutrition (IDPN), as necessary.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Parenteral nutrition may be given to provide nutrients only if oral intake is insufficient to prevent malnutrition and enteral feeding is contraindicated. IDPN may be required in client who (1) continues to lose weight, (2) has very low serum albumin despite oral supplementation, or (3) when parenteral route is unavailable or contraindicated. <emphasis>Note:</emphasis> IDPN is convenient because it is delivered during dialysis and is beneficial in some clients. However, only about 70% of the nutrients are actually delivered to the patient because of loss into the dialysate. Recent treatment guidelines and reimbursement schedules indicate that use of IDPN should be limited and initiated only after aggressive attempts at enteral feeding (Beddhu et al, 2017).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory studies, for example:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Comprehensive metabolic panel (e.g., glucose, total proteins, calcium, electrolytes)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information about the current status of a person&rsquo;s metabolism and nutrition status. Abnormal results, especially combinations of abnormal results, can indicate a dietary problem that needs to be addressed.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hemoglobin (Hgb), red blood cell (RBC), and iron levels</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Anemia is the most pervasive complication affecting energy levels in ESRD.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as appropriate, for example:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antiemetics, such as prochlorperazine (Compazine)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces stimulation of the vomiting center.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Histamine blockers, such as famotidine (Pepcid)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Gastric distress is common and may be a neuropathy-induced gastric paresis. Hypersecretion can cause persistent gastric distress and digestive dysfunction.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hormones and supplements as indicated, such as erythropoietin (EPO, Epogen) and iron infusions or oral supplements (e.g., Feosol, Ferrex 150)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although EPO is given to increase numbers of RBCs, it is not effective without iron supplementation.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Insert and maintain nasogastric (NG) or enteral feeding tube, if indicated.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be necessary when persistent vomiting occurs or when enteral feeding is desired.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0254note0649">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for impaired Skin Integrity</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Chemical injury agent (e.g., uremia; phosphorus); pharmaceutical agent(s) [and drug allergies]</para>
<para>Alteration in skin turgor/fluid volume</para>
<para>Inadequate nutrition; alteration in metabolism</para>
<para>Impaired circulation; alteration in sensation</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Tissue Integrity: Skin &amp; Mucous Membranes</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain structural intactness of epidermis and dermis.</para>
<para><emphasis role="strong">Risk Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Participate in prevention measures.</para>
</note>
<note role="none" id="ch0008s0254note0650">
<table frame="top" id="ch0008s0254ta0367"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Skin Surveillance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Perform routine skin inspections in at-risk client, documenting observed changes. Ask client about skin sensations.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Skin conditions that can affect client on dialysis include (1) itching (pruritus) from high level of phosphorus; (2) dry skin (xerosis)&mdash;CKD-related changes in sweat and oil glands; and (3) skin discoloration (hyperpigmentation) due to retention of urochromes normally excreted by kidneys (DaVita Kidney Care Staff, n.d.).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess activity limitations, noting presence and degree of restriction or ability.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Influences choice of interventions. <emphasis>Note</emphasis>: Fear of or real danger of dislodging dialysis lines or catheter may cause client to be reluctant to initiate movement.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage frequent change of position when on bedrest or chair rest; support affected body parts and joints with pillows, rolls, sheepskin, and elbow and heel pads, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreases discomfort, maintains muscle strength and joint mobility, enhances circulation, and prevents skin breakdown.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide and encourage soothing skin care (e.g., bathing with soap for sensitive skin; applying high-water content gel, lotion, or cream right after bath while skin is still damp; avoiding alcohol-based lotions).</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps to maintain softer and more elastic skin, making it more protective against breakdown.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Keep body pressure points and skin folds clean and dry. Keep bed linens dry and wrinkle-free.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces skin irritation and likelihood of breaking down/injury at pressure points. <emphasis>Note:</emphasis> Dry bed linens may be of special importance in client with uremic pruritus, which is often generalized and especially bothersome when it affects the back.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct in and assist with active and passive range-of-motion (ROM) exercises.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes circulation, maintains joint flexibility, prevents contractures, and aids in reducing muscle tension. <emphasis>Note:</emphasis> A high level of phosphorus may cause calcium-phosphorus crystals to build up in the joints, muscles, and other body organs, leading to bone and joint pain. To avoid these risks, client may be prescribed a phosphate binder (e.g., calcium acetate [PhosLo]).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client to be up and about as much as possible. Institute a planned activity or exercise program as appropriate, with client&rsquo;s input.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Improves systemic circulation (good for the skin) and increases client&rsquo;s energy and sense of well-being. <emphasis>Note:</emphasis> Recent studies report findings of significant beneficial effects of various exercise interventions in CKD patients (including those on dialysis), positively impacting muscular functioning, walking capacity, cardiovascular function, and quality of life (Heiwe &amp; Jacobson, 2014).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Provide foam, water, or air flotation mattress or soft chair cushion.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Reduces tissue pressure and may enhance circulation, thereby reducing risk of dermal ischemia and breakdown.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0254note0651">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">Self-Care deficit (specify)</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Weakness, fatigue; decrease in motivation</para>
<para>Pain, discomfort</para>
<para>Alteration in cognitive functioning; perceptual disorders (accumulated toxins)</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Impaired inability to perform ADLs</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Self-Care Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Performs ADLs within level of own ability and constraints of the illness.</para>
</note>
<note role="none" id="ch0008s0254note0652">
<table frame="top" id="ch0008s0254ta0368"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Self-Care Assistance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine client&rsquo;s physical ability to participate in self-care activities (scale of 0 to 4). Note degree of fatigue, cognitive and emotional factors that may impact self-care, and presence/location/intensity of pain.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Underlying condition dictates level of deficit, affecting choice of interventions. <emphasis>Note:</emphasis> Multiple other factors associated with CKD (e.g., fatigue, cognitive impairment, pain, depression, lack of motivation or support) also have a major impact on the client&rsquo;s abilities.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Active-listen client&rsquo;s/SOs concerns. Participate in working on solutions and mutual goal setting.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Exhibits regard for client&rsquo;s values and beliefs, clarifies barriers to participation in self-care, provides opportunity for problem-solving, and provides support.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide assistance with activities as necessary. Encourage client/SO to participate in planning and decision making of needed/desired activities.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Meets immediate needs while supporting client participation and independence.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage use of energy-saving techniques: sitting, not standing; using shower chair; resting between activities; and doing tasks in small increments.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Conserves energy, reduces fatigue, and enhances client&rsquo;s ability to perform tasks.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend scheduling activities to allow client sufficient time to accomplish tasks to fullest extent of ability.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Unhurried approach reduces frustration and promotes client participation, enhancing self-esteem.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Collaborate with PT/OT to evaluate individual abilities and assistive devices as needed.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Modified exercise program aids in maintaining muscle strength and appropriate use of assistive devices supports independence.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Provide analgesics as indicated.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Alleviation of discomforts/pain can give client energy and motivation to address needed tasks.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0254note0653">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for Constipation</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Eating habit change; insufficient food/fluid intake</para>
<para>Decrease in gastrointestinal motility</para>
<para>Electrolyte imbalance</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Bowel Elimination</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain usual or improved bowel function.</para>
</note>
<note role="none" id="ch0008s0254note0654">
<table frame="top" id="ch0008s0254ta0369"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Constipation/Impaction Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate bowel sounds. Note consistency and frequency of bowel movements (BMs) and presence of abdominal distention.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased bowel sounds, passage of hard-formed or dry stools suggest constipation and requires ongoing intervention to manage.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review current medication regimen.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Side effects of some treatment-related drugs, such as iron products and some antacids, may compound problem.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ascertain usual dietary pattern and food choices.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although restrictions may be present, thoughtful consideration of menu choices can aid in controlling problem.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggest adding fresh fruits, vegetables, and fiber to diet within restrictions, when indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides bulk, which improves stool consistency and reduces incidence of constipation. <emphasis>Note:</emphasis> The National Academy of Sciences Institute of Medicine noted that fiber prompts the absorption of calcium in person with CKD (thus improving calcium balance and bone mineral density) and helps control both high blood pressure and high blood sugar levels (Kidney Cares Community, 2013).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage or assist with ambulation, and exercise program when able.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Activity may stimulate peristalsis, promoting return to normal bowel activity.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide privacy at bedside commode and bathroom.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes psychological comfort needed for elimination.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer stool softeners, such as docusate sodium (Colace), or bulk-forming laxatives, such as psyllium (Metamucil), as appropriate.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Produces a softer, more easily evacuated stool.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0254note0655">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for acute Confusion</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Impaired metabolic functioning&mdash;electrolyte imbalances, increased blood urea nitrogen (BUN)/creatinine, azotemia, decreased hemoglobin; malnutrition</para>
<para>Alteration in sleep-wake cycle; pain; impaired mobility</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Cognition</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain or regain usual or improved level of mentation.</para>
<para>Recognize changes in thinking and behavior and demonstrate behaviors to prevent or minimize changes.</para>
</note>
<note role="none" id="ch0008s0254note0656">
<table frame="top" id="ch0008s0254ta0370"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Delirium Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess for behavioral changes or change in level of consciousness (LOC)&mdash;disorientation, lethargy, decreased concentration, memory loss, and altered sleep pattern.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May indicate level of uremic toxicity, developing complication of dialysis such as disequilibrium syndrome, and need for further assessment and intervention.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Keep explanations simple and reorient frequently as needed. Provide &ldquo;normal&rdquo; day or night lighting patterns, clock, and calendar.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Improves reality orientation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide a safe environment and providing presence (someone with client) during procedure, as appropriate.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents client injury and inadvertent removal of dialysis lines or catheter if client is confused.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Drain peritoneal dialysate promptly at end of specified equilibration period.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prompt outflow will decrease risk of hyperglycemia or hyperosmolar fluid shifts affecting cerebral function.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Investigate reports of headache, associated with onset of dizziness, nausea, and vomiting, and note onset of progressive confusion, agitation, hypotension, tremors, or seizure activity.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May reflect development of disequilibrium syndrome (DDS), a neurological phenomenon, which can occur near completion of or following HD, particularly when client is first starting dialysis therapy. It is thought to be associated with cerebral edema (Mailloux, 2016).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor lab studies such as:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>BUN/Cr and serum glucose levels, determine urea reduction ratio (URR)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Follows progression or resolution of azotemia. Pre- and postdialysis BUN levels are used to determine efficacy of procedure. Also, urea reduction ratio (URR) of at least 60% to 65% (measured monthly) is considered a desirable response to dialysis (NIDDK, 2014).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aluminum level, as indicated</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevation may warn of impending cerebral involvement or dialysis dementia.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Alternate or change dialysate concentrations according to protocol, and add insulin, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hyperglycemia may develop secondary to glucose crossing peritoneal membrane and entering circulation. May require initiation of insulin therapy.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer normal saline intravenously (IV), as appropriate.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Volume restoration may be sufficient to reverse effects of disequilibrium syndrome.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medication, as indicated, such as phenytoin (Dilantin), mannitol (Osmitrol), and barbiturates.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>If disequilibrium syndrome occurs during dialysis, medication may be needed to control seizures in addition to a change in dialysis prescription or discontinuation of therapy.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0254note0657">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">Anxiety [specify level]</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Situational crisis; stressors; threat of death</para>
<para>Threat to current status (e.g., change in health status, role functioning, or socioeconomic status)</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Worried about change in life event</para>
<para>Increase in tension; apprehensiveness; uncertainty, fear; hypervigilance; insomnia</para>
<para>Sympathetic stimulation; alteration in attention/concentration; diminished ability to problem solve</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Anxiety Self-Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize awareness of feelings and reduction of anxiety to a manageable level.</para>
<para>Demonstrate problem-solving skills and effective use of resources.</para>
<para>Appear relaxed and able to rest and sleep appropriately.</para>
</note>
<note role="none" id="ch0008s0254note0658">
<table frame="top" id="ch0008s0254ta0371"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Anxiety Reduction</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess level of concern of both client and SO. Note signs of denial, depression, or narrowed focus of attention.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps determine the kind of interventions required.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Explain procedures and care as delivered. Repeat explanations frequently, as needed. Provide information in multiple formats, including pamphlets and films.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fear of unknown is lessened by information and knowledge and may enhance acceptance of permanence of ESRD and necessity for dialysis. Alteration in thought processes and high levels of anxiety or fear may reduce comprehension, requiring repetition of important information. <emphasis>Note:</emphasis> Uremia can impair short-term memory, requiring repetition or reinforcement of information provided.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Acknowledge normalcy of feelings in this situation.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Knowing feelings are normal can allay fear that client is losing control.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide opportunities for client and SO to ask questions and verbalize concerns.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Creates feeling of openness and cooperation and provides information that will assist in problem identification and solving.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage SO to participate in care, as able and desired.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Involvement promotes sense of sharing, strengthens feelings of usefulness, provides opportunity to acknowledge individual capabilities, and may lessen fear of the unknown.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Acknowledge concerns of client and SO.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prognosis and possibility of need for long-term dialysis and resultant lifestyle changes are major concerns for this client and those who may be involved in future care.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Point out current positive indicators of treatment&mdash;improvement in laboratory values, stable BP, or lessened fatigue.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes sense of progress in an otherwise chronic process that seems endless while client still is experiencing physical deterioration and depression.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Arrange for visit to dialysis center and meeting with another dialysis client, as appropriate.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Interaction with others who have encountered similar problems may assist client and SO to work toward acceptance of chronic condition and focus on problemsolving activities.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Address financial considerations. Refer to appropriate resources.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Treatment for kidney failure is expensive, although Medicare and other health insurance programs pay much of the cost. Loss of income/need for home care and so on increase financial worries.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0254note0659">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">disturbed Body Image</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Illness; treatment regimen</para>
<para>Alteration in body function, self-perception, cognitive functioning</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Perceptions that reflect an altered view of one&rsquo;s body appearance; negative feeling about body (e.g., feelings of helplessness, powerlessness)</para>
<para>Focus on past function; refusal to acknowledge change; preoccupation with change</para>
<para>Change in lifestyle, social involvement</para>
<para>Extension of body boundary (incorporates environmental objects&mdash;dialysis equipment)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Body Image</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Identify feelings and methods for coping with negative perception of self.</para>
<para>Verbalize acceptance of body function/change in health status.</para>
<para><emphasis role="strong">Psychosocial Adjustment: Life Change</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate adaptation to changes and events that have occurred, as evidenced by setting realistic goals and active participation in care and life in general.</para>
</note>
<note role="none" id="ch0008s0254note0660">
<table frame="top" id="ch0008s0254ta0372"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Body Image Enhancement</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess level of client&rsquo;s knowledge about condition and treatment and anxiety related to current situation.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies extent of problem or concern and necessary interventions.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss meaning of loss and change to client.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Many clients and their families have difficulty dealing with changes in life and role performance as well as the client&rsquo;s loss of ability to control own body.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note withdrawn behavior, ineffective use of denial, or behaviors indicative of overconcern with body and its functions. Investigate reports of feelings of depersonalization or the bestowing of humanlike qualities on machinery.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicators of developing difficulty handling stress of what is happening. <emphasis>Note:</emphasis> Client may feel tied to and controlled by the technology central to his or her survival, even to the point of extending body boundary to incorporate dialysis equipment.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess for use of addictive substances, primarily alcohol, other drugs, and self-destructive or suicidal behavior.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May reflect dysfunctional coping and attempt to handle problems in an ineffective manner.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine stage of grieving. Note signs of severe or prolonged depression.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identification of grief stage client is experiencing provides guide to recognizing and dealing appropriately with behavior as client and SO work to come to terms with loss and limitations associated with condition. Prolonged depression may indicate need for further intervention.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Acknowledge normalcy of feelings.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recognition that feelings are to be expected helps client accept and deal with them more effectively.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage verbalization of personal and work conflicts that may arise. Actively listen to concerns.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps client identify problems and problem-solve solutions. <emphasis>Note:</emphasis> Home dialysis may provide more flexibility and enhance sense of control for clients who are appropriate candidates for this form of therapy.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine client&rsquo;s role in family constellation and client&rsquo;s perception of expectation of self and others.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Long-term and permanent illness or disability alters client&rsquo;s ability to fulfill usual role(s) in family and work setting. Unrealistic expectations can undermine self-esteem and affect outcome of illness.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend SO treat client normally and not as an invalid.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Conveys expectation that client is able to manage situation and helps maintain sense of self-worth and purpose in life.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist client to incorporate disease management into lifestyle.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Necessities of treatment assume a more normal aspect when they are a part of the daily routine.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify strengths, past successes, and previous methods client has used to deal with life stressors.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Focusing on these reminders of own ability to deal with problems can help client deal with current situation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Help client identify areas over which he or she has some measure of control. Provide opportunity to participate in decision-making process.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides sense of control over seemingly uncontrollable situation, fostering independence.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend participation in local support group.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces sense of isolation as client learns that others have been where client is now. Provides role models for dealing with situation, problem-solving, and &ldquo;getting on with life.&rdquo; Reinforces that therapeutic regimen can be beneficial.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to healthcare and community resources, such as social service, vocational counselor, and psychiatric clinical nurse specialist.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Provides additional assistance for long-term management of chronic illness and change in lifestyle.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0254note0661">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for ineffective Health Management</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Difficulty managing complex treatment regimen/navigating complex healthcare systems</para>
<para>Perceived seriousness of condition, susceptibility, benefit or barriers</para>
<para>Excessive demands; family conflict; decisional conflicts; powerlessness</para>
<para>Economically disadvantaged; insufficient social support</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Self-Management: Kidney Disease</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of condition and relationship of signs and symptoms of the disease process and potential complications.</para>
<para>Verbalize understanding of therapeutic needs.</para>
<para>Correctly perform necessary procedures and explain reasons for actions.</para>
</note>
<note role="none" id="ch0008s0254note0662">
<table frame="top" id="ch0008s0254ta0373"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note level of anxiety or fear and alteration of thought processes. Time teaching appropriately.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These factors directly affect ability to access and use knowledge. In addition, during the dialysis procedure, client&rsquo;s cognitive function may be impaired, and clients themselves state that they feel &ldquo;fuzzy.&rdquo; Therefore, learning may not be optimal during this time.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review particular disease process, prognosis, and potential complications in clear concise terms, periodically repeating and updating information, as necessary.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Providing information at the level of the client&rsquo;s and SO&rsquo;s understanding will reduce anxiety and misconceptions about what client is experiencing.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage and provide opportunity for questions.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances learning process, promotes informed decision making, and reduces anxiety associated with the unknown.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Acknowledge that certain feelings and patterns of response are normal during course of therapy.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client and SO may initially be hopeful and positive about the future, but as treatment continues and progress is less dramatic, they can become discouraged and depressed, and conflicts of dependence versus independence may develop.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Emphasize necessity of reading all product labels&mdash;food, beverage, and over-the-counter (OTC) drugs&mdash;and not taking medications or herbal supplements without checking with healthcare provider.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>It is difficult to maintain electrolyte balance when exogenous intake is not factored into dietary restriction; for example, hypercalcemia can result from routine supplement use in combination with increased dietary intake of calcium-fortified foods and medicines.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Emphasize importance of adhering to medication schedule required for the client&rsquo;s specific form of renal disease, timing of dialysis, and properties of the individual medications.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This is necessary to ensure that therapeutic levels of the drugs are reached and that toxic levels are avoided.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss significance of maintaining nutritious eating habits, preventing wide fluctuation of fluid and electrolyte balance, and avoidance of crowds or people with infectious processes.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Depressed immune system, presence of anemia, invasive procedures, and malnutrition potentiate risk of infection.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Instruct client about ESOs (e.g., epoetin [Epogen], darbepoetin [Aransep]), when used. Have client or SO demonstrate ability to administer and state adverse side effects and healthcare practices associated with this therapy.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Used for the management of the anemia associated with CRF and ESRD. Contraindications may include adverse side effects such as polycythemia, increased clotting, failure to administer correctly or have appropriate follow-up.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify healthcare and community resources, such as dialysis support group, social services, and mental health clinic.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Knowledge and use of these resources assist client and SO to manage care more effectively. Interaction with others in similar situation provides opportunity for discussion of options and making informed choices, including stopping dialysis or renal transplantation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Teaching: Procedure/Treatment</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss procedures and purpose of dialysis in terms understandable to client. Repeat explanations as required.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A clear understanding of the purpose, process, and what is expected of client and SO facilitates their cooperation with regimen and may enhance outcomes.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Instruct client and SO in home dialysis, as indicated:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Home dialysis is associated with better outcomes in general and better survival rates as dialysis is usually performed 5 to 7 days/week and is more intensive. This decreases fluctuations in fluid, solute, and electrolyte balance, more closely mimicking renal function. However, specific criteria for client and SO participation and training, home resources, and professional oversight must be met in order to consider this option.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Operation and maintenance of equipment (including vascular shunt), sources of supplies</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Information diminishes anxiety of the unknown and provides opportunity for client to be knowledgeable about own care.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aseptic or clean technique</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents contamination and reduces risk of infection.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Self-monitoring of effectiveness of procedure</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information necessary to evaluate effects of therapy and need for change.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Management of potential complications</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces concerns regarding personal well-being; supports efforts at self-care.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide contact information for dialysis support persons.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Readily available support person can answer questions, troubleshoot problems, and facilitate timely medical intervention, when indicated, reducing risk and severity of complications. <emphasis>Note:</emphasis> Home dialysis clients usually are monitored by conventional dialysis center or interdisciplinary team.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify sources for supplies at home and when away from home.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Home dialysis clients are often capable of travel, even overseas, with proper preplanning and support.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0254note0663">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS</emphasis> following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Fatigue</emphasis>&mdash;disease state, malnutrition, altered body chemistry, stress, depression</para></listitem>
<listitem><para><emphasis role="bi">excess Fluid Volume</emphasis>&mdash;compromised regulatory mechanism</para></listitem>
<listitem><para><emphasis role="bi">risk for Infection</emphasis>&mdash;invasive procedures, decreased hemoglobin, chronic disease, malnutrition</para></listitem>
<listitem><para><emphasis role="bi">ineffective Health Management</emphasis>&mdash;complexity of therapeutic regimen, economic difficulties, decisional conflicts; excessive demands made on individual and family</para></listitem>
<listitem><para><emphasis role="bi">risk for caregiver Role Strain</emphasis>&mdash;illness severity of care receiver, caregiver is spouse, presence of situational stressors, complexity/amount/duration of caregiving required</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0008s0259"><title><emphasis role="strong">PERITONEAL DIALYSIS (PD)</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Procedure</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Requires a surgically placed abdominal catheter and uses the peritoneum to filter toxins and excess fluid from the body</para></listitem>
<listitem><para>Fluid removal is controlled by adjusting the dextrose concentration in the dialysate (e.g., 1.5%, 2.5%, 4.25%) to create an osmotic gradient for water with higher dextrose concentrations and more frequent exchanges increasing the rate of fluid removal.</para></listitem>
<listitem><para>May be preferred over hemodialysis because it uses a simpler technique and provides more gradual physiological changes</para></listitem>
<listitem><para>Long-term PD typically calls for three to four exchanges a day, each with a dwell time of 4 to 6 hours, and a long (8- to 10-hour) dwell time at night.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Types (NIDDK, 2016b)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Continuous ambulatory peritoneal dialysis (CAPD)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Most commonly used type of long-term PD, allowing client to manually manage the procedure at home with bag and gravity flow</para></listitem>
<listitem><para>Some clients experience problems with the long overnight dwell time because, as dextrose in the solution crosses into body, it becomes glucose and starts to draw fluid from the peritoneal cavity back into the body, thereby reducing the efficiency of the exchange and requiring a mini-cycler machine during the night.</para>
</listitem></orderedlist></listitem>
<listitem><para>Automated peritoneal dialysis (APD)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Continuous cycler-assisted peritoneal dialysis (CCPD)</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Uses a machine (cycler) to fill and empty the abdomen three to five times during the night while the person sleeps. In the morning, the last fill remains in the abdomen with a dwell time that lasts the entire day. May be a method of choice for younger individuals engaged in work activities.</para></listitem>
<listitem><para>A combination of APD and CAP may be needed under certain client conditions (e.g., client is over the weight restrictions; client&rsquo;s peritoneum filters wastes too slowly).</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: In 2014, approximately 129,450 Americans received PD (USRDS, 2015a).</para></listitem>
<listitem><para>Mortality: In 2014, adjusted mortality rate was 157 for peritoneal dialysis patients, per 1000 patient-years (USRDS, 2015c).</para></listitem>
<listitem><para>Costs: In 2014, Medicare payments for outpatient PD were approximately $3.6 billion. Per patient per year costs for all PD patients averaged $73,612 (USRDS, 2015b).</para>
</listitem></orderedlist></listitem></orderedlist></listitem></orderedlist>
<note id="ch0008s0259note0664">
<title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Automated peritoneal dialysis (APD):</emphasis> Uses a machine to control the time of exchanges; warm, infuse, and drain the used solution at preset intervals; and fill the peritoneal cavity with new solution.</para>
<para><emphasis role="strong">Continuous ambulatory peritoneal dialysis (CAPD):</emphasis> Uses three to five cycles daily and one long overnight dwell time, 7 days/week.</para>
<para><emphasis role="strong">Continuous cycler-assisted peritoneal dialysis (CCPD):</emphasis> Mechanical device cycles shorter dwell times during the night (three to six cycles) with one 8-hour dwell time during daylight hours, thus increasing the client&rsquo;s independence.</para>
<para><emphasis role="strong">Cycle:</emphasis> The infusion and drainage of a specific volume of peritoneal dialysis solution. The dwell time may vary from a few minutes to several hours.</para>
<para><emphasis role="strong">Cycler:</emphasis> Machine used to infuse and drain dialysate from the peritoneal cavity.</para>
<para><emphasis role="strong">Dialysate (dialysis fluid):</emphasis> A mixture of water, electrolytes, and dextrose. Electrolyte levels in dialysate are proportioned to ensure that the levels in the blood remain within physiological range. Waste products, such as BUN and creatinine, are not present in the dialysate and will readily move out of the blood into the dialysis fluid.</para>
<para><emphasis role="strong">Nocturnal intermittent peritoneal dialysis (NIPD):</emphasis> Similar to CCPD, except the number of overnight exchanges is greater (six to eight) and no exchange is performed during the day.</para>
<para><emphasis role="strong">Peritoneal dialysis (PD):</emphasis> Treatment for both acute kidney injury (AKI) and end-stage renal disease (ESRD) using the peritoneum as the semipermeable membrane permitting transfer of nitrogenous waste products, toxins, and fluid from the blood into a dialysate solution.</para>
<para><emphasis role="strong">Ultrafiltrate:</emphasis> The net amount of fluid resulting when the original volume of the dialysate used for a certain dwell is subtracted from the volume of the drained dialysate (effluent-infused dialysate = ultrafiltrate).</para>
</note>
<note id="ch0008s0259note0665">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for excess Fluid Volume</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Compromised regulatory mechanism (e.g., inadequate osmotic gradient of dialysate; fluid retention&mdash;malpositioned, kinked, or clotted internal catheter)</para>
<para>Excess fluid intake&mdash;oral (PO) or intravenous (IV)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Fluid Overload Severity</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate dialysate outflow exceeding or approximating infusion.</para>
<para>Experience no rapid weight gain, edema, or pulmonary congestion.</para>
</note>
<note role="none" id="ch0008s0259note0666">
<table frame="top" id="ch0008s0259ta0374"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Peritoneal Dialysis Therapy</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor client&rsquo;s oral fluid intake (and educate client about fluid management) during and between dialysis.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fluid overload is not usually a big problem with PD because procedure is performed every day. The exception may be if client is not following kidney diet or misses a dialysis session.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain a record of inflow and outflow volumes and cumulative fluid balance.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In most cases, the amount drained should equal or exceed the amount instilled. A positive balance with more fluid in than out indicates need for further evaluation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Record serial weights, compare with intake and output (I&amp;O) balance. Weigh client when abdomen is empty of dialysate, providing a consistent reference point.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Serial body weights are an accurate indicator of fluid volume status. A positive fluid balance with an increase in weight indicates fluid retention.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Turn from side to side, elevate the head of the bed, and apply gentle pressure to the abdomen.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May enhance outflow of fluid when catheter is malpositioned or obstructed by the peritoneal omentum.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note abdominal distention associated with poor dialysate outflow, decreased bowel sounds, changes in stool consistency, and reports of constipation.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Bowel distention or constipation may impede outflow of effluent. <emphasis>Note:</emphasis> Constipation, the most common cause of poor outflow, is associated with several factors (e.g., lack of fiber in diet, fluid restrictions, peritoneal catheter malfunction or occasionally peritonitis), which can result in dialysis failure. (Refer to CP: <link linkend="ch0008s0254">Renal Dialysis: general considerations</link>, ND: <link linkend="ch0008s0254note0653">risk for Constipation</link>.)</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor blood pressure (BP) and pulse, noting escalating hypertension, shortness of breath, neck vein distention, and peripheral edema; measure central venous pressure (CVP), if available.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevations indicate hypervolemia. Assess heart and breath sounds, noting S<subscript>3</subscript> and crackles and rhonchi. Fluid overload may potentiate heart failure (HF) or pulmonary edema.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate development of tachypnea, dyspnea, and increased respiratory effort. Drain dialysate and notify physician.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Abdominal distention or diaphragmatic elevation may cause respiratory distress.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess for headache, muscle cramps, mental confusion, and disorientation.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Symptoms suggest hyponatremia or water intoxication.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor equipment:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess patency of catheter, noting difficulty in draining. Note presence of fibrin strings or plugs.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Slowing of flow rate or presence of fibrin suggests partial catheter occlusion requiring further evaluation or possible intervention.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Check tubing for kinks; note placement of bags. Anchor catheter so that adequate inflow and outflow are achieved.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Improper functioning of equipment may result in retained fluid in abdomen and insufficient clearance of toxins.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Alter dialysate regimen, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes may be needed in the glucose or sodium concentration to facilitate efficient dialysis.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor blood glucose as prescribed when client is a diabetic.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevated glucose increases fluid retention and causes dialysate imbalance and reduced effectiveness of PD.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor serum sodium.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypernatremia may be present, although serum levels can be low, reflecting dilutional effect of fluid volume overload.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Maintain fluid restriction, as indicated.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Fluid restrictions may have to be continued to decrease fluid volume overload. Between dialysis treatments, fluids accumulate in the body, particularly in the heart, lungs, and ankles.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0259note0667">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for deficient Fluid Volume</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Loss of fluid through abnormal routes (e.g., use of hypertonic dialysate with excessive removal of fluid)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Systemic Toxin Clearance: Dialysis</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Achieve desired alteration in fluid volume and weight with BP and electrolyte levels within acceptable range.</para>
<para>Experience no symptoms of dehydration.</para>
</note>
<note role="none" id="ch0008s0259note0668">
<table frame="top" id="ch0008s0259ta0375"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Peritoneal Dialysis Therapy</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain record of inflow and outflow volumes and individual and cumulative fluid balance.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information about the status of client&rsquo;s loss or gain at the end of each exchange.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Adhere to schedule for draining dialysate from abdomen.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prolonged dwell times, especially when 4.5% glucose solution is used, may cause excessive fluid loss.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Weigh when abdomen is empty, following initial 6 to 10 runs, then as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Detects rate of fluid removal by comparison with baseline body weight.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor BP lying and sitting and pulse. Note level of jugular pulsation.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased BP, postural hypotension, and tachycardia are early signs of hypovolemia.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note reports of dizziness, nausea, and increasing thirst.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May indicate hypovolemia or hyperosmolar syndrome.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Inspect mucous membranes; evaluate skin turgor, peripheral pulses, and capillary refill.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Dry mucous membranes, poor skin turgor, and diminished pulses and capillary refill are indicators of dehydration and need for increased intake or changes in strength of dialysate.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory studies, as indicated, such as:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Serum sodium and glucose levels</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypertonic solutions may cause hypernatremia by removing more water than sodium. In addition, dextrose may be absorbed from the dialysate, thereby elevating serum glucose.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Serum potassium levels</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Hypokalemia may occur and can cause cardiac dysrhythmias.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0259note0669">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for physical Trauma</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Invasive procedure (e.g., catheter inserted into peritoneal cavity, site near the bowel and bladder with potential for perforation during insertion or manipulation of the catheter)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Risk Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Experience no injury to bowel or bladder.</para>
</note>
<note role="none" id="ch0008s0259note0670">
<table frame="top" id="ch0008s0259ta0376"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Peritoneal Dialysis Therapy</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Have client empty bladder before peritoneal catheter insertion if indwelling catheter not present.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>An empty bladder is more distant from insertion site and reduces likelihood of being punctured during catheter insertion.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Anchor catheter and tubing with appropriate connectors and/or tape. Emphasize importance of client avoiding pulling or pushing on catheter.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of trauma by manipulation of the catheter.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note presence of fecal material in dialysate effluent or strong urge to defecate, accompanied by severe, watery diarrhea.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggests bowel perforation with mixing of dialysate and bowel contents. This requires immediate medical intervention as it is a potentially lethal complication including peritonitis, sepsis, and death.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note reports of intense urge to void or large urine output following initiation of dialysis run. Test urine for sugar, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggests bladder perforation with dialysate leaking into bladder. Presence of glucose-containing dialysate in the bladder will elevate glucose level of urine.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Stop dialysis if there is evidence of bowel or bladder perforation, leaving peritoneal catheter in place.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Prompt action will prevent further injury. Immediate surgical repair may be required. Leaving catheter in place facilitates diagnosing and locating the perforation.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0259note0671">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">acute Pain</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Physical agents (e.g., insertion of catheter through abdominal wall, catheter irritation, improper catheter placement; abdominal distention)</para>
<para>Chemical agents (e.g., infusion of cold or acidic dialysate, rapid infusion of dialysate)</para>
<para>Biological agents (e.g., infection within the peritoneal cavity)</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Verbalization/coded reports of pain</para>
<para>Self-focusing</para>
<para>Guarding behaviors, positioning to avoid pain</para>
<para>Expressive behavior (e.g., restlessness, irritability)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Pain Level</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize decrease of pain and discomfort.</para>
<para>Demonstrate relaxed posture and facial expression; be able to sleep and rest appropriately.</para>
</note>
<note role="none" id="ch0008s0259note0672">
<table frame="top" id="ch0008s0259ta0377"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Pain Management: Acute</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate client&rsquo;s reports of pain; note intensity (using 0 to 10 [or similar] scale), location, and precipitating factors.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assists in identification of source of pain and appropriate interventions.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Explain that initial discomfort usually subsides after the first few exchanges.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Information may reduce anxiety and promote relaxation during procedure.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor for pain that begins during inflow and continues during equilibration phase. Slow infusion rate, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pain will occur if acidic dialysate causes chemical irritation of peritoneal membrane.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note reports of abdominal discomfort that is most pronounced near the end of inflow.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Likely the result of abdominal distention from dialysate. Amount of infusion may have to be decreased initially. <emphasis>Note:</emphasis> Dialysis solution comes in 1.5-, 2-, 2.5-, or 3-liter bags for manual exchanges and 5- or 6-liter bags for automated exchanges. The dialysis dose can be increased by using a larger fill volume, but only within the limits of the person&rsquo;s abdominal capacity.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevent air from entering peritoneal cavity during infusion. Note report of pain in area of shoulder blade.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inadvertent introduction of air into the abdomen irritates the diaphragm and results in referred pain to shoulder blade. This type of discomfort may also be reported during initiation of therapy or during infusions and usually is related to stretching or irritation of the diaphragm with abdominal distention. Smaller exchange volumes may be required until client adjusts.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevate head of bed at intervals. Turn client from side to side. Provide back care and tissue massage.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Position changes and gentle massage may relieve abdominal and general muscle discomfort.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Warm dialysate to body temperature before infusing.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Warming the solution increases the rate of urea removal by dilating peritoneal vessels. Cold dialysate causes vasoconstriction, which can cause discomfort and excessively lower the core body temperature, precipitating cardiac dysrhythmias.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor for severe or continuous abdominal pain and temperature elevation, especially after dialysis has been discontinued.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May indicate developing peritonitis. (Refer to ND: <link linkend="ch0008s0259note0673">risk for Infection</link>, following.)</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage use of relaxation techniques, such as deep-breathing exercises, guided imagery, and visualization. Provide diversional activities.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Redirects attention and promotes sense of control.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer analgesics, as indicated.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Relieves pain and discomfort.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0259note0673">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for Infection</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Alteration in skin integrity (skin contaminants at catheter insertion site, contamination of the catheter during insertion</para>
<para>Invasive procedure&mdash;periodic changing of tubing and bags; sterile peritonitis [response to the composition of dialysate])</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Risk Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Identify interventions to prevent or reduce risk of infection.</para>
<para><emphasis role="strong">Infection Severity</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Experience no signs or symptoms of infection.</para>
</note>
<note role="none" id="ch0008s0259note0674">
<table frame="top" id="ch0008s0259ta0378"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Infection Protection</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe meticulous aseptic technique and wear masks during catheter insertion, dressing changes, and whenever the system is opened. Change tubing per protocol.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents the introduction of organisms and airborne contamination that may cause infection, the most common complication of PD. Infection can be associated with problems at the exit or skin tunnel sites or multiple disconnections of the transfer tubings during dialysis procedures, as well as impaired immune system functioning.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Change dressings as indicated, being careful not to dislodge the catheter. Note character, color, odor, or drainage (if any) from insertion site.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Moist environment promotes bacterial growth. Purulent drainage at insertion site suggests presence of local infection, often involving skin organisms, which can be difficult to treat and sometimes require catheter removal and temporary HD. <emphasis>Note:</emphasis> Polyurethane adhesive film (e.g., blister film) dressings have been found to decrease amount of pressure on catheter and exit site as well as reduce the incidence of site infections.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe color and clarity of effluent fluid.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cloudy effluent is suggestive of peritoneal infection.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cleanse the insertion site with antibiotic solutions such as povidone-iodine (Betadine) or chlorhexidine (CHG, Hibiclens&trade; per protocol.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps reduce infective agents on the skin.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cleanse the distal, clamped portion of catheter prior to reattachment, when intermittent dialysis therapy used.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of bacterial entry through catheter between dialysis treatments when catheter is disconnected from closed system.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate reports of nausea or vomiting, increased or severe abdominal pain, rebound tenderness, or fever.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Signs and symptoms suggesting peritonitis, requiring prompt intervention.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor white blood cell (WBC) count of effluent.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Presence of WBCs initially may reflect normal response to a foreign substance; however, continued or new elevation of WBCs suggests developing infection.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Obtain specimens of blood, effluent, and drainage from insertion site, as indicated, for culture and sensitivity.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies types of organism(s) present and influences choice of interventions. <emphasis>Note:</emphasis> Elevated leukocytes and a positive dialysate effluent culture (along with abdominal pain) are indicative of peritonitis.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor the peritoneal equilibration test (PET), as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Measures the effectiveness of dialysis and points to changes in dialysis prescription that might be needed, especially in the early phase of therapy. In the clearance test, samples of used solution (drained over a 24-hour period) are collected, and a blood sample is obtained during the same day when the solution is collected. The amount of urea in the solution is compared with the amount in the blood to see how effective the current PD schedule is in clearing the blood of urea.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer broad-spectrum antibiotics (e.g., cephalosporins, vancomycin) intravenously or in dialysate, as indicated.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Early and vigorous antibiotic therapy may be used to treat peritonitis without having to remove PD catheter or changing to hemodialysis modality. <emphasis>Note:</emphasis> Studies are inconclusive about the advantage of one route of antibiotic administration over another. However, intraperitoneal antibiotics may be preferred over intravenous, as infection is most often localized and bacteremia is rare (Ballinger et al, 2014).</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0259note0675">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for ineffective Breathing Pattern</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Body position that inhibits lung expansion [abdominal pressure, restricted diaphragmatic excursion, rapid infusion of dialysate]</para>
<para>Pain</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Ventilation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Display an effective respiratory pattern with clear breath sounds and arterial blood gases (ABGs) within client&rsquo;s normal range.</para>
<para>Experience no signs of dyspnea or cyanosis.</para>
</note>
<note role="none" id="ch0008s0259note0676">
<table frame="top" id="ch0008s0259ta0379"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Respiratory Monitoring</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor respiratory rate and effort.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tachypnea, dyspnea, shortness of breath, and shallow breathing during dialysis suggest diaphragmatic pressure from distended peritoneal cavity or may indicate developing complications.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate lungs, noting decreased, absent, or adventitious breath sounds, such as crackles, wheezes, and rhonchi.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased areas of ventilation suggest presence of atelectasis, whereas adventitious sounds may suggest fluid overload, retained secretions, or infection.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note character, amount, and color of secretions.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client is susceptible to pulmonary infections, possibly due to chronic debilitating disease and altered immune response. <emphasis>Note:</emphasis> Death rates from pulmonary infections are estimated to be 14- to 16-fold higher in dialysis patients than in the general population (Guo et al, 2008).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevate head of bed or have client sit up in chair. Promote deep-breathing exercises and coughing.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Facilitates chest expansion and ventilation and mobilization of secretions.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review ABGs, pulse oximetry, and serial chest x-rays.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes in PaO<subscript>2</subscript> and PaCO<subscript>2</subscript> and appearance of infiltrates and congestion on chest x-ray suggest developing pulmonary problems.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer supplemental oxygen, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maximizes oxygen for vascular uptake, thus preventing or lessening hypoxia.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer analgesics, as indicated.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Alleviates pain and promotes comfortable breathing and maximal cough effort.</para>
</entry></row></tbody></tgroup></table></note>
</sect1>
<sect1 id="ch0008s0260"><title><emphasis role="strong">HEMODIALYSIS (HD)</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Procedure</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Removal of urea and other toxic products from the bloodstream and correction of fluid and electrolyte imbalances</para></listitem>
<listitem><para>Blood is shunted through an artificial kidney or membrane (dialyzer) for removal of toxins and excess fluid and then returned to the venous circulation.</para></listitem>
<listitem><para>Requires placement of vascular access (Sofocleous et al, 2015)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Arteriovenous (AV) fistula: A direct connection is created surgically between a native artery and vein (termed <emphasis>native arteriovenous fistulas</emphasis> [AVFs]). Once matured, the fistula allows access to blood flow for dialysis through a percutaneous needlestick. Usually requires a maturation time of at least 4 to 6 weeks to heal before it can be used, which allows time for the vein to enlarge and thicken enough to withstand multiple needle sticks every week.</para></listitem>
<listitem><para>AV graft (AVG): a looped tube (of polyurethane or other materials, such as bovine vessels or saphenous veins) that connects an artery to a vein; usually ready for use within 2 to 4 weeks</para></listitem>
<listitem><para>Temporary access: provides immediate access with insertion of a central line catheter into a vein in the neck, chest, or groin. Used for immediate access while waiting for an AVF to mature or for short-term dialysis, such as with acute kidney failure.</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Types of hemodialysis (HD)</emphasis>&mdash;Determining factors in which modality is chosen include the client&rsquo;s catabolic state, hemodynamic stability, and whether the primary goal is solute removal (e.g., uremia, hyperkalemia), fluid removal, or both (Golper, 2016).</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Intermittent HD</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Requires permanent AV access, such as primary AV fistula or synthetic graft</para></listitem>
<listitem><para>Standard modality in hemodynamically stable client with acute kidney failure (AKF)</para></listitem>
<listitem><para>Permanent renal replacement therapy for client with stage 5 chronic kidney disease (CKD) who is not a candidate for kidney transplant or to whom a kidney transplant is unavailable</para></listitem>
<listitem><para>Usually performed three times per week for 3 to 5 hours per procedure, or six to seven times per week for 1.5 to 2 hours</para>
</listitem></orderedlist></listitem>
<listitem><para>Continuous renal replacement therapy (CRRT)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Blood is usually accessed via a central venous catheter.</para></listitem>
<listitem><para>Treatment for acute kidney injury (AKI) with fluid and toxins removed at a continuous and slower rate than intermittent HD</para></listitem>
<listitem><para>Also indicated for clients with AKI who are too hemodynamically unstable to tolerate conventional hemodialysis</para></listitem>
<listitem><para>Commonly used types of CRRT</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Continuous arteriovenous hemofiltration (CAVH): removes fluid and solutes by convection; solute removal generally slow since no diffusion occurs</para></listitem>
<listitem><para>Continuous venovenous hemofiltration (CVVH): similar to CAVH, except the venovenous access requires use of blood pump</para></listitem>
<listitem><para>Slow continuous ultrafiltration (SCUF): a dehydrating procedure with no intent to substantially remove solute</para></listitem>
<listitem><para>Continuous arteriovenous hemodialysis (CAVD): similar to CAVH with two exceptions&mdash;dialysate is run at low flow rate countercurrent to blood flow, and the ultrafiltration rate does not protect against the development of hypotension</para></listitem>
<listitem><para>Continuous venovenous hemodialysis (CVVD): similar to CAVD but uses venous access and a blood pump</para></listitem>
<listitem><para>Continuous arteriovenous hemodiafiltration (CAVHDF): similar to CAVD, except that ultrafiltration is allowed, and solute removal is aggressive. Volume of ultrafiltered fluid is large, so that replacement fluid must be given.</para></listitem>
<listitem><para>Continuous venovenous hemodiafiltration (CVVHDF): similar to CAVHDF except that venous access is utilized and blood pump is needed.</para>
</listitem></orderedlist></listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: In 2014, 87.9% of all incident cases began renal replacement therapy with hemodialysis, and 63.1% of prevalent cases were receiving hemodialysis therapy. Among hemodialysis cases, 88.0% used in-center hemodialysis, and 1.8% used home hemodialysis (USRDS, 2015a). As many as 25% of hospital admissions in the dialysis population have been attributed to vascular access problems, including fistula malfunction and thrombosis (Al-Jaishi et al, 2014).</para></listitem>
<listitem><para>Mortality: The mortality rate for hemodialysis patients in 2014 was 169 per 1000 patient-years. The reported mortality is highest in month 2 of HD but declines thereafter; this effect is more pronounced for patients aged 65 and over.</para></listitem>
<listitem><para>Cost: Medicare expenditures for HD in 2014 were $26.1 billion and $87.638 per patient per year, remaining nearly flat compared to 2013 expenditures (USRDS, 2015b).</para>
</listitem></orderedlist></listitem></orderedlist>
<note id="ch0008s0260note0677">
<title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Arteriovenous (AV) fistula:</emphasis> An artery, usually in the forearm, is surgically connected to a vein.</para>
<para><emphasis role="strong">Arteriovenous (AV) graft:</emphasis> A synthetic tube or graft is surgically implanted in the arm to connect an artery and vein.</para>
<para><emphasis role="strong">Continuous renal replacement therapy (CRRT):</emphasis> Continuous 24-hour dialysis therapy, which provides a more normal physiological response by removing plasma water more slowly, thus compensating for the loss of intravascular volume; particularly useful in intensive care setting.</para>
<para><emphasis role="strong">Thrill:</emphasis> Palpable vibration or buzzing sensation caused by turbulence of high-pressure arterial blood flow entering low-pressure venous system, indicating AV shunt is patent.</para>
<para><emphasis role="strong">Venous access:</emphasis> The point on the body where a needle or catheter is inserted to gain entry to the bloodstream. AV access is via graft, fistula, or central venous line.</para>
</note>
<para><emphasis role="strong">*****This plan of care addresses the typical HD procedure usually performed three times per week and carried out in the hospital, community dialysis center, or at home.</emphasis></para>
<note id="ch0008s0260note0678">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for Injury</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>[Clotting/problem with vascular access; infection]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Hemodialysis Access</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain patent vascular access.</para>
<para>Demonstrate behaviors, lifestyle changes to reduce risk factors and protect self from injury.</para>
</note>
<note role="none" id="ch0008s0260note0679">
<table frame="top" id="ch0008s0260ta0380"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Hemodialysis Therapy</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Clotting</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess client&rsquo;s pulse and tissue color distal to shunt.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determines general circulatory status of limb.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor internal AV fistula or graft patency at frequent intervals:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Clotting (thrombosis) and fistula malfunction are the most common complications (Sofocleous et al, 2015).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Palpate for thrill.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A constant vibration should be palpable above venous exit site. If the thrill stops or even feels different, this could indicate clotting. With early intervention, many clots can be dissolved or removed.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate for a bruit.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Bruit is the sound caused by the turbulence of arterial blood entering the venous system and should be audible by stethoscope, although may be very faint. If the bruit gets higher in pitch, it could mean narrowing of the blood vessels; if it stops, clot may have formed.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe for a decrease in amount of delivered doses of dialysis (infusion difficulties). Note color of blood in visible tubing at access site, and watch for obvious separation of cells and serum. Document and immediately report changes to appropriate provider(s).</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Signs of access problems. Change of color from uniform medium red to dark purplish red suggests sluggish blood flow and early clotting. Separation in tubing is indicative of clotting. Very dark reddish-black blood next to clear yellow fluid indicates full clot formation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Palpate skin around shunt for warmth.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Diminished blood flow results in &ldquo;coolness&rdquo; of shunt.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Evaluate reports of pain, numbness, and tingling; note extremity swelling distal to access.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May indicate inadequate blood supply.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Handle tubing gently and maintain cannula alignment. Limit activity of extremity. Avoid taking blood pressure (BP) or drawing blood samples in shunt extremity. Instruct client not to sleep on side with shunt or carry packages, books, or purse on affected extremity.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreases risks of shunt-related complications (e.g., clotting, dislodgement, or disconnection).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Infection</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess skin around vascular access, noting redness, swelling, local warmth, exudate, and tenderness.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Signs of local infection, which can progress to sepsis if untreated.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Avoid contamination of access site. Use aseptic technique and masks when giving shunt care, applying and changing dressings, and starting and completing dialysis process.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents introduction of organisms that may cause infection.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor temperature. Note presence of fever, chills, and hypotension.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Signs of infection or sepsis requiring prompt medical intervention.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Culture the site and obtain blood samples, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determines presence of pathogens and how best to treat.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor prothrombin time (PT) and activated partial thromboplastin time (aPTT), as appropriate.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information about coagulation status, identifies treatment needs, and evaluates effectiveness.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Low-dose heparin</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Infused on arterial side of filter to prevent clotting in the filter without systemic side effects.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antibiotics&mdash;systemic and topical</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prompt treatment of infection may save access and prevent sepsis.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for/assist with procedures, such as angioplasty and vascular stenting/stent grafting, or catheter-directed thrombolysis.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>All three types of vascular access&mdash;AV fistula, AV graft, and venous catheter&mdash;can have complications that require further treatment or surgery. The most common complications are access infection and low blood flow due to blood clotting in the access. In the past two decades, radiological interventions have greatly improved the treatment of venous stenosis and fistula thrombosis without surgery. However, shunt revision can require surgical intervention and replacement of stenotic area or placement of new vascular access (<ulink url="http://www.RadiologyInfo.org">RadiologyInfo.org</ulink>, 2017; Sofocleous et al, 2015).</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0260note0680">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for deficient Fluid Volume</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Active fluid volume loss (e.g., ultrafiltration, systemic heparinization, actual blood loss&mdash;disconnection of the shunt)</para>
<para>Fluid restrictions</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Fluid Balance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain fluid balance as evidenced by stable vital signs, good skin turgor, moist mucous membranes, absence of bleeding, and appropriate weight.</para>
</note>
<note role="none" id="ch0008s0260note0681">
<table frame="top" id="ch0008s0260ta0381"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Fluid Monitoring</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Measure all sources of intake and output (I&amp;O).</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aids in evaluating fluid status, especially when compared with weight. <emphasis>Note:</emphasis> Voided urine output is an inaccurate evaluation of renal function in dialysis clients. Some individuals have water output with little renal clearance of toxins, whereas others have oliguria or anuria.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Weigh daily, as well as before and after dialysis run.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Weight loss over precisely measured time is a measure of ultrafiltration and fluid removal. Dry weight determines how much excess fluid has been removed and serves as a guide for subsequent dialysis run time and solution.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor BP, pulse, and hemodynamic pressures, if available, during dialysis.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypotension, tachycardia, and falling hemodynamic pressures suggest volume depletion.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe for access site bleeding, noting severity. Elevate arm and apply firm (nonocclusive) pressure as indicated. Document and report bleeding that fails to stop or becomes hemorrhage.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Bleeding may be due to a combination of factors: (1) uremic coagulopathy, (2) large needles used for fistula cannulation, and (3) heparin used in the dialysis circuit to prevent clotting. <emphasis>Note:</emphasis> In the immediate postdialysis period, medication (Protamine) may be used to reverse the effect of heparin, thus reducing risk of heavy or life-threatening bleeding (Krause, 2015).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Hemodialysis Therapy</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Ascertain whether diuretics and antihypertensives are to be withheld.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Dialysis potentiates hypotensive effects if these drugs have been administered.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Verify continuity of shunt or access catheter.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Disconnected shunt or open access permits exsanguination.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Apply external shunt dressing. Permit no puncture of shunt.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Minimizes stress on cannula insertion site to reduce inadvertent dislodgement and bleeding from site.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Hemorrhage Emergency Measures</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Attach two cannula clamps to shunt dressing. Have tourniquet available. If cannulae separate, clamp the arterial cannula first, then the venous. If tubing comes out of vessel, clamp cannula that is still in place and apply and maintain direct pressure to bleeding site. Place client in a supine or Trendelenburg position, as necessary.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents massive blood loss while awaiting medical assistance if cannula separates or shunt is dislodged. Maximizes venous return if hypotension occurs.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Fluid Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory studies, as indicated, such as the following:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hemoglobin/hematocrit (Hgb/Hct)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be reduced because of anemia, hemodilution, or actual blood loss.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Serum electrolytes and pH</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Imbalances may require changes in the dialysate solution or supplemental replacement to achieve balance.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Clotting times&mdash;PT/aPTT and platelet count</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Use of heparin to prevent clotting in blood lines and hemofilter alters coagulation and potentiates active bleeding.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer IV solutions during dialysis, as indicated, for example:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Normal saline (NS)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Saline or dextrose solutions, electrolytes, and NaHCO<subscript>3</subscript> may be infused in the venous side of continuous arteriovenous hemofilter when high ultrafiltration rates are used for removal of extracellular fluid (ECF) and toxic solutes.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Volume expanders, such as albumin</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Volume expanders may be required during or following hemodialysis if sudden or marked hypotension occurs.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Packed red blood cells (RBCs), if needed</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Destruction of RBCs (hemolysis) by mechanical dialysis, hemorrhagic losses, or decreased RBC production may result in profound and progressive anemia requiring corrective action.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Reduce rate of ultrafiltration during dialysis, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces the amount of water being removed and may correct hypotension or hypovolemia.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer protamine sulfate, as appropriate.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be needed to return clotting times to normal or if heparin rebound occurs within 16 hours after hemodialysis.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0260note0682">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for excess Fluid Volume</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Excessive [or rapid] fluid intake: receiving hemodialysis (e.g., IV, blood, plasma expanders, saline given to support BP during dialysis)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Fluid Balance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain &ldquo;dry weight&rdquo; within client&rsquo;s normal range; be free of edema; with clear breath sounds and serum sodium levels within normal limits.</para>
</note>
<note role="none" id="ch0008s0260note0683">
<table frame="top" id="ch0008s0260ta0382"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Fluid Monitoring</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Measure all sources of I&amp;O. Weigh routinely.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aids in evaluating fluid status, especially when compared with weight. Weight gain between treatments should not exceed 0.5 kg or approximately 1 lb/d.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor BP and pulse.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypertension and tachycardia between hemodialysis runs may result from fluid overload and heart failure (HF).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note rate and regularity of pulse.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Rapid rate, or irregularity in heart rate, may indicate changes in volume status.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note presence of peripheral or sacral edema, respiratory crackles, dyspnea, orthopnea, distended neck veins.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fluid volume excess due to inefficient dialysis or repeated hypervolemia between dialysis treatments may cause or exacerbate HF, as indicated by signs and symptoms of respiratory and systemic venous congestion.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor serum sodium levels. Restrict sodium intake, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>High sodium levels are associated with fluid overload, edema, hypertension, and cardiac complications.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Restrict fluid intake as indicated, spacing allowed fluids throughout a 24-hour period.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>The intermittent nature of hemodialysis results in fluid retention and volume overload between procedures and may require fluid restriction. Spacing fluids helps reduce thirst.</para>
</entry></row></tbody></tgroup></table></note>
</sect1>
<sect1 id="ch0008s0261"><title><emphasis role="strong">URINARY DIVERSIONS: UROSTOMY (POSTOPERATIVE CARE)</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Procedure</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Diversion of urine out of the body through an opening in the abdominal wall bypassing the bladder, which requires a pouch to be worn outside the body</para></listitem>
<listitem><para>Types: At present, several varieties of urinary diversions are performed using different bowel segments and based on the individual&rsquo;s disease, functional condition, and desire. Both continent and incontinent (also called noncontinent) urinary diversions are being performed, although the latter is still done more frequently. In recent years (and especially in larger surgical centers), client may be offered a continent cutaneous diversion or an orthotopic neobladder urinary reconstruction (ONR) (Siracusano et al, 2012).</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Noncontinent urinary diversions</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Ileal conduit (or urostomy): <emphasis role="bi">most common type of the procedure</emphasis></para></listitem>
<listitem><para>Colonic conduit: uses a segment of the bowel to anastomose ureters to the anterior body wall for ostomy bag drainage</para></listitem>
<listitem><para>Cutaneous ureterostomy: directly anastomoses ureters to anterior body wall for ostomy bag drainage</para>
</listitem></orderedlist></listitem>
<listitem><para>Continent urinary diversions (Costa &amp; Kreder, 2016)</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Uses bowel segments (either ileum or combination of ileum and ascending colon fashioned into a spherical shape for a reconstructed bladder [pouch] that is anastomosed to the urethra). This is known as an orthotopic diversion.</para></listitem>
<listitem><para>Orthotopic diversions are categorized into three types:</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Neobladder diversion (also known as orthotopic neobladder reconstruction [ONR]), widely accepted as a first procedure where possible (Herdiman et al, 2013)</para></listitem>
<listitem><para>Continent catheterizable diversion: A one-way valve is fashioned at the insertion site that leads into the reconstructed urinary storage system. Catheterization is carried out through a small stoma on the abdominal wall.</para></listitem>
<listitem><para>Ureterosigmoidostomy: consists of anastomosing the ureters to the sigmoid colon in a nonrefluxing manner. This diversion method relies on the anal sphincter for continence and is rarely performed.</para>
</listitem></orderedlist></listitem></orderedlist></listitem></orderedlist></listitem>
</orderedlist></listitem>
<listitem><para><emphasis role="strong">Indications (Costa &amp; Kreder, 2016)</emphasis>&mdash;Need for urostomy is associated with several factors, which is connected to a problem in the urinary system that needs to be removed or bypassed, or disorders resulting in severe incontinence, including:</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Bladder cancer, primary or metastatic, requiring cystectomy&mdash;<emphasis role="bi">fourth most common cancer in men in the United States</emphasis> (American Cancer Society [ACS], 2017)</para></listitem>
<listitem><para>Neurologic dysfunction, such as may occur from a birth defect, trauma, surgery, or spinal injury, causing intractable incontinence</para></listitem>
<listitem><para>Severe radiation injury to the bladder</para></listitem>
<listitem><para>Chronic pelvic pain syndromes, such as might occur with chronic prostatitis without evidence of urinary tract infection, Crohn&rsquo;s disease, interstitial cystitis, past sexual abuse, pelvic inflammatory disease (Mayo Clinic Staff, 2017)</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics (ACS, 2017; National Cancer Institute, Surveillance, Epidemiology, and End Results [SEER], 2017)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: In 2013, a nationwide inpatient sample study of trends in urinary diversion reported that 92% of patients undergoing radical cystectomy for bladder cancer received incontinent urinary diversion, while 8% patients received continent diversion in the time period from 2001 to 2008 (Kim et al, 2013). In 2014, there were an estimated 696,440 people living with bladder cancer in the United States.</para>
</listitem>
<listitem><para>Mortality: It is estimated by both the ACS and SEER that 16,870 deaths from bladder cancer occurred in 2017.</para></listitem>
<listitem><para>Costs: Estimates of national expenditures for treatment of bladder cancer in 2016 were $4.5 billion (NCI, 2017).</para>
</listitem></orderedlist></listitem></orderedlist>
<note id="ch0008s0261note0684">
<title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Appliance:</emphasis> Pouch and accessories worn over stoma to collect urine.</para>
<para><emphasis role="strong">Colonic conduit:</emphasis> Similar to an ileal conduit but uses a segment of colon instead of ileum.</para>
<para><emphasis role="strong">Continent urinary diversion:</emphasis> Ureters carry urine to a pouch or reservoir created inside the body from a section of stomach or small or large intestine.</para>
<para><emphasis role="strong">Cystectomy:</emphasis> Surgical removal of the urinary bladder.</para>
<para><emphasis role="strong">Enterostomal:</emphasis> A surgically created permanent opening into the intestine through the abdominal wall.</para>
<para><emphasis role="strong">Ileal conduit:</emphasis> Ureters are anastomosed to a segment of ileum, usually 15 to 20 cm long, and resected with the blood supply intact. The proximal section is closed, and the distal end is brought through an opening in the skin to form a stoma or a passageway, not a storage reservoir.</para>
<para><emphasis role="strong">Incontinent or noncontinent urinary diversions:</emphasis> Urine flows through ureters directly anastomosed to the abdominal wall (cutaneous ureterostomy) or into a short segment of ileum or colon also attached to the abdominal wall where the urine drains into an external collecting device through a permanent stoma.</para>
<para><emphasis role="strong">Intractable incontinence:</emphasis> Loss of bladder control that becomes impossible to manage, alleviate, or remedy.</para>
<para><emphasis role="strong">Orthotopic neobladder:</emphasis> A urinary reservoir fashioned from a bowel segment that is in the normal anatomic position of the bladder and attached directly to the urethra, with discharge of urine through the urethra.</para>
<para><emphasis role="strong">Peristomal:</emphasis> Skin around and closest to the stoma.</para>
<para><emphasis role="strong">Stoma:</emphasis> An opening that, when used in reference to ostomy care, is the segment of bowel or ureter brought to the surface of the abdomen. It is formed of mucosal tissue and is red and moist in appearance.</para>
<para><emphasis role="strong">Ureterostomy:</emphasis> The ureter(s) is brought directly through the abdominal wall to form its own stoma.</para>
<para><emphasis role="strong">Urostomy:</emphasis> Surgically constructed method of bypassing a dysfunctional or removed bladder in order to discharge urine. Most commonly, a conduit is created from a section of the ileum and the ureters are connected to it. The open end of the conduit is brought to the abdomen to create a stoma.</para>
</note>
<sect2 id="ch0008s0262"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Client is treated in acute surgical unit.</para>
</sect2>
<sect2 id="ch0008s0263"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0014s0370">Cancer, general considerations</link></para>
<para><link linkend="ch0005s0164">Peritonitis</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0014s0348">Surgical intervention</link></para>
<table frame="top" id="ch0008s0261ta0383"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Data depend on underlying problem, duration, and severity, for example, malignant bladder tumor, congenital malformations, trauma, chronic infections, or intractable incontinence due to injury or disease of other body systems, such as with multiple sclerosis. (Refer to appropriate CP.)</para>
</entry></row><row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC DIVISION<?lb?>MAY REPORT</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Discharge plan considerations:</emphasis> May require assistance with management of ostomy and acquisition of supplies</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0008s0261ta0384"><title><emphasis role="strong">PREOPERATIVE DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST<?lb?>WHY IT IS DONE</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">URINE TESTS</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Urodynamic tests (e.g., may include uroflowmetry, postvoid residual measurement, cystometric test, leak point pressure measurement, pressure flow study, electromyography, video urodynamic tests)</emphasis></para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Any or all of these tests may be done preoperatively to determine the presence of urinary tract obstruction, or urine storage abnormalities, and help determine which urinary diversion will be most appropriate (Costa &amp; Kreder, 2016).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Blood tests (e.g., serum creatinine [CR] liver function tests [LFTs])</emphasis></para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A contraindication to any type of continent diversion is compromised renal function or chronic renal failure.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">OTHER DIAGNOSTIC STUDIES</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Imaging studies (e.g., ultrasound, CT, MRI)</emphasis></para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Will have been done to determine the etiology for which urinary diversion is required.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Intravenous pyelogram (IVP) and retrograde pyelogram:</emphasis> X-ray examination and fluoroscopic visualization of the kidneys, ureters, and bladder using contrast material. Retrograde pyelogram requires cystoscopy and the placement of a small tube into the lower part of the ureter to inject contrast and opacify the ureter and renal pelvis.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Study of choice for evaluating a person for a urinary diversion procedure if the client is not azotemic from kidney insufficiency or allergic to contrast media (Costa &amp; Kreder, 2016). Shows size, shape, and location of urinary structures. Identifies filling defects caused by tumors or other obstructive disorders. Retrograde pyelogram may also be done to delineate urinary tract system anatomy in preparation for surgery.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Cystoscopy with biopsy:</emphasis> Diagnostic procedure that uses a cystoscope (endoscope), which is specially designed to examine the bladder, lower urinary tract, and prostate gland. It can also be used to perform biopsies. Ultraviolet cystoscopy outlines bladder lesions. Bladder washings can also be done during cystoscopy for cytological evaluation.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Initially, may be done to evaluate painless hematuria. If bladder tumor is detected, biopsy will be done to stage the malignancy.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Pelvic magnetic resonance imaging (MRI) or computed tomography (CT) scans:</emphasis> Imaging techniques that use x-rays, or magnetic energy, and computer analysis to provide a complete picture of pelvic body tissues and structures.</para></listitem></itemizedlist>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Defines size of tumor mass and degree of cancer spread into surrounding tissues.</para>
</entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0008s0264"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Prevent complications.</para></listitem>
<listitem><para>Assist client and significant other (SO) in physical and psychosocial adjustment.</para></listitem>
<listitem><para>Support independence in self-care.</para></listitem>
<listitem><para>Provide information about procedure, prognosis, treatment needs, potential complications, and resources.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0008s0265"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Complications prevented or minimized.</para></listitem>
<listitem><para>Adjusting to perceived or actual changes.</para></listitem>
<listitem><para>Self-care needs met by self or with assistance, as necessary.</para></listitem>
<listitem><para>Procedure, prognosis, therapeutic regimen, and potential complications understood and sources of support identified.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<para><emphasis role="strong">****This plan of care primarily addresses the nursing care of the client with incontinent urinary diversion with a permanent stoma and urine-collecting device.</emphasis></para>
<note id="ch0008s0261note0685">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for impaired Skin Integrity</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Excretions (e.g., continuous flow of urine, improper fitting of appliance); moisture</para>
<para>Chemical injury agent (e.g., reaction to skin product or chemicals)</para>
<para>Mechanical factors (e.g., surgery, removal of adhesive)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Tissue Integrity: Skin and Mucous Membranes</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Display timely healing of stoma and peristomal skin.</para>
<para><emphasis role="strong">Ostomy Self-Care</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Identify individual risk factors.</para>
<para>Demonstrate behaviors and techniques to promote healing and prevent skin breakdown.</para>
</note>
<note role="none" id="ch0008s0261note0686">
<table frame="top" id="ch0008s0261ta0385"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Ostomy Care</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Be aware of skin problems common to urostomies (e.g., rashes, ill-fitting pouch openings, allergies to adhesives, urine pooling).</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps guide assessment and points to appropriate interventions. Early identification of changes provides for timely interventions to prevent skin complications (resources for interventions and rationale in this section: American Cancer Society [ACS], 2014; Wound, Ostomy and Continence Nurses Society [WOCN], 2012).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inspect stoma frequently in early postoperative period.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Stoma should be pink or reddish, similar to mucous membranes. Color changes may be temporary, but persistent changes could require surgical intervention.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ensure proper opening for adhesive backing of pouch. Using a stoma-measuring guide or ostomy sizer, find the smallest opening that fits over the stoma and does not allow any skin exposure. Cut the barrier to size with adequate adhesive area left to apply pouch.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents trauma to the stoma tissue and protects the peristomal skin from effects of urine pooling and crystalizing on the skin. Adequate adhesive area is important to maintain a pouch seal, but too tight a fit may cause stomal edema or stenosis.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Measure stoma periodically, for example, each appliance change for first 6 weeks, then monthly times six.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>As postoperative edema resolves, size of appliance must be altered to ensure proper fit so that urine is collected as it flows from the stoma and contact with the skin is prevented.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Touch stoma gently as needed.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Important to prevent irritation. Mucosa has good blood supply and bleeds easily with rubbing or trauma. <emphasis>Note:</emphasis> Small spots of blood on (or from) the stoma are normal in early postoperative period.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cleanse peristomal skin with water and pat dry.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintaining a clean and dry peristomal area helps prevent or limit severity of skin reaction. <emphasis>Note:</emphasis> Soap is not usually needed but may be used to remove oily residual from adhesive.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Apply effective sealant barrier, such as Skin Prep or similar product, as recommended by appliance manufacturer. Consider the use of extended wear barrier, when indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Protects skin from pouch adhesive, enhances adhesiveness of pouch, and facilitates removal of pouch when necessary. The extended wear barrier does not break down like a standard wear barrier when it comes in contact with urine.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Use a transparent, odor-proof, drainable pouch. Keep gauze square over stoma while cleansing area, and have client cough or strain before applying skin barrier wafer.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A transparent appliance during first 4 to 6 weeks allows easy observation of stoma and ureteral stents (when used), without necessity of removing appliance and irritating skin. Covering stoma prevents urine from wetting the peristomal area during pouch changes. Coughing empties distal portion of conduit, followed by a brief pause in drainage to facilitate application of appliance.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoid use of karaya-type appliances.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Will not protect skin because urine melts karaya.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Connect collecting pouch to continuous bedside drainage system when necessary or desired.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be needed during times when rate of urine formation is increased, such as while intravenous (IV) fluids are administered or at night if client prefers. Weight of the urine can cause pouch to pull loose and leak when pouch becomes more than half full.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cleanse ostomy pouch on a routine basis, using vinegar solution or commercial product designed for this purpose.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Frequent pouch changes are irritating to the skin and should be avoided. Emptying and rinsing the pouch with vinegar or commercial solution not only removes bacteria but also deodorizes the pouch.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Change pouch every 3 to 7 days, or as needed for leakage. Remove appliance gently while supporting skin. Use adhesive removers as indicated and wash off completely.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents tissue irritation or damage associated with pulling skin barrier wafer off.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate reports of burning or itching around stoma.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggests peristomal irritation or possibly yeast infection, both requiring intervention. <emphasis>Note:</emphasis> Continuous exposure of skin to urine can cause hyperplasia around stoma, affecting pouch fit and increasing risk of infection.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate adhesive product and appliance fit on an ongoing basis.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides opportunity for problem-solving. Determines need for further intervention.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor for distention of lower abdomen in presence of ileal conduit; assess bowel sounds.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Intestinal distention can cause tension on new suture lines with possibility of rupture.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Consult with ostomy nurse specialist.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ostomy nurse specialist can help client and caregiver by providing support and education, helping with problem-solving and choosing products appropriate for client&rsquo;s stoma characteristics, evaluating physical and mental status, and seeking financial resources. The client or caregiver should be capable of changing ostomy appliance prior to discharge or receive home care until such time as the client is able to provide self-care.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Apply antifungal spray or powder, as indicated.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Assists in healing if peristomal irritation is caused by fungal infection. <emphasis>Note:</emphasis> These products can have potent side effects and should be used sparingly. Creams and ointments are to be avoided because they interfere with adhesion of the appliance.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0261note0687">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">disturbed Body Image</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Illness; alteration in body structure/function (e.g., presence of stoma, loss of control of usual means of urine elimination)</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Alteration in view of one&rsquo;s body (e.g., appearance, structure, function); actual change in structure and function (ostomy)</para>
<para>Fear of reaction by others</para>
<para>Negative feeling about body; avoids looking at/touching body part [stoma]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Body Image</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate beginning acceptance by viewing and touching stoma and participating in self-care.</para>
<para>Verbalize understanding of body changes; begins to express feelings about situation.</para>
<para>Verbalize acceptance of self in situation, incorporating change into self-concept without negating self-esteem.</para>
</note>
<note role="none" id="ch0008s0261note0688">
<table frame="top" id="ch0008s0261ta0386"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Body Image Enhancement</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review reason for surgery and future expectations.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may find it easier to accept and deal with an ostomy done for chronic or long-term disease, such as intractable incontinence or infections, than for traumatic injury or cancer.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ascertain whether counseling was initiated when the possibility or necessity of urinary diversion was first discussed.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information about client&rsquo;s and SO&rsquo;s levels of knowledge about individual situation and process of acceptance. Client with new ostomy is also often struggling to adjust to cancer or other devastating medical condition requiring the diversion.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Answer all questions concerning urostomy and its function.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Establishes rapport and conveys interest and concern of caregiver. Provides additional information for client to consider.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client and SO to verbalize feelings. Acknowledge normality of feelings of anger, depression, and grief over loss.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides opportunity to deal with issues and misconceptions. Helps client and SO to realize that feelings are not unusual and that feeling guilty for them is not helpful.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note behaviors of withdrawal, increased dependency, manipulation, or noninvolvement in care.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggestive of problems in adjustment that may require further evaluation and more extensive therapy. May reflect grief response to loss of body part and function, worry over acceptance by others, and fear of further disability or loss of life from cancer.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide opportunities for client and SO to view and touch stoma, using the moment to point out positive signs of healing, normal appearance, and so forth.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although integration of stoma into body image can take months or even years, looking at the stoma and hearing comments made in a normal, matter-of-fact manner can help client with this process. Touching stoma reassures client and SO that it is not fragile.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide opportunity for client to deal with ostomy through participation in self-care.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Independence in self-care helps improve self-esteem.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain positive approach during care activities, avoiding expressions of disdain or revulsion. Do not take client&rsquo;s angry expressions personally.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assists client and SO to accept body changes and feel all right about self. Anger is most often directed at the situation and lack of control individual has over what has happened.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Plan stoma care activities with client.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes client&rsquo;s sense of control and gives message that client can handle this situation, enhancing self-esteem.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss contacting a person with a urostomy and make arrangements for visit if client desires.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Having a visit from person of same gender and type of procedure can provide an empathetic and valuable support to client in early days of adjustment and self-care. Shared experiences can facilitate acceptance of change as client realizes &ldquo;life does go on&rdquo; and can be relatively normal.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Discuss sexual functioning and potential physical changes that may occur or medications that affect sexual function, if applicable. (Refer to ND: <link linkend="ch0008s0261note0695">risk for Sexual Dysfunction</link>.)</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Client may experience anticipatory anxiety and fear of failure in relation to sex after surgery, often because of lack of knowledge. Surgery that removes both the bladder and prostate may disrupt parasympathetic nerve fibers that control erection in men. Newer techniques may be used in individual cases to preserve nerve function.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0261note0689">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">acute Pain</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Biological injury agent (e.g., disease process [cancer], trauma)</para>
<para>Physical injury agent&mdash;surgical incisions, drains</para>
<para>[Psychological factors&mdash;fear, anxiety]</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Self-report of intensity and characteristics of pain, using standardized pain scale</para>
<para>Guarding, protective behaviors</para>
<para>Expressive behaviors&mdash;restlessness</para>
<para>Self-focus</para>
<para>Changes in vital signs</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Pain Level</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize relief or control of pain.</para>
<para>Appear relaxed and be able to sleep and rest appropriately.</para>
<para><emphasis role="strong">Pain Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate use of comfort measures, relaxation skills, and diversional activities.</para>
</note>
<note role="none" id="ch0008s0261note0690">
<table frame="top" id="ch0008s0261ta0387"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Pain Management: Acute</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess pain, noting location, characteristics, and intensity (0 to 10 [or similar] coded scale).</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps evaluate degree of discomfort and effectiveness of analgesia or may reveal developing complications. Surgical causes for abdominal pain usually subside gradually as healing begins. Continued or increasing pain may be a sign of infection or intestinal obstruction.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate bowel sounds; note passage of flatus.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicates reestablishment of bowel function. Lack of return of bowel sounds and function within a reasonable timeframe may indicate presence of complication, such as peritonitis, hypokalemia, or mechanical obstruction.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note urine flow and characteristics, and evaluate need for more intensive interventions.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased flow may reflect urinary retention due to edema, or leakage into peritoneal cavity, with failure of anastomosis. Cloudy urine may be normal initially because of mucus from intestinal tract but, if it fails to clear over time, may indicate infectious process.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client to verbalize concerns. Active-listen these concerns and provide support by acceptance, remaining with client and giving appropriate information.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduction of anxiety and fear can promote relaxation and comfort.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide comfort measures, such as back rub, repositioning, and ambulating. Assure client that position change will not injure stoma.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Activity, movement, and comfort measures can reduce muscle tension, promote relaxation, and enhance coping abilities.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage use of relaxation techniques, such as guided imagery, visualization, and diversional activities.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps client rest more effectively and refocuses attention, which may enhance coping ability, reducing pain and discomfort.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate and report abdominal muscle rigidity, involuntary guarding, and rebound tenderness.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggestive of peritoneal inflammation, requiring prompt medical intervention.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer medications as indicated, such as opioids, analgesics, and patient-controlled analgesia (PCA).</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Relieves pain, enhances comfort, and promotes rest. PCA may be more beneficial than intermittent analgesia, especially following radical resection.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Maintain patency of nasogastric (NG) tube, when used.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Decompresses stomach and intestines; prevents abdominal distention when intestinal function is impaired.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0261note0691">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for Infection</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Alteration in skin integrity, stasis of body fluids</para>
<para>Immunosuppression; chronic illness</para>
<para>Invasive procedure; increased exposure to pathogens [exposure to multiple healthcare workers/settings]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Infection Severity</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Achieve timely wound healing.</para>
<para>Be free of signs of localized postoperative or systemic infections.</para>
<para><emphasis role="strong">Risk Control: Infectious Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of individual causative or risk factors.</para>
<para>Demonstrate techniques or lifestyle changes to reduce risk.</para>
</note>
<note role="none" id="ch0008s0261note0692">
<table frame="top" id="ch0008s0261ta0388"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Infection Protection</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Empty ostomy pouch when it becomes one-third to one-half full, once continuous pouch drainage is discontinued.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of urinary reflux and maintains integrity of appliance seal if pouch does not have an antireflux valve.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Document urine characteristics and note whether changes are associated with reports of flank pain.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cloudy, odorous urine indicates infection, possibly pyelonephritis; however, urine normally contains mucus after a conduit procedure because of natural secretions of the intestine.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Report sudden cessation of urethral drainage (when present).</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Constant drainage usually subsides within 10 days; however, abrupt cessation may indicate plugging and lead to abscess formation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note red rash around stoma.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Rash is most commonly caused by yeast. Urine leakage or allergy to appliance or products may also cause red, irritated, or macerated skin.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain dry dressings; change dressings as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Moist dressings act as a wick to the wound and provide media for bacterial growth.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess skinfold areas in groin, perineum, and under arms and breasts.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Use of antibiotics and trapping of moisture in skinfold areas increases risk of <emphasis>Candida</emphasis> infections.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor vital signs.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>An elevated temperature suggests incisional infection, urinary tract infection (UTI), or respiratory complications.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate breath sounds.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may be at high risk for development of respiratory complications because of length of time under anesthesia. Often this client is older and may already have a compromised immune system. Also, painful abdominal incisions cause client to breathe more shallowly than normal and to limit coughing effort. Accumulation of secretions in respiratory tract predisposes to atelectasis and infections.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Use pouch with antireflux valve, if available.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents backflow of urine into stoma, reducing risk of infection.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Obtain specimens of exudates, urine, sputum, and blood, as indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies source of infection and most effective treatment. Infected urine may cause pyelonephritis. <emphasis>Note:</emphasis> Urine specimen must be obtained from the conduit because the pouch is considered contaminated.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cephalosporins, such as cefoxitin (Mefoxin) and cefazolin (Ancef)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Given to treat identified infection or may be given prophylactically, especially with history of recurrent pyelonephritis.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Antifungal powder</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Used to treat yeast infections around stoma.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0261note0693">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">impaired urinary Elimination</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Surgical diversion, tissue trauma, postoperative edema</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Incontinence (loss of continence)</para>
<para>Changes in amount, character of urine; urinary retention</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Urinary Elimination</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Display continuous flow of urine, with output adequate for individual situation.</para>
</note>
<note role="none" id="ch0008s0261note0694">
<table frame="top" id="ch0008s0261ta0389"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Urinary Elimination Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note presence of stents or ureteral catheters. Label &ldquo;right&rdquo; and &ldquo;left&rdquo; (or they may be color-coded), and observe urine flow through each.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Stents and ureteral catheters may be placed during surgery to facilitate healing of internal anastomoses.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Record urinary output. Investigate sudden reduction or cessation of urine flow.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sudden decrease in urine flow may indicate obstruction or dysfunction, such as blockage by edema or mucus, or dehydration. <emphasis>Note:</emphasis> Reduced urinary output not related to hypovolemia, associated with abdominal distention, fever, and clear, watery discharge from the incision; suggests urinary fistula, also requiring prompt intervention.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe and record color of urine. Note hematuria or bleeding from stoma.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Urine may be slightly blood-tinged, which should clear up in 2 to 3 days. Rubbing or washing stoma may cause temporary oozing because of vascular nature of mucosal tissues. Continued bleeding, frank blood in the pouch, or oozing around the base of stoma requires medical evaluation and intervention.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Position tubing and drainage pouch so that it allows unimpeded flow of urine. Monitor and protect stents.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Blocked drainage allows pressure to build within urinary tract, risking anastomosis leakage and damage to renal parenchyma. <emphasis>Note:</emphasis> Stents are typically left in place 5 to 10 days to make sure the ureters remain patent during the first few days of healing while the anastomosis (surgical attachment) sites heal. They are not usually sutured in place and may fall out of the urostomy the first week or so, although most surgeons prefer they remain in place at least 5 days (Cowan, 2016).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage increased fluids and maintain accurate intake.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintains hydration and good urine flow.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor vital signs. Assess peripheral pulses, skin turgor, capillary refill, and oral mucosa. Weigh daily.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicators of fluid balance. Reflects level of hydration and effectiveness of fluid replacement therapy.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer fluids, as indicated.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Assists in maintaining hydration and adequate circulating volume and urinary flow.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0261note0695">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for Sexual Dysfunction</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Alteration in body structure and function</para>
<para>Vulnerability (concern about response of SO)</para>
<para>Misinformation or insufficient knowledge</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Sexual Functioning</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of relationship of physical condition to sexual difficulties.</para>
<para>Identify satisfying, acceptable sexual practices and explore alternative methods.</para>
<para>Resume sexual relationship, as appropriate.</para>
</note>
<note role="none" id="ch0008s0261note0696">
<table frame="top" id="ch0008s0261ta0390"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Sexual Counseling</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ascertain client and SO&rsquo;s sexual relationship before surgery, if possible. Identify future expectations and desires.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Mutilation and loss of control of a bodily function can affect client&rsquo;s view of personal sexuality. When coupled with the fear of rejection by a partner, the desired level of intimacy can be greatly impaired. Sexual needs are very basic, and client will be rehabilitated more successfully when a satisfying sexual relationship is continued or developed. <emphasis>Note:</emphasis> Even with nerve-sparing procedures, 15% to 50% of men will experience erectile dysfunction, and 30% to 40% of women will experience painful intercourse (Costa &amp; Kreder, 2016).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review with client and SO anatomy and physiology of sexual functioning in relation to own situation.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Understanding normal physiology helps client and SO understand the mechanisms of nerve damage and need for exploring alternative methods of satisfaction.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reinforce information given by the physician. Encourage questions. Provide additional information as needed.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reiteration of previously given information assists client and SO to hear and process the knowledge again, moving toward acceptance of individual limitations or restrictions and prognosis, for example, that it may take months to regain potency after a radical procedure or that a penile prosthesis may be necessary.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss resumption of sexual activities, beginning slowly and progressing, such as cuddling and caressing until both partners are comfortable with body image and function changes. Include alternative methods of stimulation, as appropriate.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Knowing what to expect in progress of recovery helps client avoid performance anxiety and reduce risk of &ldquo;failure.&rdquo; If the couple is willing to try new ideas, this can assist with adjustment and may help achieve sexual fulfillment.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage dialogue between client and SO. Suggest wearing pouch cover, T-shirt, or short nightgown.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Disguising urostomy appliance may aid in reducing feelings of self-consciousness and embarrassment during sexual activity.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage use of sense of humor.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Laughter can help individuals deal more effectively with difficult situation and promote a positive sexual experience.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Problem-solve alternative positions for coitus.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Minimizing awkwardness of appliance and physical discomfort can enhance satisfaction.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss and role-play possible interactions or approaches when dealing with new sexual partners.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Rehearsal helps deal with actual situations when they arise, preventing self-consciousness about &ldquo;different&rdquo; body image.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide birth control information, as appropriate, and stress that impotence does not mean client is necessarily sterile.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Confusion about impotency and sterility can lead to an unwanted pregnancy.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Arrange meeting with an ostomy visitor or support group, if appropriate.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sharing of how these problems have been resolved by others can be helpful and reduce sense of isolation.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer for counseling or sex therapy, as indicated.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>If problems persist longer than several months after surgery, a trained therapist may be required to facilitate communication between client and partner.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0261note0697">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">deficient Knowledge regarding condition, prognosis, treatment, self-care, and discharge needs</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient information or knowledge of resources; misinformation presented by others; insufficient interest in learning</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Insufficient information</para>
<para>Inaccurate follow-through of instruction or performance of urostomy care</para>
<para>Development of preventable complications</para>
<para>Inappropriate or exaggerated behaviors&mdash;hostile, agitated, apathetic, withdrawn</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Chronic Disease Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of condition, disease process, prognosis, and potential complications.</para>
<para><emphasis role="strong">Ostomy Self-Care</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Participated in learning process.</para>
<para>Perform necessary procedures correctly and explain reasons for the action.</para>
<para>Initiate necessary lifestyle changes and participate in treatment regimen.</para>
</note>
<note role="none" id="ch0008s0261note0698">
<table frame="top" id="ch0008s0261ta0391"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate client&rsquo;s emotional and physical capabilities.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These factors affect client&rsquo;s ability to master tasks and willingness to assume responsibility for ostomy care.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review anatomy, physiology, and implications of surgical intervention. Discuss future expectations.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides knowledge base from which client can make informed choices and an opportunity to clarify misconceptions regarding individual situation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Include written and visual resources.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides references after discharge to support client efforts for independence in self-care.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct client/SO in stomal care, as appropriate. Allow time for return demonstrations and provide positive feedback for efforts.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes positive management and reduces risk of improper ostomy care and development of complications.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss ways to ensure that stoma and appliance are odorless and nonleaking.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>When client feels confident about urostomy, energy and attention can be focused on other tasks.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend routine trimming of hair around stoma to edges of pouch adhesive.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hair can be pulled out when the pouch is changed, causing irritation of hair follicles and increasing risk of local infection.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage optimal nutrition.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes wound healing and increases utilization of energy to facilitate tissue repair. Anorexia may be present for several months postoperatively, requiring conscious effort to meet nutritional needs.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss use of acid-ash diet: cranberries, prunes, plums, cereals, rice, peanuts, noodles, cheese, poultry, and fish; avoidance of salt substitutes, sodium bicarbonate, and antacids; and cautious use of products containing calcium.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be useful in acidifying urine to decrease risk of infection and crystal or stone formation. Products containing bicarbonate or calcium potentiate risk of crystal and stone formation, affecting both urinary flow and tissue integrity.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss importance of maintaining normal weight.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes in weight can affect size of stoma and appliance fit. <emphasis>Note:</emphasis> Weight loss of 10 to 20 lb is not uncommon because of intestinal involvement and anorexia.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Stress necessity of increased fluid intake of at least 2 to 3 L/d (or as prescribed) and cranberry juice or ascorbic acid and vitamin C tablets. Explain to client that urine should be pale yellow to almost colorless.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintains urinary output and promotes acidic urine to reduce risk of infection and stone formation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss resumption of presurgery level of activity and possibility of sleep disturbance, anorexia, and loss of interest in usual activities.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client should be able to manage same degree of activity as previously enjoyed and in some cases increase activity level, except for contact sports. &ldquo;Homecoming depression&rdquo; may occur, lasting several months after surgery, requiring patience, support, and ongoing evaluation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage regular activity and exercise program.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Immobility or inactivity increases urinary stasis and calcium shift out of bones, potentiating risk of stone formation and resultant urinary obstruction or infection.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize need for smoking cessation, if indicated. Refer for medication and smoking cessation assistance if client is cooperative.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Smoking cessation is critical to the health of the new bladder, ureters, and kidneys because of the vasoconstrictive, acidic, and carcinogenic effects of smoking.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify signs and symptoms requiring medical evaluation: changes in character, amount, and flow of urine; unusual drainage from wound; fatigue or muscle weakness; anorexia; abdominal distention; and confusion.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Early detection and prompt intervention of developing problems (e.g., UTI, ureteral stricture, intestinal fistula) may prevent more serious complications. Urinary electrolytes, especially chloride, are reabsorbed in the intestinal conduit, which leads to compensatory bicarbonate loss, lowered serum pH or metabolic acidosis, and potassium deficit.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize importance of follow-up appointments.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitors healing and disease process and provides opportunity for discussion of appliance problems, general health, and adaptation to condition.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Identify community resources, such as the United Ostomy Association, local ostomy support group, enterostomal therapist, visiting nurse, and pharmacy or medical supply house.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Continued support after discharge is essential to facilitate the recovery process and client&rsquo;s independence in care. Enterostomal nurse can be very helpful in solving appliance problems and identifying alternatives to meet individual client needs.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0261note0699">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS</emphasis> following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<para><emphasis role="strong">In addition to postsurgical concerns:</emphasis></para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">impaired urinary Elimination</emphasis>&mdash;anatomic diversion</para></listitem>
<listitem><para><emphasis role="bi">situational low Self-Esteem</emphasis>&mdash;loss of or altered control of body function</para></listitem>
<listitem><para><emphasis role="bi">risk for ineffective Health Management</emphasis>&mdash;complexity of therapeutic regimen, perceived barriers</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0008s0266"><title><emphasis role="strong">URINARY STONES (CALCULI)</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology (Chirag et al, 2016; Massini et al, 2014)</emphasis> Urolithiasis is the presence of stones (uroliths/calculi) anywhere in the urinary tract caused by accumulation of solid material (crystals), which is damaging to the lining of the urinary tract and decreases the inhibitor substances that would prevent crystal accumulation.</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Stones most commonly are formed in the kidney and leave the body in the urine stream. There may be a single or multiple calculi, ranging in size from very small (a grain of salt) to the size of a pebble or larger (such as the staghorn calculus, which fills the kidney pelvis, with branches extending into the infundibula and calices).</para></listitem>
<listitem><para>Client may remain asymptomatic until a stone moves into a ureter or urine flow is obstructed, at which time the potential for renal damage is acute and the level of pain is at its highest.</para></listitem>
<listitem><para>Heredity may play a part in hypercalciuria; some familial correlations have been found.</para></listitem>
<listitem><para>Risk factors: The lifetime risk of kidney stones is about 19% in men and 9% in women. In men, the first episode is most likely to occur after age 30, but it can occur earlier (NKF, 2016).</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Formed of mineral deposits&mdash;predominantly calcium oxalate and calcium phosphate. <emphasis>Note:</emphasis> About 75% to 85% of renal calculi are calcium stones. Uric acid (5% to 10%), struvite (5%), and cystine (1%) are also calculus formers.</para></listitem>
<listitem><para>Casual associations have been made with:</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Certain chronic conditions (e.g., cystic fibrosis, inflammatory bowel disease, gout; hyperparathyroidism, hypertension)</para></listitem>
<listitem><para>Systemic dehydration; drinking too little water over time</para></listitem>
<listitem><para>Exercise (too much or too little)</para></listitem>
<listitem><para>Obesity; eating food with too much salt or sugar over time</para></listitem>
<listitem><para>Weight loss surgery</para></listitem>
<listitem><para>Prolonged bedrest or immobility such as with spinal cord injury</para></listitem>
<listitem><para>Excessive intake of vitamins A and D, antacids, aspirin; side effects of some medications, such as acetazolamide (Diamox), Dilantin; certain antibiotics (e.g., ceftriaxone [Rocephin], ciprofloxacin [Cipro])</para></listitem>
<listitem><para>Some geographic locations&mdash;southeastern United States (Wedro, 2017).</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: The prevalence of kidney stones in the United States increased from 3.8% in the late 1970s to 8.8% in the late 2000s. Each year in the United States, more than 500,000 people go to emergency rooms for kidney stone problems (NKF, 2016; National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK], 2015).</para></listitem>
<listitem><para>Mortality: Rare and related to development of acute kidney injury or comorbidities. In 2015, urolithiasis was listed as the underlying cause of death in 498 people in the United States. Of those who died, the sex, race, and age group most affected were women, Caucasians, ages 85+ (CDC, 2015).</para></listitem>
<listitem><para>Cost: In 2009, charges for emergency department visits increased to $5 billion (does not reflect hospitalization or treatment costs). In 1984, the annual estimated financial burden imposed by urinary calculi was $898 million, <emphasis role="bi">rising to $5.3 billion in 2014</emphasis> (Ghani et al, 2014).</para>
</listitem></orderedlist></listitem></orderedlist>
<note id="ch0008s0266note0700">
<title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Calcium oxalate stones:</emphasis> Kidney stones formed by calcium and oxalate crystals, which usually develop in acidic urine.</para>
<para><emphasis role="strong">Calcium phosphate stones:</emphasis> Kidney stones formed by calcium and phosphate crystals, which usually develop in alkaline urine.</para>
<para><emphasis role="strong">Calculi:</emphasis> Stones or concretions, especially in the kidney, gallbladder, or urinary bladder.</para>
<para><emphasis role="strong">Cystine stones:</emphasis> Kidney stones made of cystine crystals.</para>
<para><emphasis role="strong">Extracorporeal shock wave lithotripsy (ESWL):</emphasis> Procedure whereby a shock wave is transmitted through the body to target a stone, thus fragmenting it.</para>
<para><emphasis role="strong">Hematuria:</emphasis> Blood in the urine.</para>
<para><emphasis role="strong">Hypercalciuria:</emphasis> High calcium in the urine&mdash;an inherited condition.</para>
<para><emphasis role="strong">Hyperoxaluria:</emphasis> Excretion of excessive amounts of oxalate in the urine.</para>
<para><emphasis role="strong">Lithotripsy:</emphasis> Procedure that uses <emphasis role="strong">shock waves</emphasis> to break up stones in the kidney, bladder, or ureter.</para>
<para><emphasis role="strong">MET:</emphasis> Medical expulsive therapy: use of medications to shorten the duration of stone passage and increases the likelihood of stone passage. Medications include alpha blockers and calcium channel blockers in combination with NSAIDs.</para>
<para><emphasis role="strong">Pyuria:</emphasis> Pus in the urine.</para>
<para><emphasis role="strong">Renal calyces:</emphasis> The perimeter of the renal pelvis is interrupted by cuplike projections called calyces. A minor calyx surrounds the renal papillae of each pyramid and collects urine from that pyramid. Several minor calyces converge to form a major calyx. From the major calyces, the urine flows into the renal pelvis and from there into the ureter.</para>
<para><emphasis role="strong">Renal colic:</emphasis> Flank (side) pain caused by obstruction to the flow of urine caused by kidney or ureteral stones.</para>
<para><emphasis role="strong">Renal pelvis:</emphasis> The area at the center of the kidney where urine collects and is funneled into the ureter.</para>
<para><emphasis role="strong">Renal tubular acidosis:</emphasis> Condition associated with dehydration, metabolic acidosis, low potassium, and high chloride. Often associated with renal stones due to hypercalciuria (high calcium in urine).</para>
<para><emphasis role="strong">Staghorn calculi:</emphasis> Develops in the center of the kidney or pelvis, filling the entire pelvis and extending out into the calyces.</para>
<para><emphasis role="strong">Stent:</emphasis> Tube inserted into the ureter to bypass a stone or to keep the ureter open so urine flows freely from the kidney to the bladder.</para>
<para><emphasis role="strong">Struvite stone:</emphasis> Also known as magnesium ammonium phosphate&mdash;stones that are often present with infection.</para>
<para><emphasis role="strong">Ureteroscopy:</emphasis> Examination of the upper urinary tract, performed with a flexible ureteroscope passed through the urethra and the bladder, and then directly into the ureter. The procedure is useful in the diagnosis and treatment of kidney stones. Smaller stones in the lower ureter can be removed in one piece, while bigger ones are usually broken before removal.</para>
<para><emphasis role="strong">Ureterovesical junction:</emphasis> Joining of the ureters and bladder: a narrow point where stones can get lodged.</para>
<para><emphasis role="strong">Uric acid stones:</emphasis> Kidney stones made of pure uric acid crystals. These stones develop in acidic urine.</para>
<para><emphasis role="strong">Urolithiasis:</emphasis> A term that refers to the presence of stones in the urinary tract, while nephrolithiasis (nephro = kidney + lithiasis = stone) refers to kidney stones, and ureterolithiasis refers to stones lodged in the ureter (Wedro, 2017).</para>
</note>
<sect2 id="ch0008s0267"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Treatment is often handled at the community level or as an outpatient; acute episodes occasionally require inpatient treatment on a medical or surgical unit. On occasion, surgery is necessary to remove the stone(s).</para>
</sect2>
<sect2 id="ch0008s0268"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0008s0244">Acute kidney injury (acute renal failure)</link></para>
<para>Fluid and electrolyte imbalances (see Davis<emphasis>Plus</emphasis>)</para>
<para>Metabolic acidosis&mdash;primary base bicarbonate deficiency (see Davis<emphasis>Plus</emphasis>)</para>
<para>Metabolic alkalosis&mdash;primary base bicarbonate excess (see Davis<emphasis>Plus</emphasis>)</para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<table frame="top" id="ch0008s0266ta0392"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Dependent on size, location, and etiology of calculi.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC DIVISION<?lb?>MAY REPORT</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Sedentary occupation or occupation in which client is exposed to high environmental temperatures</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Activity restrictions or immobility due to a preexisting condition&mdash;debilitating disease, spinal cord injury&mdash;causing bones to release more calcium</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Elevated blood pressure (BP) and pulse associated with pain, anxiety, or kidney failure</para></listitem>
<listitem><para>Warm, flushed skin, pallor</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ELIMINATION</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Decreased urinary output, bladder fullness</para></listitem>
<listitem><para>Burning, urgency with urination</para></listitem>
<listitem><para>History of recent or chronic urinary tract infection (UTI)</para></listitem>
<listitem><para>Previous kidney stones</para></listitem>
<listitem><para>Diarrhea</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Alterations in voiding pattern</para></listitem>
<listitem><para>Oliguria (retention, scant urine), hematuria, pyuria</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Nausea and vomiting (common)</para></listitem>
<listitem><para>A high-protein, high-sodium, low-calcium diet, which may increase risk of some types of stones</para></listitem>
<listitem><para>Insufficient fluid intake, does not drink fluids well (common)</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Abdominal distention, decreased or absent bowel sounds</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Acute episode of excruciating, colicky pain, with location depending on stone location; in the flank in the region of the costovertebral angle, may radiate to back, abdomen, and down to the groin and genitalia; constant dull pain suggests calculi located in the renal pelvis or calyces</para></listitem>
<listitem><para>May be described as acute, severe, and not relieved by positioning or any other measures</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Guarding, distraction behaviors, self-focusing</para></listitem>
<listitem><para>Tenderness in renal areas on palpation</para></listitem></itemizedlist>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Use of alcohol can contribute to dehydration and to uric acid stone formation.</para></listitem>
<listitem><para>Fever (uncommon)</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Family history of kidney stones, kidney disease, hypertension, gout, chronic UTI, or hereditary disease, such as renal tubular acidosis, cystinuria, hyperoxaluria</para></listitem>
<listitem><para>History of small bowel disease, previous abdominal surgery, hyperparathyroidism</para></listitem>
<listitem><para>Use of antibiotics, antihypertensives, sodium bicarbonate, allopurinol, phosphates, thiazides, excessive intake of calcium or vitamin D</para></listitem>
<listitem><para>Use of herbal remedies for kidney stones, such as valerian, skullcap, wild yam, khella, marshmallow, slippery elm</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May require dietary modifications, exercise program, pain management plan</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0008s0266ta0393"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST<?lb?>WHY IT IS DONE</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum and urine blood urea nitrogen/creatinine (BUN/Cr):</emphasis> Helpful in delineating obstructive uropathy due to urolithiasis.</para>
</listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Blockage of urine flow below the kidneys causes postrenal azotemia (ratio greater than 15:1) without intrinsic renal disease. Abnormal levels&mdash;high in serum and low in urine&mdash;are secondary to high obstructive stones with reduced urine output.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum and urine pH</emphasis></para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May provide insight regarding patient&rsquo;s renal function and type of calculus (e.g., calcium oxalate, uric acid, cystine), respectively.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Complete blood count (CBC):</emphasis> Battery of screening tests, which typically includes hemoglobin (Hb); hematocrit (Hct); RBC count, morphology; and white blood cell (WBC) count and differential.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hgb/Hct&mdash;abnormal if client is severely dehydrated or client is anemic (hemorrhage, kidney dysfunction or failure). RBCs&mdash;usually normal. WBCs&mdash;may be increased, indicating infection.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Blood chemistry:</emphasis> Measures levels of calcium, phosphate, uric acid, sodium, potassium, chloride, bicarbonate, and albumin. If serum calcium levels are elevated, then testing for hyperparathyroidism is performed.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These tests are done if complications associated with kidney stones are suspected or present.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">URINE TESTS</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Urinalysis:</emphasis> Simple screening test may suggest type of stone and presence of infection.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Color may be yellow, dark brown, or bloody. Commonly shows RBCs, WBCs, crystals (cystine, uric acid, calcium oxalate), casts, minerals, bacteria, and pus. The pH may be less than 5.0, which promotes cystine and uric acid stones, or higher than 7.5, which promotes magnesium, struvite, phosphate, or calcium phosphate stones.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Urine (24-hour):</emphasis> Measures urine volume, pH, and levels of calcium, sodium, uric acid, oxalate, citrate, and creatinine.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps identify degree of obstruction and type of stone&mdash;especially important for long-term management in client who is prone to stone formation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Urine culture:</emphasis> Identifies presence of infection and causative agent.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May reveal UTI and identify organism (e.g., <emphasis>Staphylococcus aureus, Proteus, Klebsiella, Pseudomonas</emphasis>) as cause for stone development&mdash;struvite or infection stone.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">OTHER DIAGNOSTIC STUDIES</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Unenhanced renal computed tomography [helical (spiral) CT scan]):</emphasis> Continuous motion image providing detailed views of the kidneys, ureters, and bladder in a shorter period of time.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies and delineates calculi and other masses, as well as kidney, ureteral, and bladder distention. Contrast is not used because it masks the stones. <emphasis>Note:</emphasis> This test has largely replaced IVP as the definitive diagnostic test for stones (Chirag et al, 2016).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Abdominal x-ray of kidneys-ureters-bladder (KUB):</emphasis> Usually ordered to evaluate hematuria flank pain.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess the total stone burden, as well as anatomic changes in the area of the kidneys or along the course of the ureter. May show small stones that can pass unnoticed.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Kidney ultrasound and intrarenal Doppler ultrasound:</emphasis> Determines obstructive changes and location of stone without the risk of kidney failure that can be induced by contrast medium.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ultrasound is used to determine presence of a renal stone, and enlargement of the kidney (hydronephrosis) or ureteral dilation to the kidney. However, small kidney stones that are not obstructing may be missed. Renal Doppler ultrasound improves the detection of early obstruction by evaluating for elevated resistive index (RI) in kidney with nondilated collecting system.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Intravenous urogram (IVU; also known as intravenous pyelogram [IVP]):</emphasis> Kidney x-ray performed by injecting radiopaque contrast into a vein. Multiple pictures of the kidneys are taken to follow the uptake and excretion of the contrast by the kidneys.</para></listitem></itemizedlist>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Provides rapid confirmation of urolithiasis as a cause of abdominal or flank pain. Shows abnormalities in anatomical structures, such as distended ureter, and outline of calculi.</para>
</entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0008s0269"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Alleviate pain.</para></listitem>
<listitem><para>Maintain adequate renal functioning.</para></listitem>
<listitem><para>Prevent complications.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, and treatment needs.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0008s0270"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Pain relieved or controlled.</para></listitem>
<listitem><para>Fluid and electrolyte balance maintained.</para></listitem>
<listitem><para>Complications prevented or minimized.</para></listitem>
<listitem><para>Disease process, prognosis, and therapeutic regimen understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0008s0266note0701">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">acute Pain</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Biological injury agents (e.g., tissue trauma, ureteral contractions, edema formation, cellular ischemia)</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Self-report of intensity and characteristics of pain using a standardized pain scale</para>
<para>Expressive behaviors (e.g., restlessness, moaning)</para>
<para>Self-focus; facial mask of pain (e.g., grimacing)</para>
<para>Guarding behaviors</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Pain Level</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Report pain is relieved, with spasms controlled.</para>
<para>Appear relaxed and able to sleep/rest appropriately.</para>
</note>
<note role="none" id="ch0008s0266note0702">
<table frame="top" id="ch0008s0266ta0394"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Pain Management: Acute</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Document location, duration, intensity (0 to 10 or similar coded scale), and radiation. Note nonverbal signs&mdash;elevated BP, pulse and respirations, moaning and thrashing about.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps evaluate site of obstruction and progress of calculi movement. Flank pain suggests that stones are in the kidney area, upper ureter. Flank pain radiates to back, abdomen, groin, and genitalia because of proximity of nerve plexus and blood vessels supplying these areas. Sudden, severe pain may precipitate apprehension, restlessness, and severe anxiety.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Explain cause of pain and importance of notifying care providers of changes in pain occurrence or characteristics.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides opportunity for timely administration of analgesia and alerts care providers to possibility of passing of stone or developing complications. Sudden cessation of pain usually indicates stone passage.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide such comfort measures as back rub and restful environment.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes relaxation, reduces muscle tension, and enhances coping.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Increase fluid intake to at least 3 to 4 L/d within cardiac tolerance.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Vigorous hydration promotes passing of stone, prevents urinary stasis, and aids in prevention of further stone formation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Apply warm compresses to back.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces muscle tension and may reduce reflex spasms.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist with and encourage use of focused breathing, guided imagery, and diversional activities.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Redirects attention and aids in muscle relaxation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note reports of increased or persistent abdominal pain.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Complete obstruction of ureter can cause perforation and extravasation of urine into perirenal space. This represents an acuter surgical emergency.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Analgesics, including narcotics (e.g., morphine sulfate [Astramorph], butorphanol [Stadol]; combination opioids such as oxycodone and acetaminophen [Percocet]; and NSAIDs such as ketorolac [Toradol], diclofenac [Voltaren], and ibuprofen)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Acute renal colic may be the most painful event a person can endure. Striking without warning, the pain is often described as excruciating, and the client is unable to find a position of comfort. Parenteral narcotics are typically prescribed for acute renal colic and are often required in the early phases of treatment, but NSAIDs are also effective for moderate to severe pain. <emphasis>Note:</emphasis> Opioid and NSAIDs in combination are often more effective than either alone (Chirag et al, 2016).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antispasmodics, such as flavoxate (Urispas) and oxybutynin (Ditropan); calcium channel blockers, such as nifedipine (Adalat); and alpha-adrenergic blockers, such as tamsulosin (Flomax)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreases reflex spasm and relaxes ureteral smooth muscle, which facilitates stone passage. <emphasis>Note:</emphasis> Oral analgesics, NSAIDs, and alpha-adrenergic blockers help facilitate stone passage after acute attack.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain patency of catheters when used.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Prevents urinary stasis or retention, reduces risk of increased renal pressure and infection.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0266note0703">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">impaired urinary Elimination</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Anatomic obstruction</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Dysuria</para>
<para>Urgency; frequency</para>
<para>Retention</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Urinary Elimination</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Void in normal amounts of greater than or equal to 30 mL/hr and usual pattern.</para>
<para>Experience no signs of retention.</para>
</note>
<note role="none" id="ch0008s0266note0704">
<table frame="top" id="ch0008s0266ta0395"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Urinary Elimination Enhancement</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note urine output and characteristics of urine.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information about kidney function and presence of complications (such as infection and dehydration). Bleeding may also indicate increased obstruction or irritation of ureter.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Determine client&rsquo;s normal voiding pattern and note variations.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Calculi may cause urinary tract nerve excitability, which causes sensations of urgent need to void. Frequency and urgency usually increase as calculus nears the ureterovesical junction.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage increased fluid intake to 3 to 4 L/d (if nausea is not present and not contraindicated by cardiac/other disease conditions).</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased hydration dilutes urine and flushes bacteria, blood, and debris and may facilitate stone passage&mdash;especially small stones.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Strain all urine. Document any stones expelled and send to laboratory for analysis.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Retrieval of calculi allows identification of type of stone and influences choice of therapy.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Investigate reports of bladder fullness; palpate for suprapubic distention. Note decreased urine output and presence of periorbital or dependent edema.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Urinary retention may develop, causing bladder, ureteral, and kidney distention, exacerbating pain and potentiating risk of infection and renal failure.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe for changes in mental status, behavior, or level of consciousness (LOC).</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Accumulation of uremic wastes and electrolyte imbalances can be toxic to the central nervous system (CNS).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain patency of indwelling catheters&mdash;ureteral, urethral, or nephrostomy&mdash;when used.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be required to facilitate urine flow, preventing retention and corresponding complications. Catheters are positioned above the stone to promote urethral dilation and stone passage. Continuous or intermittent irrigation can be carried out to flush kidneys and ureters and adjust pH of urine to permit dissolution of stone fragments following lithotripsy.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Acetazolamide (Diamox) and allopurinol (Zyloprim)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increases urine pH (alkalinity) to reduce formation of uric acid stones. Antigout agents such as allopurinol also lower uric acid production and potential of uric acid stone formation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Alpha-adrenergic blockers, for example: tamsulosin (Flomax), terazosin (Hytrin)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although these drugs are designed specifically for prostatic hypertrophy, they have off-label use in treatment of kidney stones as smooth muscle relaxants, which facilitate passage of ureteral stones.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Corticosteroids, such as prednisone (Deltasone)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be used short term to reduce tissue edema to facilitate movement of stones.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Penicillamine (Cuprimine), tiopronin (Thiola), and potassium citrate (Polycitra-K)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Drugs may be prescribed to make urine more alkaline or bind cystine in the urine when cystine stones cannot be controlled.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ammonium chloride and potassium or sodium phosphate</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces phosphate stone formation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antibiotics</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antibiotics may be needed in presence of UTI or to keep urine bacteria-free to prevent struvite stone formation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory studies, for example:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Electrolytes, BUN, and Cr</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevated BUN, Cr, and certain electrolytes indicate presence and degree of kidney dysfunction.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Urine culture and sensitivities</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determines presence of UTI, which may be causing or complicating kidney stone symptoms; determines appropriate antibiotic therapy.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare client for and assist with endoscopic procedures, such as the following:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>For treatment of most kidney stones, shock wave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy have largely replaced open surgery <emphasis>Note:</emphasis> Extracorporeal shock wave lithotripsy (SWL) and ureteroscopy (URS) with endoscopic lithotripsy are both accepted first-line therapies, according to the American Urology Association guidelines on the management of ureteric calculi (Grasso et al, 2016).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Therapeutic ureteroscopy</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Performed with a flexible scope passed through the urethra and the bladder and then directly into the ureter. The most common indication for therapeutic ureteroscopy is to treat upper urinary tract stones, particularly those that are either unsuitable for extracorporeal shock wave lithotripsy (EWSL) or unresponsive to that form of treatment. Smaller stones in the lower ureter can be removed in one piece, while bigger ones are usually broken before removal. A basket procedure is sometimes performed through the scope to retrieve a stone once located in the ureter. Stents are sometimes placed after ureteroscopy, to help prevent ureteric obstruction and pain resulting from ureteral edema or passage of a stone fragment (Grasso et al, 2016; Preminger, 2016).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Shock wave lithotripsy (SWL), also called extracorporeal shock wave lithotripsy (ESWL)</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>SWL is the most frequently used outpatient procedure for treatment of smaller stones in the upper ureters that are not responsive to medical therapies and is effective 60% of the time (NKF, 2009; Preminger, 2016). Stones are pulverized by shock waves delivered from outside the body while client reclines in water bath or on soft cushion. <emphasis>Note:</emphasis> ESWL is not ideal for large stones.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Percutaneous nephrolithotomy (PNL) or open incision stone removal</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>PNL and open surgery are equally effective for the management of renal stones. PNL is a minimally invasive procedure to remove stones from the kidney by means of a small puncture wound through the skin. It is most suitable to remove stones of more than 2 cm in size and that are present near the kidney pelvic region. It is usually done under general anesthesia or spinal anesthesia. Open surgery may be necessary in less than 1% (Preminger, 2016) to remove a stone that is (1) too large to pass through ureters (e.g., &gt;8 mm in diameter), (2) is caught in a difficult place, (3) blocks flow of urine, (4) causes or exacerbates ongoing urinary tract infection (UTI), (5) causes constant bleeding, or (6) is potentially damaging to kidney tissue. One advantage to the open procedure is that stone fragments are removed at surgery rather than relying on natural passage from the kidneys or urinary tract. Client may have a small drainage tube left in kidney or ureters during the healing process.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0266note0705">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">risk for deficient Fluid Volume</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Active fluid volume loss (e.g., nausea, vomiting)</para>
<para>Failure of regulatory mechanisms (e.g., postobstructive diuresis)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Fluid Volume</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain adequate fluid balance as evidenced by vital signs and weight within client&rsquo;s normal range, palpable peripheral pulses, moist mucous membranes, and good skin turgor.</para>
</note>
<note role="none" id="ch0008s0266note0706">
<table frame="top" id="ch0008s0266ta0396"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Fluid/Electrolyte Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor and document I&amp;O, noting 24-hour fluid balance.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Comparing actual and anticipated output may aid in evaluating presence and degree of renal impairment. <emphasis>Note:</emphasis> Impaired kidney functioning and decreased urinary output can actually result in higher circulating volumes with signs and symptoms of heart failure (HF).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Document incidence and note characteristics and frequency of vomiting and diarrhea, as well as accompanying or precipitating events.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nausea or vomiting and diarrhea are commonly associated with renal colic because celiac ganglion serves both kidneys and stomach. Documentation may help rule out other abdominal occurrences as a cause for pain or pinpoint calculi.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increase fluid intake to 3 to 4 L/d within cardiac tolerance.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintains fluid balance for homeostasis and &ldquo;washing&rdquo; action that may flush the stone(s) out. <emphasis>Note:</emphasis> Patients with recurrent kidney stones traditionally have been instructed to drink enough fluid to decrease chance of urinary supersaturation with stone-forming salts. The goal is a total urine volume in 24 hours in excess of 2 liters (Chirag et al, 2016).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor vital signs. Evaluate pulses, capillary refill, skin turgor, and mucous membranes.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicators of hydration and circulating volume and need for intervention.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Weigh daily.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Rapid weight changes suggest water loss or retention.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor Hgb/Hct and electrolytes.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assesses hydration and effectiveness of, or need for, interventions.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer IV fluids.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintains circulating volume if oral intake is insufficient, promoting renal function.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide appropriate diet, clear liquids, and bland foods, as tolerated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Easily digested foods decrease gastrointestinal (GI) activity or irritation and help improve fluid and nutritional balance.</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer medications, as indicated, for example, antiemetics, such as metoclopramide (Reglan), ondansetron (Zofran), promethazine (Phenergan), or droperidol (Inapsine).</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Reduces nausea and vomiting.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0266note0707">
<title><emphasis role="strong">NURSING DIAGNOSIS:</emphasis>&nbsp;<emphasis role="strong">deficient Knowledge regarding condition, prognosis, treatment, self-care, and discharge needs</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient information or interest in learning</para>
<para>Insufficient knowledge of resources</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Insufficient knowledge</para>
<para>Inaccurate follow-through of instructions or performance of a procedure</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Acute Illness Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of disease process and potential complications.</para>
<para>Correlate symptoms with causative factors.</para>
<para>Verbalize understanding of therapeutic needs.</para>
<para>Initiate necessary lifestyle changes and participate in treatment regimen.</para>
</note>
<note role="none" id="ch0008s0266note0708">
<table frame="top" id="ch0008s0266ta0397"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para>
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review disease process and future expectations.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides knowledge base from which client can make informed choices.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Emphasize importance of increased fluid intake (including water, coffee, milk), roughly 3 to 4 L/d if not contraindicated. Encourage client to notice dry mouth and excessive diuresis or diaphoresis and to increase fluid intake whether or not feeling thirsty.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Water is essential for stone formers as it significantly reduces calcium oxalate and calcium phosphate saturation, and uric acid production. Water also flushes renal system, decreasing opportunity for urinary stasis and stone formation. Research has shown that other fluids taken in sufficient volume (such as coffee [diuretic effect] and milk [raises urinary volume, meets calcium dietary reference intake (DRI), and chelates oxalate in foods and beverages]) are also beneficial in reducing stone formation (Goldfarb et al, 2005). Increased fluid losses or dehydration require additional intake beyond usual daily needs.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review dietary regimen, as individually appropriate, for example:</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Diet may or may not be an issue. However, understanding reason for modifications provides opportunity for client to make informed choices, increases cooperation with regimen, and may prevent recurrence.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoid excess salt and protein. Advise that client discuss with physician or nutritionist specific recommendations for protein and animal fat.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>If a person is susceptible to forming stones, then foods high in animal proteins and salt may increase the risk; however, if a person isn&rsquo;t susceptible to forming stones, diet probably will not change that risk. There is lack of consensus among clinicians concerning how little or how much protein affects stone formation, because studies have not produced sufficient evidence one way or another. Some clinicians have concluded that eating amounts of protein near the DRI does not increase risk of stone formation or recurrence, even if protein is from animal sources. Others are concerned that consuming meat increases renal acid load and may cause supersaturation of calcium, phosphate, and uric acid (Massini et al, 2014).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Low-oxalate diet, such as limited chocolate, beets, nuts, rhubarb, strawberries, spinach, and wheat bran</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces calcium-oxalate stone formation. <emphasis>Note:</emphasis> Research suggests that daily inclusion of coffee, beer, or wine decreases the risk of stone formation, whereas regular intake of apple or grapefruit juice increases the risk (Finkelstein &amp; Goldfarb, 2006; Massini et al, 2014).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoid very high (&gt;2500 mg/d) or very low (&lt;500 mg/d) total intake of calcium and aim for the dietary reference intake (DRI) of 800 to 1000 mg/d. Use calcium citrate when supplements are required.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Research suggests that restricting dietary calcium is not helpful in reducing calcium stone formation and may actually increase oxalate stone formation (Ross et al, 2011). Use of citrate (such as in Diet 7Up, Sprite Zero, diet ginger ale) is protective against kidney stones by binding oxalate and improving calcium utilization (Eisner et al, 2010).</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Shorr regimen: low-calcium and phosphorus diet with aluminum carbonate gel 30 to 40 mL 30 minutes after meals and at bedtime.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents phosphoric calculi by forming an insoluble precipitate in the GI tract, reducing the load to the kidney nephrons. Also effective against other forms of calcium calculi. <emphasis>Note:</emphasis> May cause constipation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage foods rich in magnesium and vitamins B and K.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These nutrients reduce stone formation.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss medication and herbal supplement regimen, avoidance of over-the-counter (OTC) drugs, and reading all product and food ingredient labels.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Drugs may be given to acidify or alkalize urine, depending on underlying cause of stone formation. Ingestion of products containing individually contraindicated ingredients, such as calcium and phosphorus, potentiates recurrence of stones. <emphasis>Note:</emphasis> Some herbal supplements&mdash;valerian, skullcap, wild yam, khella, and marshmallow&mdash;are known to have antispasmodic properties or are soothing to irritated urinary tissues.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage client to reveal all medications and herbals to physician or pharmacist.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>To reduce risk of dangerous interactions and side effects.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Emphasize need for smoking cessation, when indicated.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cigarette smoking may contribute to kidney stones because it increases urine levels of cadmium, a heavy metal.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage regular activity and exercise program.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inactivity contributes to stone formation through calcium shifts and urinary stasis.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Active-listen to concerns about therapeutic regimen and lifestyle changes.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps client work through feelings and gain a sense of control over what is happening.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify signs and symptoms requiring medical evaluation, such as recurrent pain, hematuria, and oliguria.</para>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>With increased probability of stone recurrence, prompt interventions may prevent serious complications, including heightened risk of end-stage renal disease. Rate of recurrence at 1 year is 14%; at 2 years, 35%; and at 10 years, 52% (Chirag et al, 2016). <emphasis>Note:</emphasis> A recent study reported that in recurrent stone formers, there is elevated risk for both chronic kidney disease and all-cause mortality, most likely the result of repeated, transient reductions in kidney function that accompany each episode of kidney stone formation (Haley et al, 2016).</para>
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Demonstrate proper care of incisions or catheters if present.</para>
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Promotes competent self-care and independence.</para>
</entry></row></tbody></tgroup></table></note>
<note id="ch0008s0266note0709">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS</emphasis> following acute hospitalizations (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">impaired urinary Elimination</emphasis>&mdash;recurrence of calculi</para></listitem></itemizedlist>
</note>
</sect2></sect1></chapter>